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ABSTRACT
Operant behaviour techniques were used to show that rats have
a preferred paw and to support the existence of a motor function plus
another function of DA in the nigro-striatal pathway. Other lesions to
motor systems in the brain (neurotoxic lesions of the striatum and
electrolytic lesions of the striato-nigral pathway in the crus cerebri),
will mimic the motor effects of a unilateral 6-OHDA lesion on paw use,
but not its effects on performance. Similarly, peripheral paralysis of
the preferred forelimb results in a change in paw use, with no perform¬
ance deficit. Training rats to use the "other" paw does not result in
a performance deficit. However, it is possible the 6-OHDA induced
deficit in performance results from depletion of limbic DA which is
affected by the 6-OHDA injection, but not the other lesions. The 6-
OHDA specific component may be involved in the motivation for or
initiation of movements.
Electrophysiological evidence is presented suggesting the existence of
two mechanisms controlling the activity of DA cells. One involves the
striato-nigral pathway and the other involves the release of DA from the
dendrites in the SN. Evidence for this comes mainly from experiments
showing that the effects of haloperidol and picrotoxin on cell firing rate
are additive. Antidromic and orthodromic effects on the activity of DA
cells resulting from striatal stimulation resulted in complex sequences of
events. Lesions of the striato-nigral pathway seemed to have little
effect on the results of striatal stimulation and so it has been suggested
that all the observed effects may in fact not be mediated by the striato-
nigral pathway, but by some other means. The lesions do cause an increase
in the spontaneous firing rate of the DA cells, attributed to a removal of
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The nigro-striatal dopamine (DA) system, originating in the pars
compacta of the substantia nigra (SNC), has been the subject of in¬
tensive study for the past few decades (150,151,481). It is thought
to be of real importance in the integration of the sensory motor
functioning of an animal. The key position of the pathway in relation
to other brain areas related to sensory pathways and motor control
supports such a role, as does the behavioural evidence resulting from
interference with the system. The nigro-striatal pathway and its
target nucleus the striatum are also of importance in several clinical
disorders - such as Parkinson's Disease and Tardive Dyskinesia,
therefore the system is of interest to medicine. The nigro-striatal DA
system may also have a role in mediating the reward value of certain
stimuli.
Two aspects of the nigro-striatal system have been investigated
in this thesis. The first of these, described in Chapter III, studies
the system at the level of the whole animal. Here the components of a
behavioural deficit caused by 6-hydroxydopamine (6-OHDA) injected
into the nigro-striatal path are dissected using operant behaviour
techniques. The second, described in Chapter IV, looks at the
functioning of the DA neurons at a cellular level, using electrophysio¬
logical methods. The effects of lesions of the striato-nigral pathway
and of some dopaminergic and GABA-ergic drugs are studied on the
spontaneous firing of these neurones and in response to striatal
stimulation.
This chapter will consider the anatomical position of the system
within the brain. The more specific background material for Chapters
III and IV is dealt with at the start of each of these chapters. Overlap
2.
between this chapter and these has been kept to a minimum, but for
the sake of clarity some has been unavoidable.
General methods used in both Chapters III and IV are dealt
with in Chapter II but, again, those used specifically in one of these
chapters only are covered in the relevant chapter. Also the results
from each section are discussed in that section, but a final general
conclusion is given in Chapter V.
From the details given in the rest of this chapter, it is clear
that the connections of the substantia nigra (SN) and the striatum are
extremely complex. As there are also numerous connections between
the regions that the SN and striatum project to and receive afferents
from (see review by Dray, 151, for details), it is difficult to envisage
how the nuclei interact in their functioning.
The large degree of topography in the projections is worth noting.
It is this that enables the system to co-ordinate movements of all parts
of the body. Also the frequency of reciprocal connections is interest¬
ing. The reason for this is not entirely clear but it must be related to
the control of the activity of the projections.
Connections exist that would allow interaction between the SN
and the striatum and the relay nuclei in the thalamus and the sensory-
motor processing area in the cortex. Connections also exist that allow
the flow of information between the extrapyramidal motor system and the
limbic system. These may be involved in the emotional control of
movement. Areas of cortex other than the sensorimotor cortex also
project to the striatum. These may be involved in the process of turning
thought into action and in the responses to various environmental and
internal stimuli.
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Due to the complexity of the interconnections, it is difficult to
analyse the systems in relation to their function as far as the whole
animal is concerned, and so not much is known about what each system
does in the behaviour of the animal.
There now follows an anatomical review of the systems related to
the SN and the striatum. These are summarised in Figures 1 and 2 at
the end of Section 1.5.
1.2 Interrelations between the substantia nigra and the striatum
The substantia nigra
The SN was so named because of the dark pigment seen in the
nucleus in primates. This pigment is not seen in other groups of
animals. It is situated bilaterally in the midbrain, between the cerebral
peduncles and the tegmentum. The nucleus is divided into three parts:
the pars compacta (SNC), the pars reticulata (SNR) and the pars
lateralis (SNL) (194,248,255,305,501,541). The SNR lies beneath the
SNC and is larger. It has less densely packed, but more highly
organised cells, which are large, medium or small in size. The SNC
lies dorsal to the SNR and is relatively rich in cells, which are mostly
medium or small in size (305). The SNL has been relatively little studied
in its own right, although it is phylogenetically the oldest part of the
nucleus. It is an elliptical mass of cells lateral to the SNR and SNC
(255,305) and has a similar cytological structure to the rest of the
nucleus. It forms connections with the SNR through the dendrites of
medium and large cells. The actual size of these cells depends to some
extent on the particular study and on the species. It seems that in the
cat the smallest cells are about 19 urn in diameter and in the rat they are
about 8 urn. The largest cells in the cat are of the order of 74 urn and
in the rat, 40 urn (248,255,305).
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The smaller cells presumed to be interneurones are present in all
the three areas (194,246,305,541).
The cells of the SNC send aspiny dendrites into the SNR,, whereas
the dendrites of the SNR tend to stay within the SNR, but extend
throughout it. From this it can be seen that there is extensive overlap
between the SNC and the SNR (541).
Recent anatomical studies have suggested that the SNR may be
further split into two layers (305). One region is just below the SNC
and contains the dendrites of the SNC cells. These dendrites run
dorsoventrally and rostrocaudally. The other region is below this and
is next to the peduncle. The dendrites in this region run parallel to
the peduncle.
The largest number of synapses in the SN are on the dendrites
in the SNR and relatively few are on the soma in either division of the
nucleus (501). Many "en passage" synapses are seen allowing several
points of connection with the same dendrite. As well as axo-dendritic
and axosomatic synapses, axoaxonic synapses are also seen on the
axon hillock or terminals of other cells (240,247).
The striatum
The striatum, situated in the telencephalon, consists of the
caudate nucleus and the putamen, separated in primates by the internal
capsule. It is the largest of the basal ganglia (see reviews by
Carpenter, 67, and Niewenhuys, 429, and Fox and Rafols, 192). It
has in the past been considered as a homogeneous entity with respect
to cellular organisation, the caudate nucleus and the putamen having
the same, densely packed cells, with no special arrangement (326).
However, some groupings of cells and synapses can be seen within the
structures forming various shapes (325,396,529,586). Using certain
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treatments, patterns can be seen. For example, when stained for
acetylcholinesterase mosaic-like patterns can be seen (238,272). It
is likely that these patterns are related to the topographic inputs from
other brain areas (229,520).
Fibres within the striatum are generally fine (0.3-1.6 urn) and
poorly myelinated. Intrinsic and other fibres form a close-packed
network around the cells in the nucleus. The cells can simply be
divided into two groups - small, pale cells, with larger multipolar
cells scattered through them. However, Golgi staining suggests a
further division into spiny and aspiny neurones, in as many as six
groups ( 145,258,325). The spiny types of cells may constitute as
many as 95% of the cells. Originally these were thought only to have
short axons not projecting out of the striatum (325) but it is now known
that 50% or even as much as 60-70% of the cells do project out of the
striatum (46,55,145,239) and that at least some of the medium-sized
spiny neurones do project to the SN (556,558,559). It is possible
that the Golgi method failed to demonstrate the fine axons of these cells.
There appears to be two types of aspiny neurone (326). One is
large with myelinated axons projecting out of the striatum and was
originally thought to be the output neurones,having collaterals in the
striatum. The other type is smaller and has smooth radiating dendrites
leading to their name: spidery cells. Axons from these cells could not
be seen in the Golgi preparation.
Synapses are seen making contacts between axons and soma and
dendritic shafts, spines or the initial segments of other axons (258).




Early studies using retrograde degeneration techniques have
suggested the existence of a nigro-striatal pathway (28,70,265,276,339,
513,597), despite the fact that other studies using the Nauta method
(415) have failed to do so (4,71,172). Some of these have suggested
a nigro-pallidal system (68,338,399) and the difference may arise from
methodological problems.
However, more recent studies have confirmed the existence of the
pathway. Injection of anterogradely transported radiolabeled amino
acids into the SNC shows the presence of radioactivity in autoradio-
graphs of the neostriatum and hence supports the existence of a
nigrostriatal pathway. Similarly, the injection of retrogradely transported
proteins [e.g. horse radish peroxidase (HRP) or tetanus toxin] into the
neostriatum leads to the labelling of cells in the SNC, indicating that
axons travel from there to the injection site in the striatum.
From lesions at various sites in the pathway, a route for the
fibres has been worked out. The fibres leave the SNC, pass through
the ventral tegmental area and gather in the lateral hypothalamus, just
medial and dorsal to the ventral tip of the crus cerebri (the medial
forebrain bundle, MFB). Then, at the level of the median eminence, it
enters the ventral crus cerebri and travels rostrally and dorsally in
the internal capsule to innervate the neostriatum (12,193,456,471,597).
From electron microscope work it seems that the terminals of the
SNC DA cells terminate on the dendritic spines and cell bodies of spiny
neurones and the cell bodies of spidery neurones in the striatum (274,
322,405).
Morphologically in rats the projection appears to be uniform to
all of the striatum (122,322) but in some systems, for example the adult
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rat treated with alpha-methyl paratyrosine (450) and the developing
cat (237,238), there appear to be islands of dopamine as shown by
fluorescence histochemistry. These islands have also been seen in
autoradiographic studies looking at the input from the SN (638). The
islands may be functionally significant in relation to other transmitter
systems.
From selective lesion studies, the general topography seems to be
mediolateral and anteroposterior, that is medioanterior sites in the
SNC project to ventral and anterior sites in the striatum and lateral
and posterior sites project to posterior striatum. There is also an
inverse dorso-ventral relationship (28,70,166,250,582,591).
The information from these studies is supported by work on the
transmitter involved. DA has been confirmed as the transmitter in the
nigro-striatal pathway by biochemical, fluorescence and electrophysio¬
logical work. DA levels fall in the neostriatum after lesions of the
SNC (16,173,265,471,537) often in proportion to the extent of the
lesion (268,404,470). Fluorescence histochemistry has shown the
presence of DA in the SNC cell bodies (122) and in the striatum (12)
which disappears on lesioning the nigro-striatal pathway (268,365,591).
Electron microscope studies have even shown that DA is contained in
the terminals and that the type of terminal containing DA falls in number
after lesions of the SNC (202,274). Stimulation of the SNC results in
the release of DA in the neostriatum (16,325,423) and causes changes
in cell firing that can be mimicked, at least in some cases, by the
iontophoretic application of DA (92,93), and is blocked by DA antagonists
(177,469,550).
Some recent work has suggested the possibility that the SNC is
divided into two layers. A ventral layer has large pyramidal cells,
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with varicose dendrites reaching into the SNR. This ventral layer
of the SNC has a mediolateral and antero-posterior topography in the
ipsilateral striatum. The dorsal layer consists of fusiform cells, whose
dendrites stay within the SNC and whose axons project to the olfactory
tubercle and amygdala (167).
A sparse contralateral projection to the striatum from the SN has
also been proposed. Evidence for this comes from studies with the
retrograde transport of dyes in rats and cats (171,521).
There is also the suggestion that not all the cells are dopaminergic.
Studies using 6-OHDA lesions which specifically destroy DA cells
combined with fluorescence studies using retrogradely transported
dyes and immunohistochemistry have suggested that as much as 20% of
the projection may be non-DA (265,369), although it may be as little
as 5% (251,602,606). The 20% value comes from lesion studies combined
with fluorescence and the 5% from retrograde labelling combined with
fluorescence. This methodological difference may account for the
differences in value.
It has been suggested that these non-DA nigro-striatal cells may
take a different route than the DA ones (267) and that their origin may
be in the SNR. These could be collaterals from other nigral efferents
such as the nigro-thalamic ones (254).
The striato-nigra! pathway
A striato-nigral pathway had been described several times during
the first half of this century (454,523,609,630), but had not been
described in detail until the 1960's with the work of Voneida (611) and
Szabo (579,580,581). These studies used degeneration methods to
demonstrate the existence and topography of this pathway. The head
of the caudate nucleus projects to the rostral third of the substantia
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nigra with a mediolateral correspondence. The putamen projects to the
caudal two-thirds of the substantia nigra, dorsal parts going to lateral
SN and ventral parts to medial SN. In the rat there is also an antero¬
posterior topography, with the tail of the striatum going to the more
lateral parts. The early studies mentioned above, in the cat and monkey,
along with others (240,323,541) showed all afferents ending in the SNR
although it appears that in the rodent the whole SN is innervated
(both the SNC and SNR) (55,87,620). This topography was later
confirmed by biochemical and immunohistochemical techniques (591).
Both axosomatic and axodendritic synapses exist, but the axodendritic
ones are more common in cats (259) and in the rat the axosomatic type
is more common (252).
The striato-nigral path is one of the two largest output pathways
from the striatum (the other being the striato-pallidal system). Both
of these were at first thought to originate from only 5% of the striatal
cells (192,326) but recent work has suggested that far more cells do
project out of the striatum, possibly as many as 30-50% (23,55,239,309,
345) or even as much as 70% (46). The low values were obtained with
Golgi staining and this may not have shown the full length of the axons.
The later studies used the retrograde transport of dyes to the striatum
from the target nuclei of the striatal output and have been able to show
projections out of the striatum.
A significant proportion of the cells projecting to the SN are the
medium-sized spiny neurones (23,345,559) once thought to be inter-
neurones .
The fibres leave the striatum and pass through the globus
pallidus to enter the internal capsule in which they travel through
the midbrain tegmentum to the SN which they enter from the ventral side.
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Two candidates have been proposed as transmitters in the striato-
nigral pathway: an inhibitory one and an excitatory one. The former
is probably gamma-amino-butyric acid (GABA) and the other may be
substance P (SP).
There is strong evidence for the inhibitory transmitter being
GABA. The SN has one of the highest concentrations of this compound
in the central nervous system (164,165,336,442), which along with the
existence of glutamic acid decarboxylase (GAD), the synthesising
enzyme, in the terminals in the area (190,497) is good support for a
transmitter role for GABA.
Lesions of the striatum, or the striato-nigral pathway lead to a
drop of GABA and GAD in the SN (190,262,312,389). Also electrical
and K+ stimulation of SN slices will release GABA by a Ca++ dependent
process (441,494), and a reuptake mechanism for GABA exists in the
SN (441,574). In vivo stimulation studies where the striatum is
stimulated show an increased release of GABA in the SN (346,578)
and an increased rate of loss of prelabelled GABA after inhibition of
GAD (33,376). Striatal stimulation also leads to a decrease in the cell
firing rate or inhibitory evoked potentials in the SN (650) and this can
be blocked with bicuculline or picrotoxin, both thought to be GABA
antagonists (87,111,153,651). These drugs also affect the responses to
iontophoretic GABA (111). Tetanus toxin, an agent thought to block
the presynaptic release of GABA in the central nervous system blocks
the effects of striatal stimulation on the SN cells but not the effects of
iontophoretic GABA (125).
All the above pieces of evidence support the existence of GABA
as the inhibitory transmitter in the striato-nigral pathway.
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As well as GABA of striatal origin in the SN there is also other
GABA ( 190,262,313,411,574). Some of this may be from the globus
pallidus and some of it may be intrinsic or from other GABA ergic
output cells (156,411).
The evidence for the excitatory transmitter is not as good. It
does not seem to be an excitatory amino acid or acetylcholine as alpha-
amino adipate (86) or atropine (310) do not seem to block the effects of
striatal stimulation. The best candidate is SP (156). Like GABA the
levels of SP are extremely high in the SN (51,86,117,210,404,473),
mostly in the rostral SNC and caudal SNR where it would be closest
to the DA cells and dendrites (119,370). Monoclonal antibody studies
have shown that SP is contained in terminals in the SN and that these
synapse mainly on dendritic processes (116).
SP also has a synaptic localisation in subcellular fractions of SN
homogenates (117,158,430,494). It can also be released from the SN
on stimulation (295).
SP applied iontophoretically will excite the SN cells, both in the
SNC and SNR (87,123,468,615), however, a SP antagonist has not yet
been developed to blockthis pharmacologically, and to compare this with
the effect on striatal stimulation. One compound, Lioresa), was thought to
be a specific antagonist (525) but was later shown to be non-specific
(123). Lesions of the striato-nigral path reduce the amount of SP in
the SN especially the more anterior lesions in striatum (277,296,308,
407,458).
All these facts also support a role for SP as a transmitter in the
striato-nigral pathway. Lesion studies show that the two transmitters
exist in different neurones, as anterior lesions reduce SP levels far
more than they reduce GABA levels (51,117,204), suggesting an anterior
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localisation for SP and a more caudal one for GABA (412) although GABA
does exist throughout the striatum. This distribution has been
confirmed using KA, to specifically kill cell bodies, rather than
electrolytic lesions (204) and is also supported by immunological studies
(308).
The striato-pallidal and pallido-nigral pathways
The second main output from the striatum is the striato-pallidal
pathway (75,192,296,323) and in fact this seems to be even larger
than the striato-nigral one (598,608). Along with the striato-nigral
projection this pathway was supposed to originate from only 5% of the
striatal cells, but recent work has shown that this figure is in fact
much higher (46,55,239).
The projection is topographic to both segments of the globus
pallidus, projecting like the spokes of a wheel with the head of the
caudate nucleus going to the dorsal and rostral pallidus and the putamen
going to the ventral and caudal pallidus (454). In the monkey the
lateral cuadate goes to the external pallidal segment and the medial
caudate to the internal one (579). The dorsal putamen projects to be
dorsomedial pallidus and the ventral putamen to ventral pallidus (580).
The body of the caudate goes to the dorsomedial third of the globus
pallidus with an anteroposterior and mediolateral topography (581).
In cats, stimulation of the caudate nucleus leads predominately
to an inhibition in the entopeduncular nucleus (equivalent to the
internal segment of the primate globus pallidus), with a few excitatory
responses (375,480,652,653). From stimulation studies it has been
suggested that the inhibitory responses may in part come from collaterals
of the striato-nigral GABA cells as they pass through this nucleus (192,
314,652,653). The inhibitory transmitter is most likely to be GABA,
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especially if the fibres are collaterals of the striato-nigral fibres (438,
498). Only GABA mimicked the effect of caudate stimulation on the
pallidal cells (438).
The excitatory transmitter may be a peptide as in the striato-
nigral pathway. Recent work using lesions combined with immuno-
cytochemistry has shown the possible existence of a leu-enkephalin
pathway from the striatum to the globus pallidus of rats (116,120).
A pathway also goes from the globus pallidus to the SN (296)
although positive confirmation of this was more difficult than for the
striato-nigral pathway due to the fact that the striato-nigral fibres
pass through this region and any effects in SN could be attributed
to lesions of these.
Early studies did suggest the existence of such a pathway using
degeneration techniques, but these were inconclusive because of the
problem of lesioning the striato-nigral fibres as well (190,300,389,417,
496). Stimulation studies have the same problems as the lesioning ones,
in that there are inevitably complications from the activation of the
striato-nigral fibres.
Confirmation of the existence of the pathway had to wait until the
development of retrograde tracing techniques. These have shown that
such a pathway does exist (55,73,239,296). GABA is also indicated as
the transmitter in this pathway from immunocytochemical work, combined
with lesions (296,496,498). There may also be an excitatory transmitter
in this pathway, and this is likely to be SP as SP immunoreactive cells
have been seen in the globus pallidus (308).
It has been suggested that the pallido-nigral cells may be innervated
by the DA cells from the SNC (260,366), possibly by collaterals from the
nigro-striatal pathway (653).
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1.3 Afferent connections of the substantia nigra
The most important input to the SN comes from the ipsilateral
striatum and globus pallidus (see Section 1.2), but the SN does also
receive several other inputs, including those from raphe nuclei,
possibly the cortex, subthalamic nucleus, the locus coeruleus, the
cerebellum, the nucleus accumbens and the reticular formation.
The raphe-nigral pathway
The projection from the raphe nuclei appears to have a medio-
lateral topography, and to come from both the median and dorsal raphe
nuclei (MRN and DRN) (45,55,94,122,152,154,464). However, some
studies with retrograde tracing techniques have failed to show the
projection from the MRN (55,182). Many of the fibres from the DRN
are collaterals of the projection from the DRN to the striatum (605).
The effect of the raphe-nigral projection on SN neurones appears
to be mainly inhibitory (152,154) and is monosynaptic in nature (152).
Some excitatory responses from intracellular studies have also been
reported (312), and it has been suggested that the inhibitions seen in
extracellular studies are due to polysnaptic mechanisms (312). This is
certainly conceivable in view of the collaterals to the striatum.
The transmitter in this path is likely to be 5-hydroxytryptamine
(5-HT). Autoradiography with^-S-HT has demonstrated the pathway
(575) and fluorescence studies have shown the presence of 5-HT in the
raphe nuclei (122,591). Lesions of the raphe nuclei lead to decreases
in the levels of 5-HT and in uptake of 5-HT in the SN (453,493).
Iontophoresis of 5-HT onto the cells in the SNC has little effect,
but it will consistantly block the excitatory effects of glutamate (7).
The effect on the SNR cells is variable, resulting in inhibitions,
excitations and no effect (7).
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One study suggests that the projection is densest to the SNC
(152), while another appears to show a greater projection to the
SNR (493). The discrepancies are probably due to the fact that the
fibres pass through the SNR on their way to the SNC and some studies
might be detecting these. Also the dendrites of the SNC cells go into
the SNR and so synapses in this area could affect the DA cells in the
SNC.
The cortico-nigral pathway
This pathway was first suggested on the evidence from early
degeneration studies (398,609), but its existence was later questioned
by improved silver staining techniques, which suggested the degenera¬
tion seen was due to fibres of passage in the SN (3,503). However,
recently improved methods have again raised the question of the
existence of a small cortico-nigral path. Retrograde tracing techniques
have suggested the existence of a small projection (55) and degeneration
studies using electron microscopy have shown degenerating terminals
in the SNC and SNL (3,499), and only a few in the SNR.
Electrophysiology has shown variable latency excitations, with
either single spike responses or occasionally 2-4 spikes in response to
cortical stimulation (232). However, it is possible that it is a poly¬
synaptic pathway (232). One possibility is via the subthalamus. This
nucleus is excited by cortical stimulation and does send projections to
the SN as can be shown by antidromic driving (137).
The possible transmitter is not known, but it might be glutamate
in view of the fact that KA lesions of the frontal cortex reduce glutamate
uptake in the SN (72).
16.
Other nigral afferents
Other relatively minor and unstudied projections to the SN
come from the subthalamic nucleus, the locus coeruleus, the cerebellum,
the nucleus accumbens and the reticular formation.
HRP studies have shown an input to the SN from the subthalamic
nucleus (308), with possibly as many as 90% of the fibres sending
axon collaterals to the globus pallidus or the entopeduncular nucleus
(134,264,604). Electrophysiology shows that the pathway is excitatory
(254). It has also been suggested that the subthalamic nucleus is
a continuation of the DA cells of the SNC (395).
The pathway from the locus coeruleus has not been demonstrated
by anatomical means but has been inferred from other types of experi¬
ment. Noradrenaline (NA) is present in the SN (168), and nigral cells
will respond to iontophoretic application of NA with either excitations
or inhibitions (112,156). NA uptake in slices of SN is Ca++ dependent
suggesting a transmitter role and it can also be released by K + . On
stimulation of the locus coeruleus, an excitation followed by an inhibition
is seen in the SNC (88).
The cerebellar afferents come from the contralateral cerebeller
nuclei and have been demonstrated by HRP in conjunction with silver
impregnation (555). Stimulation of the cerebellar nucleus results in
the decrease of DA from the SN dendrites (426) by an as yet unknown
mechanism.
The projection from the nucleus accumbens to the SN is ipsilateral
and projects topographically onto both the SNC and SNR (95,418,474,
577,626), and is apparently monosynaptic (557). Stimulation of the
nucleus results in mixed excitatory and inhibitory responses in the SN
(155,201). The response is blocked by bicuculline (201), suggesting
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that the transmitter may be GABA, although lesions have been reported
not to decrease levels of GAD in the SN (155). This could, however,
be due to a masking effect of the large amount of GABA from other
sources in the SN.
Connections from the midbrain reticular formation to the SN have
been shown by electrophysiological methods (455). The input is
thought to be excitatory (455). Cells have also been antidromically
activated from the SN (647). Little else is known.
1.4 Efferent connections of the substantia nigra
The main projections from the SN go to the striatum (see Section
1.2), the thalamus and the brainstem, but other projections exist to
the amygdala, the cerebellum, locus coeruleus, raphe nuclei, cortex
and possibly spinal cord.
The nigro-thalamic pathway
The nigro-thalamic pathway seems to come exclusively from the
SNR (67,69,70,73,83,174,183,272,500), more specifically a longitudinal
band of cells in central and' lateral SN (174). It projects to the VA/VL
(VM in rats) thalamus and also to the dorsomedial thalamus. Some of
the cells also give off collaterals to the striatum or the superior colliculus.
This is demonstrated both by stimulation studies (13,136,196) and by
double retrograde labelling (32,568,569). There also appear to be short
axon collaterals, arborising within the SN, sometimes not outwith the
dendritic field of the parent cell (133). There may be a few bilateral
fibres (637).
The pathway is inhibitory and monosynaptic to the thalamic cells
(13,138,250,254,589) but again excitations as well as inhibitions have
been reported on SN stimulation. However, it seems likely that the
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excitations result from activation of cortico-thalamic fibres passing
near to or through the SN, as the short latency excitation disappears if
the cortex is lesioned (138).
The transmitter in the pathway is most likely to be GABA.
Lesions of the SN lead to a decrease in GAD in the thalamus (143,
335) and GABA antagonists block the inhibition caused by SN stimula¬
tion (393,649).
Nigral connections with the brainstem
Degeneration and tracing techniques have shown the existence
of a pathway from the SN to the midbrain reticular formation (278,
502,636), the tectum (deep layers of the superior colliculus) (174,236,
278,290,502,636) and the periaquaductal grey (276,290). This
projection also seems to be exclusively from the SNR, from a longitud¬
inal ventral band (174) and the projection to the superior colliculus
is bilateral (135,636,637), with some cells projecting both ipsilaterally
and bilaterally (135). The medial superior colliculus receives a
bilateral input, whereas the lateral portion receives only ipsilateral
innervation from the SN (135,290).
Some nigro-tectal cells also send collaterals to the thalamus
(13,32,569).
The effect of nigral stimulation is inniDition of the brainstem
neurones with a few reported excitations (647). As with the nigro-
thalamic path the excitations are likely to be from activation of cortico-
fugal fibres (80,647). The transmitter is probably GABA. Iontophoretic
GABA mimics the effects of nigral stimulation on the superior colliculus
cells (81) and GAD levels fall in the superior colliculus on lesioning
the SN (610).
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Similarly, the nigro-reticular path is inhibitory and monosynaptic,
with excitations resulting from the activation of corticofugal fibres in
the SN (231,455).
Other nigral efferents
The SN also sends efferents to the cerebellum (see review by
Dray, 151), the amygdala, the locus coeruleus, possibly the spinal
cord, the cortex and the raphe nuclei.
The projection to the amygdala appears to come from the SNC
(167) and as DA inhibits cell firing in the basolateral amygdala, this
may be the transmitter (29). The projection goes to the lateral and
central amygdala (167,306,307).
The path to the locus coeruleus is uncrossed and has been shown
by retrograde transport of HRP (526). That to the spinal cord has
only been suggested from biochemistry. Lesions of the SN lead to a
drop in DA levels in the spinal cord (91). The nigro-cortical pathway
comes from the SNC and therefore may be DA (19). The projection from
the raphe nuclei to the SN has been shown electrophysiologically (570)
and by retrograde transport of HRP (457). It appears to be mainly
inhibitory with a few excitations (570), again possibly from the activation
of corticofugal fibres.
1. 5 Afferent and efferent connections of the striatum
In addition to the input from the SN (see Section 1.2), the striatum
receives other inputs, the major ones being the cortical and thalamic
ones. There are also several other less extensive inputs. These other
striatal afferents are now discussed.
20.
The cortico-striatal pathway
The striatum receives an extensive topographic input from all
parts of the cerebral cortex (66,72,99,148,209,218,229,303,324,356,
362,363,364,583,623). It has been estimated that, in cats, 13% of
the synapses in the caudate nucleus, come from the cortex, whereas
33% of the synapses in the putamen are with terminals from the cortex
(258). The projection is ipsilateral, with some areas, e.g. sensori¬
motor cortex (66), projecting bilaterally. There is evidence that
suggests that at least some of the cortico-striatal fibres are collaterals
from other corticofugal fibres, given off as the internal capsule passes
the nucleus. Both degeneration studies (218,622,623) and studies using
intracellular injections of HRP have suggested this. However, some
electrophysiological work has suggested that some fibres are not
collaterals (43,341), by showing that there was no activity in the
striatum on stimulation of the pyramids.
The cortico-striatal fibres consist of fine non-myelinated axons
(218,622) and are thought to terminate on the dendritic spines of the
spiny striatal cells (1,99,327,328). The projections from the different
cortical areas are not homogeneously distributed in the striatum.
They appear as intricate patterns, the projection from the prefrontal
cortex being described as consisting of clusters surrounding unlabelled
cores (229) and that from the motor cortex as consisting of patches or
clusters (583). In the monkey the projection from the sensory-motor
cortex goes to restricted areas of the striatum and it was suggested
that other areas of cortex might supply the "spaces", leading to a high
degree of overlap between the different cortical projections (303).
Electrophysiology suggests a reverse topography in the cortico-
striatal projection, that is medial cortex projecting to lateral striatum,
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and anterior cortex to posterior striatum (43,209,362,364 ).
As well as being topographic, the projection from the sensorimotor
cortex appears to be somatotopic (364).
The projections from the cortex have been shown to converge
with those from the SN and the thalamus by means of autoradiography
(26) and electrophysiology (53,281,345,382). Electrophysiology has
also shown the pathway to be monosynaptic (340,345,510), as has the
retrograde transport of HRP (340). In at least some cases the input
is onto striatal output cells as shown by anatomical (556) or by electro¬
physiological techniques (382).
Activating the cortico-striatal pathway leads to an excitation of
the striatal cells. This has been shown both by extracellular (363,534,
510,561) and intracellular recording (53,340,345). In fact cortical
stimulation has been used as a means of activating the striatal cells
which normally have a very low spontaneous firing rate (534). Although
not proven, it seems likely that the transmitter in the pathway is an
excitatory amino acid, most probably glutamate. The glutamate
antagonist glutamic acid diethyl ester when applied iontophoretically
blocks the effect of cortical stimulation (562). Lesions of the cortex
lead to reduced striatal levels of glutamate (337). A high affinity uptake
system for glutamate is present in the striatum (146) and this is also
reduced by cortical lesions (72,388). Despite the evidence for glutamate
as the transmitter, aspartate cannot be entirely ruled out as the trans¬
mitter. Glutamate receptors, shown by KA binding, do exist in the
striatum (552) and after KA lesions of the striatum, cortico-striatal
terminals are seen synapsing with degenerating cells four times as
often as with other cells (263).
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Initially it was thought that the projection ended on striatal
interneurones rather than on output cells, due to the lack of cells
driven from the cortex and antidromically activated from the output
area of the nucleus (199,345,363). However, more recent work has
shown that far more cells than were originally thought do project out
of the striatum, and that the cortical afferents do terminate on striato-
nigral cells (47,199,363,556,558).
The cortex may also influence the striatum polysynaptically via
the thalamus. If the thalamus is lesioned, the mean latency of response
to cortical stimulation in the striatum falls, and the response variability
is reduced (79).
The thalamo-striatal pathway
The largest projection to the striatum comes from the ipsilateral
thalamus and this mainly arises in the intralaminar nuclei especially the
centromedianum-parafasicular complex (CM-PF) (67,104,258,304,316,
322,327,328,475,476,520,521,529). It has been estimated that 35% of
the input to the caudate nucleus comes from the thalamus, whereas 16%
of those in the putamen do so (258).
The projection traverses the internal capsule and projects
topographically onto the striatum (476). Autoradiography shows the
terminals ending in patches, bands or semicircular configurations (520),
mainly on the dendritic spines of the spiny neurones (327,328). The
CM projection is denser than that from the PF area and both appear to
have a dorsoventral topography (520).
Retrograde degeneration studies show that the CM-PF complex
in monkeys preferentially projects to the putamen, whereas other
intralaminar nuclei project to the caudate nucleus (476). Also in the
rabbit and rat degeneration studies show a projection from the midline
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and intralaminar nuclei (104,475), with the midline nuclei and CM area
going to the caudate and the PF nucleus to the putamen in the rabbit
(104).
Retrograde transport studies, using HRP, support the projections
seen with the degeneration techniques: the intralaminar nuclei and
CM-PF complex project to the striatum (304,529) and also send a few
axons to the cortex. HRP studies also show some nuclei outside the
intralaminar areas also project to the striatum: the ventroanterior and
mediodorsal and centrolateral areas (521,529).
The thalamo-striatal projection has also been demonstrated
electrophysiologically and these studies suggest that the CM-PF complex
projects to the putamen, while the CL area probably goes to the cortex
and fibres are activated on the way through the striatum (355,487).
The thalamo-striatal pathway is excitatory in nature, and the
input converges with those of the SN and the cortex (53,345,382,406).
The transmitter is thought to be acetylcholine (ACh) as release increases
on stimulation of the thalamus (390) and levels fall in the striatum on
lesioning the thalamus (551). Also iontophoretic application of ACh
mimics the effects of thalamic stimulation and the effects of both the
iontophoretic application of ACh and thalamic stimulation are blocked by
atropine (391).
Raphe-striatal projection
Antero- and retrograde tracing techniques have both shown the
existence of a pathway from the DRN to the striatum, and only a
minimal projection, if any, from the MRN to the striatum (19,20,45,94,
285,401,521). As many as 70-80% of these fibres also give off collaterals
to the SN (603,605), as they pass in the MFB. The densest projection
is to the caudal caudate nucleus and appears to be primarily ipsilateral,
although a few crossed fibres may exist (19,45,94,285).
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Activation of the DRN leads to a long-lasting monosynaptic
inhibition in the striatum (124,401,447) although a few facilitatory
responses have been reported from intracellular studies (607).
Only very few cells respond to stimulation of the median raphe
nucleus (447) in support of the very sparse projection seen in the
anatomical studies. However, the possibility exists that even the few
responses seen were due to current spread to the DRN.
The transmitter appears to be 5-HT, 5-HT fluorescence has been
shown in the pathway from the DRN to the striatum (122,591) and the
5-HT fluorescence in the striatum disappears on lesioning of the DRN
(354). Tryptophan hydroxylase levels fall, as does 5-HT uptake in
the striatum after lesions of the DRN (48,354). 5-HT levels in
cerebro-spinal fluid from the lateral ventricle increases on stimulation
of the DRN and at least some of this is presumed to come from the
striatum (275).
Other striatal afferents
Other afferents to the striatum incude projections from the
midbrain reticular formation, the amygdaloid complex, the nucleus
accumbens, the locus coeruleus and the globus pallidus. None of these
projections have yet been extensively studied and so little is known about
them, apart from their existence.
The projection from the reticular formation is diffuse and relatively
minor (373,507,508), and has been demonstrated by retrograde trans¬
port of HRP and by electrophysiology (373,508). It is possibly part
of the ascending reticular activating system (507).
The projection from the amygdala has been demonstrated both by
retrograde degeneration and retrograde tracing techniques (414,521),
and by electrophysiology (228,436). This pathway may be a means by
which the limbic system can affect the extrapyramidal system.
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A small projection from the nucleus accumbens has been shown
by autoradiography and degeneration studies to go to the anterior tip
of the striatum (95,474).
A very small projection to the striatum comes from the locus
coeruleus ana has been shown by catecholaminergic fluorescence
studies (122) and by autoradiography (39). This projection is supported
by the existence of small amounts of NA in the striatum (168).
Finally, very recently a pathway has been shown to go from the
globus pallidus to the striatum (564). This could not be shown until
the development of the combined HRP- wheat germ agglutinin technique
which allows much more localised injections.
Efferent connections of the striatum
There are very few efferents from the striatum other than those
to the SN and the globus pallidus. However, HRP work has suggested
the existence of a striato-cortical pathway (289) and degeneration studies
have suggested the existence of a small projection to the contralateral
striatum (397).
1.6 Kainic acid and n-methyl aspartate lesions
The neurotoxic lesions described later were made with KA or n-
methyl aspartate (NMA), both analogues of the central excitant glutamate
(621). The structures of these compounds are shown in Figure 3.
KA has been reported to be from 8-80 times as potent as glutamate
in exciting cells in the spinal cord (37,301) and the d-isomer of NMA
(NMDA) is from 7-18 times as potent in similar experiments (121,301).
The 1-isomer (NMLA) is similar to glutamate in its excitatory potency
in the spinal cord (121). The excitotoxic nature of these drugs, as
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FIGURE 3: Chemical structures of glutamate, kainic acid and n-methyl
aspartate, showing the similarities in structure.
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and in 1979 by Nadler (410). Systemic application of these agents
will cause neurotoxic reactions in a wide range of species and brain
nuclei. The neurotoxic potency seems to be related to the excitatory
potency, hence the term excitotoxic. When injected directly into the
striatum, KA is more potent than NMA which is in turn more potent
than glutamate itself. This corresponds to the order of potency seen
when these agents are injected systemically (446).
The mechanism of cell death is still unclear, but it has been
postulated (444,445) that excitotoxic agents lead to a continuous state
of depolarisation and increase in plasma membrane permeability. This
would lead to a strain on the cell's energy stores as the cell attempted
to restore the ionic balance and death would result when the energy
stores were depleted or the ionic environment of the cell became lethal.
A variation on this idea is that the analogues do not act directly on the
glutamate receptors on the affected cells but that they act presynaptically
on the glutamate terminals to block uptake or increase release of
glutamate (387). This could lead to excessive amounts of glutamate in
the synaptic cleft, and a continuous, toxic depolarisation. This might
explain why intrastriatal KA seems to be more effective in the presence
of the cortico-striatal pathway than in its absence (38,385). This
observation, however, could be explained by a removal of a tonic
excitatory drive to the nucleus on removal of the cortico-striatal pathway,
meaning that a greater amount of KA will be needed to cause the same
amount of excitation as when the drive was present (387).
KA has widely been used as an agent that will kill the cell bodies
in a brain area while sparing the axons of passage and terminals.
This is supported by light and electron microscope studies (108,147,
261,444,445). Up to 48 hours after the lesion progressive chromatolysis,
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shrinkage of perikarya, clumping of the nuclear chromatin and finally
disruption of the nuclear membrane occurs. From 1-3 weeks after the
injection of the KA, proliferation of the astrocytes is seen where the
neurones used to be. Histofluorescence shows that the DA axon and
terminals seem to be relatively undamaged. Electron microscopy of the
striatum after the injection of KA has shown that the corticofugal
fibres that traverse the striatum are undamaged, as are the terminals
of afferents to the striatum. These often have remnants of post synaptic
membranes attached.
Despite the above evidence for an axon sparing action of KA,
there is other evidence that indicates the action of KA might not be
quite as specific for cell bodies as has been claimed. Damage to the
fibre tracks passing through injected areas has been seen (639) and this
seems to affect primarily the thicker myelinated axons, leaving the fine
unmyelinated axons intact (353). It also seems that in some cases
certain striatal cells seem to escape damage while others are destroyed.
The resistant cells appear to be the large fusiform ones that may project
to the SN (353). Reduced levels of tyrosine hydroxylase (TOH) have
also been reported after KA lesions (98), and could be evidence for a
non-specific, toxic action of KA. However, this could represent the
dying back of axons resulting from the lack of any innervating tissue
(444).
Many of the reports that indicate non-specific damage use higher
doses and injection volumes than the other studies and this may be the
reason for the non-specific damage.
The striatum has received a lot of attention in experiments with KA,
possibly because it is an easily studied structure from many points:
behaviourally it mediates known effects, it is easily dissected and cut for
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biochemistry and histology. Also KA lesions of the striatum are
thought to resemble the pathology of the striatum in Huntingdons'
Chorea (107,109,179,279,384,527,528,536).
Intrastriatal KA leads to large depressions in several parameters
of striatal activity. Levels of choline acetyltransferase (CAT) and
ACh, choline uptake and ACh release are all reduced (195,384,537).
GAD and GABA levels and GABA uptake and release are all affected
by KA lesions in the striatum (195,384,421,537,538). Dopamine-
sensitive adenyl cyclase (DA-AC) is also greatly reduced (537).
Inconsistent results have been obtained in relation to TOH levels.
They seem to increase (384), decrease (98) or show no change (179).
These inconsistent changes could be due to the changing morphology
after the lesion. Histofluorescence work has shown that DA increases
near to the lesion, but it decreases further away from the lesion,
presumably due to the "bunching" of the remaining tissue in the area
(232). This would mean that results from biochemistry might depend on
the method of tissue sampling. However, DA release seems to be
relatively unaffected (195). DA binding changes in a manner consistent
with the loss of the DA-AC (186). 5-HT release is also relatively
unaffected although binding is reduced (195,536). The levels of
glutamate and aspartate in the nucleus also decrease. GAD and GABA
fall in the SN after striatal KA lesions (141,549,612).
Longer term studies after KA indicate that care ought to be
taken in interpreting the results of biochemical experiments. Even
months after the lesion was made, pre and post synaptic elements were
seen in electron micrographs of the area. This means that binding
studies may pick up sites that are on the lesioned cells, although they
are not functional (654).
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Rats lesioned with KA acid also show some behavioural changes,
and changes in body weight, as do 6-OHDA lesions of the SN. These
are discussed in the introduction to Chapter III.
Chronic unilateral lesions with KA will lead to turning behaviour
in response to apomorphine (540). The acute effects of this lesion
result in ipsilateral circling for about 2 hours after the injection,
then this is followed by a period of from 10 to 36 hours of violent
contralateral circling (293). These effects of KA are dependent on the
presence of the cortico-striatal pathway and the ipsilateral phase is
prolonged by the prior removal of the striato-nigral pathway. This
is supported by the increase in SNR and SNC cell firing seen on acute
application of KA (49,288).
NMA has been much less used than KA, but NMDA has recently
been reported to cause similar postoperative changes in behaviour (585),
although the contralateral running phase does not occur. Photographs
of KA and NMA lesions are shown in Section 3.3.
As well as the neurotoxic lesions of the striatum, electrolytic
lesions in the crus cerebri are also used to interupt striatal output.
The position of this lesion is at a point where the striato-nigral pathway
has been shown to run separately from the nigro-striatal fibres (206,
588). These lesions lead to ipsilateral turning when the animals are
challenged with 2 mg/kg of apomorphine. The apomorphine activates
the receptors on the intact side of the brain rather than preferentially
activating those that have become supersensitive on the lesioned side
as happens after 6-OHDA. The lack of supersensitivity also explains
why a much higher dose of apomorphine is needed to cause turning in
all the striato-nigral lesioned animals than in the 6-OHDA lesioned ones




In this chapter, all the methods that are used in both Chapters
III and IV are described. These methods include all the lesion
procedures: electrolytic lesions in the crus cerebri, KA lesions and
NMA lesions in the striatum, and 6-OHDA lesions in the medial fore-
brain bundle. The 6-OHDA lesions are only used in Chapter III.
They also include details of the histological procedures used as well as
the biochemical ones for CAT and GAD and for the protein estimation.
All other more specific methods are dealt with in the relevant chapters.
2.1 Histology
All tissues were stained by a modification of the luxol fast blue
and cresyl violet method. The brains were frozen and then cut into
40 urn sections on the cryostat (Dittes). The sections were cut in
the coronal plane and on cutting these were melted onto washed micro¬
scope slides (Chance Propper Ltd) and allowed to dry.
The slides marked with pontamine blue dye (Section 4.2) were
left overnight in formalin vapour (BDH) to fix the dye, before staining.
A list of the solutions and the times used is given below:
95% ethanol 30 min
0.1% luxol fast blue (BDH)
in 95% ethanol + 30 min (or longer if fixed in
0.5 ml 10% acetic acid formalin)
per 100 ml
70% ethanol/0.05% LiC03
10 s alternately in each, until
the myelin (blue) and grey matter
(unstained) were nicely differentiated
Distilled H20






20 min or until blue and pink staining
were both clearly seen
Xylene (BDH) 5 min or until mounted.
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On removal from the xylene the slides were covered with cover-
slips mounted in D.P.X. (BDH).
2.2 Lesioning procedures
Four types of lesions were performed: KA and NMA injections
into the striatum, 6-OHDA injections into the nigro-striatal pathway
in the MFB and electrolytic lesions of the striato-nigral pathway in
the crus cerebri. All types of lesion were used in the behavioural
experiments but only the KA, NMA, and the electrolytic ones in the
electrophyisology experiments. After the experiments, the lesions were
verified by one or more of the following methods: behavioural (turning),
biochemical (GAD and CAT levels) or histological.
General surgical procedure
All operations were performed under halothane anaesthesia
(Fluothane, ICI Ltd) with a 4% mixture in medical air, and maintaned
at 1.5% through a rubber nose-cuff. After induction, the rats were
placed in the small animal stereotactic frame (David Kopf), with blunt
earbars, tip angle 45 degrees. The toothbar was set at 2.4 mm below
the earbar zero. The nose of the animal was placed in a rubber nose-
cuff, supplied with the anaesthetic and attached to a suction pump for
removal of the expired anaesthetic.
A midline incision was made and the skull surface exposed to reveal
the suture lines. A 2 mm burr hole was drilled with a dental drill at
the points determined by the coordinates for the particular operation.
Bregma was used as a reference point in all cases. In the cases where
an injection was being made through a needle, the orientation of the
needle tip was considered as this affected the position of the sphere of
the ejected liquid.
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The needle through which the injection was made and the lesioning
electrode were both inserted through these burr holes. After the
removal of the needle or the electrode, the hole was filled with bone
wax (Ethicon Ltd) and the wound sprayed with antibiotic and fungicidal
spray (Rikospray, Rikolaboratories Ltd) and the wound stitched together.
The animal was then placed in a recovery cage to regain consciousness.
Supplementary feeding (bread and milk) was given to aid the recovery
process.
6-OHDA injections
The animals were pretreated with 50 mg/kg pargyline (Sigma)
and 25 mg/kg desmethylimipramine (Geigy Pharmaceuticals) for 30 minutes
before being anaesthetised and placed in the frame.
8 |ig of 6-OHDA base were injected into the brain in a volume of
4 |il over 5 minutes into the lateral hypothalamic area in the region of
the MFB . The injection was made from an Agla syringe, by a perfusion
pump. The needle was left in place for 5 minutes after the end of the
injection to prevent reflux up the needle track. The coordinates for
the injection site were:
3.6 mm posterior to bregma
1.0 mm lateral to bregma
8.5 mm ventral from the skull surface
Kainic acid injections
2 ug of kainic acid (Sigma) were injected into the striatum in
0.2 ul of saline, the pH being adjusted to 7.4. The injection was made
over 4 minutes from a Hamilton syringe (1 ul), attached to a 30-guage
needle, and the needle was left in place for another 5 minutes to prevent
reflux. The coordinates used for the injection were as follows:
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0.5 mm anterior to bregma
2.5 mm lateral to bregma
4.5 mm ventral from the brain surface
After regaining consciousness the animals were further anaesthetised
for 6-10 hours with pentobarbitone (Sagatal, May and Baker Ltd).
This was to prevent the extensive convulsive activity seen in these
animals for several hours after the injection.
In the animals used for the behavioural experiments, the side of
the lesion, left or right, depended on the preferred paw of the animal
(see Section 3.2).
N-methyl aspartate injections
Initially, a series of injections was given to determine the best
doses of the neurotoxin to use. Those tried were 2.5, 5, 10 and 20 ug
injected from a 1 ul Hamilton syringe through a 30-gauge needle, in
volumes of 0.2, 0.4 and 0.8 ul of saline. Again, the pH was adjusted
to 7.4. The injection was made at a rate of 0.1 ul/min and the needle
left in position for a further 5 or 10 minutes to prevent reflux.
In initial experiments the same coordinates as were used for the
KA injections were used, but it was later seen that the following led
to a more effective lesion:
1.0 mm anterior to bregma
3.0 mm lateral to bregma
4.5 mm ventral from the brain surface.
Electrolytic lesions
Lesioning electrodes were made from twisted teflon coated stain¬
less steel wire (0.16 mm diameter, Pheonix Wire Inc.), bared only at
the tip. These were monopolar and were used as the cathode in the
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circuit outlined in Figure 4. The lesion was made by giving 6 mC of
current either once or twice. If the latter, the electrode was moved
slightly before the second current application. Two sets of co¬
ordinates were used for this lesion, both placing the lesion in the
same place, but using different approaches. The first approach used
the following coordinates, putting the electrode into the brain at an
angle of 46° to the vertical:
3.8 mm posterior to bregma
7.7 mm lateral oblique to bregma
6.0 mm
and ventral oblique from the surface of the brain
7.0 mm
The term "oblique" is used to allow for the angle of the electrode.
The second injection was placed further down on the same penetration.
The second approach was to put the electrode in vertically, at the
following coordinates:
3.8 mm posterior to bregma
2.1 mm
and lateral from bregma
2.4 mm
7.8 mm ventral from the brain surface
In this case to make two lesions the electrode must be removed and
replaced at the second lateral, position.
Behavioural assessment of the lesions
Seven or 14 days after the operations, the animals were challenged
with apomorphine (Macfarlane Smith Ltd) to determine the turning res¬
ponse to the drug. This was done by placing the rats in a hemispherical
plastic bowl, 18 in. in diameter, and attaching them to a spring by a
length of bandage. The spring was attached to automatic counters
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FIGURE 4: Diagram of the circuit used for making electrolytic lesions
in the crus cerebri. The electrode is the cathode and the
circuit is completed via the ear bar.
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(Rat rotometers), which, by using photocells, count the number of
revolutions made by the rat in each direction in a given time. The rats
were observed frequently to ensure they were turning as slight
inaccuracies could result if a rat "oscillated" about the counting point
of the system.
The 6-OHDA lesioned animals were given 0.3 mg/kg apomorphine,
dissolved in saline with ascorbic acid, intraperitoneally. A response
of about 200 or more turns in one direction in 45 minutes was taken to
be indicative of a lesion. The other lesioned animals were given 2 mg/
kg of the apomorphine and about 100 turns in 30 minutes was taken to
suggest a lesion.
Histological assessment of the lesions
The lesions in the crus cerebri and the striatum were examined
histologically. In the case of the KA lesions, only the posterior part of
the lesion was studied as the anterior portion (in front of the injection
track) was used for biochemistry.
The procedure used to prepare and stain the tissue is described
in Section 2.1.
Photographs of the lesions are shown in Section 3.3.
2. 3 Biochemistry procedures
The biochemical effect of the KA lesions was determined by
measuring the levels of GAD and CAT in the portion of the striatum
just anterior to the injection site of the neurotoxin. The posterior
portion was kept for histology (see Section 2.1). The NMA lesions
were estimated by measuring the GAD in the substantia nigra ipsilateral
to the lesion, and histology was done on the whole striatum. In each
case the GAD assay was the same.
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All brains were removed from the animals immediately on death
which was caused by decapitation after stunning by a strong blow on
the thorax. The samples were dissected out on ice as shown in
Figure 5. After dissection the samples were wrapped in aluminium foil
and dropped into liquid nitrogen where they were stored until the assay
was performed. Each side of the brain of each animal was assayed
individually.
In each case the results were expressed as nmol/mg protein/hour
so the amount of protein in the samples was also measured.
CA T assay
The reaction catalysed by the enzyme is as follows:
l-^C-acetyl CoA + choline ^"C-ACh + CoASH
The method used was modified from that of Fonnum (189). The
product, labelled 14C-acetylcholine is bound to tetraphenylboron, in
the organic phase of a two-phase solvent system. The organic phase
is also the scintillant phase of the system and so the labelled product
is in contact with the scintillant while the labelled "precursor, which
stays in the aqueous phase, is not. CAT activity is expressed as nmol
acetylcholine produced per hour per mg of protein.
- Reagents:
1. Homogenisation Buffer:
1 mM ethelenediamine tetra-acetic acid (EDTA),
(BDH) pH 7.0, containing 1 |il Triton X 100/100 ml (BDH).
2. Incubation Medium:
a) 100 mM EDTA (BDH), pH 7.4
b) 200 mM choline chloride (Sigma)
c) 3M NaCl (BDH)
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FIGURE 5: Dissection of the striatum and substantia nigra for bio¬
chemistry.
A. Base of the brain, showing the position of the cuts.
B. Dissection of striatal tissue: the area outlined with the dotted
line was scooped out with a pair of small curved forceps.
C. Dissection of nigral tissue: the SN was isolated by scalpel cuts
along the dotted lines and then removed with forceps.
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d) 500 mM NaH2P0lt buffer, pH 7.4 (BDH)
e) 2 mM eserine salycilate (Sigma)
f) 9 mg/ml bovine serum albumin (BSA) (Sigma)
g) (l-llfC) acetyl CoA (Amersham Radiochemical Centre);
solid (50 dpm/nmol) taken up in 2 mM unlabelled acetyl CoA
to give 18,500 dpm/nmol.
Each 100 |il of medium was prepared as follows:
20 ul 100 mM EDTA
10 ul 200 mM choline chloride
20 ul 3M NaCl
20 ul 0.5M NaH2POk buffer, pH 7.4
10 ul 2 mM eserine salycilate
10 ul 9 mg/ml BSA
10 ul acetyl (1- lltC) CoA
3. 10 mM NaHgPO^ buffer, pH 7.4, containing 18 mg unlabelled ACh
in each 500 ml.
4. 186.9 mg sodium tetraphenylboron (Sigma-important) dissolved
in each 20 ml of acetonitrile (Koch Light Laboratories).
5. Scintillant: 8.5 g 2,5-diphenyloxazole (PPO) in 2 1 toluene (BDH).
6. Internal Quench Standard (llt C-Me)-toluene, 2uCi (Amersham
Radiochemicals Ltd). Toluene is diluted approximately 1 in 4
with cold toluene (BDH), to give a solution of around 20,000 dpm/
80 ul. Volumes were determined by weight for accuracy. The
density of unlabelled toluene is 0.8645 g/ml at 20°C.
- Procedure:
1. Tissue was homogenised in 50 ul/mg of the homogenisation buffer
in an Eppendorf tube. If the required volume was more than
200 ul, the homogenisation was done in 200 ul and then diluted
later. This prevented overflow from the tube during homogenisation.
This homogenate was then further diluted tenfold, to make a 0.2%
homogenate. This was then used for the assay and the undiluted
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homogenate kept for the protein estimation. The homogenates
were kept on ice until needed.
2. The incubation medium was made up on ice.
3. 2 ml of the tetraphenylboron/acetonitrile mix, 5 ml of the 10 mM
NaH2PO^ and acetyl choline and 10 ml of the scintillant were
added to the required number of scintillation vials.
4. 10 m1 of diluted homogenate and 10 |il of incubation medium were
added together in an uncapped Eppendorf tube and incubated
for 20 min in an Eppendorf Dri-bloc at 37°C.
5. The reaction was stopped by shaking for at least 5 s in the
scintillation vial, ensuring the fluid penetrated the Eppendorf
tube. Care was also taken not to shake too vigorously as this
prevented the phases separating cleanly.
6. The vials were then left in the scintillation counter for at least
an hour before counting to allow chemiluminescence to settle.
After this the vials were counted for 4 min each.
Each sample was assayed in duplicate, as were the blanks.
Extra blanks were included to allow for quench correction. For this,
80 pi llfC toluene was added to the vials along with 10 Ml of a dilute
homogenate, before placing in the counter.
Calculation:
The results were calculated as follows:
nmol/hr/mg protein = cpm (sample) - cpm (blank)
dpm added in 80 m1 toluene/cpm (blk+tol) - cpm
1/18500 (dpm to nmoles)
1000/mg protein (from ug to mg)
3 (up to 1 hour)
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CAD assay
The reaction catalysed by this enzyme is:
1- C-glutamate -*■ GABA + 1'tC02
The method was adapted from that of Drummond and Phillips (157).
The radiolabeled 11+C02 is taken up in Protosol, mixed with the
scintillant and then counted. The results are expressed as nmol
carbon dioxide produced per hour per mg protein.
- Reagents:
1. Homogenisation Buffer:
100 ul of 10% Triton X-100 (BDH) and
100 ul of 1 mM KP04 buffer, pH 6.5.
The buffer is made up of 300 ml of solution A (below) with
approximately 100 ml of solution B - as much as is needed to
obtain the correct pH.
A: 54.4 g/400 ml KH2P01+ (BDH)
B: 34.84 g/200 ml K2HPOlt (BDH).
2. Incubation Medium:
a) 1M KPO4. buffer (made as for 1 mM, but using gram quantities).
b) 10 mM pyridoxal phosphate (Sigma) made up daily.
c) 10 mM dithiothreitol (Sigma) made up daily.
d) 10 mM sodium arsenite (BDH) made up daily.
e) 100 mM sodium glutamate (Sigma) made up daily.
f) 1% Triton X-100 (BDH).
g) (l-llfC) glutamic acid, 55 mCi/mmol, 50 |iCi/ml (Amersham
Radiochemical Centre).
3. 6N H2SO^ for stopping the reaction.
4. Scintillant NE260 (Nuclear Enterprises Ltd).
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- Procedure:
1. The tissue was removed from the liquid nitrogen, placed in an
Eppendorf tube and homogenised in 20 pi of homogenisation buffer
per mg of tissue, giving a 5% homogenate.
2. The incubation medium was then made up on ice.
3. 10 pil of the incubation medium was placed in the required number
of Eppendorf tubes placed inside insert vials in scintillation vials
containing 250 pi Protosol. This whole procedure was carried out
on ice. 10 ul of the homogenates was then added to the incubation
medium and the vials were placed in a shaking water bath at 37°C
for 20 min.
4. After the 20 min, the reaction was stopped by adding 100 jil of
6N H2S04 through the rubber seal. The vials were then left for
another hour in the water bath to ensure that all the C02 had been
taken up by the Protosol.
5. The seals were then removed and the outside of the insert vials
washed with 2 ml ethanol to remove any Protosol/C02. The ethanol
was collected in the vial.
6. 10 ml of scintillant was then added and the vials placed in the
counter and counted for 4 min each.
The results were calculated as follows:
nmol/hr/mg protein = cpm - cpm (blank)
x 3 (to hours)
x 1.23 (correct for 83% efficiency)
x 1000/|ig protein in 10 ul homog. (to mg)
x 1/552.5 (cpm to nmol)
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Protein estimation
The method of Lowry et al (372) was used to estimate the amount
of protein in each homogenate. This method consists of reacting the
protein with copper and then quantifying the protein-copper complex
spectrophotometrically.
- Reagents:
1. 2% Na2C03 in 0.1N NaOH.
2. a) 1% CuSO 4. 5H20
b) 2% Na.K .Tartarate
3. 50 parts 1 + 1 part 2 (equal parts of a and b).
4. Folin Ciocalteau reagent (BDH).
- Standards:
Standards for the range 15-60 ug protein were used and more than
covered the range in the experimental samples. 2.5 ml/ml BSA was used
as the standard stock solution. 100-400 ul of this were used to obtain
a standard curve. This volume was diluted to 5 ml and 0.3 ml was used
for the estimation.
- Method:
1. 10 |il of the homogenate used for the GAD assay and 50 ul of the
undiluted homogenate for the CAT assay were diluted to 0.3 ml with
distilled water.
2. 3 ml of reagent 3 were added, mixed and allowed to stand for
15 min.
3. 0.3 ml of reagent 4 was added, mixed and allowed to stand for
45 min.
4. The amount of product was then read on a Gilson Spectrophotometer
at 750 nm.
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The results were calculated by averaging the readings at different
amounts of standard on the linear part of the curve. Above this range
it becomes non linear, and values must be read from the graph.
A reading for 1 tig of protein was calculated and this was then used
to estimate the amount of protein used in each sample.
Dopamine estimation
The measurement of DA in Chapter III was done for me, using
a radio-enzyme assay, a modification of the methods of Coyle and Henny
(106) and Palkovits et al (452).
CHAPTER III
The Function of the Nigro-Striatal Pathway
Studied by Operant Behaviour Techniques
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In the introduction to this Chapter, the background detail to
the experiments is given, followed by the experimental rational and the
methods not already given. After this the results are presented and
discussed.
3.1 Introduction
Lateral hypothalamic syndrome and nigro-striatal lesions
It has long been known that lesions in the lateral hypothalamic
(LH) area cause severe aphagia and adipsia in the lesioned animals.
This leads to death more rapidly than food or water deprivation would
(379). If given food and water intragastrically, the LH lesioned
animals will eventually begin to eat and drink spontaneously again,
but not in a normal fashion. They do not eat in the heat and do not
respond normally to cellular dehydration. Also, they will not drink
at all in the absence of food and will not eat in response to lowered
insulin levels as control rats will. However, they will overeat in a cold
environment. The LH lesioned rats also show taste preference abnormal¬
ities : they will refuse water made bitter with quinine at much lower
levels than that refused by control rats (379). It was later seen that
the aphagia and adipsia caused by these lesions could be mimicked by
damage to the ascending DA systems resulting either from injection of
6-OHDA into the LH, SN or ventral tegmental area (VTA), or from
electrocoagulation of the SN (21,184,379,594). This suggested that
the effects of LH lesions are mediated by the DA fibres passing through
that area, in the MFB, rather than by cells with cell bodies in that area.
KA injections, thought to destroy cell bodies and leave passing axons
intact, do affect ingestatory behaviour and so possibly not all effects
of LH lesions are caused by the lack of DA fibres (576). Animals
lesioned electrolytically in the LH show different food preferences after
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the lesion from animals with depletions of DA only (379). However,
despite this there is a good case for the involvement of DA in the LH
syndrome.
As further evidence for the involvement of DA in causing the
aphagic and adipsic effects of the lesions, these can also be produced
by neuroleptic administration (657) and by electrolytic (419,532) and
KA lesions (459,527,528) in the striatum. The electrolytic striatal
lesions are similar to the LH ones in that the DA terminals are destroyed.
However, in the KA acid lesioned animals, the DA terminals are intact,
but the cells they synapse with are destroyed and so the effects might
be expected to be the same. However it appears that the feeding
behaviour after KA lesions in the striatum is different from that seen
after the LH lesions. The KA lesioned animals show a prolonged reduc¬
tion in body weight when compared with controls, but when food and
water ingested are monitored there appears to be no difference between
lesioned and control animals. These animals have been reported to show
increased locomotion at night (527) and so they may have higher
calorific requirements than controls, and the lower body weight is
explained by a reduced "set point" as has been suggested for the LH
lesioned animals. The KA acid animals will also increase their water
consumption if they are deprived of food (non-prandial drinking)
unlike the LH animals which only take water to help digest dry food
pellets. Amphetamine induced anorexia is increased in the KA lesioned
animals whereas it is decreased in the LH lesioned animals (184).
The former ones also show increased stereotypy, unlike the LH ones
which show decreased stereotypy in response to amphetamine (50a).
The increased anorexia may be due to increased competition between the
two activities, eating and stereotypy.
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The DA systems passing through the LH are also thought to be
involved in the mediation of intracranial self-stimulation (ICSS), where
rats will learn to lever press to give themselves electric current in
certain brain regions. This process is thought to activate a reward
mechanism in the animals (114,180). Rats will also learn to lever press
for food reward and for intravenous administration of amphetamine or
apomorphine (127), as well as for ICSS, further supporting a rewarding
role for DA in this system.
The anatomical localisation of sites in the brain which will support
ICSS corresponds well, but not exclusively, with the DA distribution
in the brain (113,180,632), some of the most effective sites being in
the LH, near to where lesions produce the LH syndrome symptoms. The
area of importance in the striatum for this behaviour is possibly the
ventral, anterior striatum, as injections of 6-OHDA in this area affect
ICSS, as do crystalline DA implants (418a,420). Studies of fluorescence
build up of DA after the LH lesions shows that DA builds up in the SN
and VTA DA neurons (85). The involvement of NA in the rewarding
effects of ICSS and neuroleptic administration has also been suggested
(113,632) but the extent of this involvement has been questioned (180).
It is possible another, different, reinforcement mechanism exists using
NA (114).
The interpretation of the LH syndrome and lever pressing experi¬
ments is complicated by the close involvement of DA in the motor
behaviour of the animals. As well as being aphagic and adipsic, animals
suffering from the LH syndrome do not show much spontaneous movement
and have a strongly depressed response to sensory stimulation. It is
possible that this may contribute to the eating and drinking deficits.
However, these animals do display consistent regulatory changes in body
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weight and motivational changes in feeding "preferences" once they
have started feeding spontaneously again (379). This fact is difficult
to explain on the basis of a purely sensorimotor deficit, although the
possibility of this being the case has been suggested because of the
lack of movement shown by these animals.
Bilaterally LH lesioned animals are difficult to design experiments
for, as they are so akinetic. Also it is difficult to differentiate
between an animal that cannot perform or learn a task, and one that
simply does not want to.
Manipulation of lever pressing behaviour is a much easier model
to use than that of the bilaterally LH lesioned animal. DA antagonists
will cause an attenuation of lever pressing for ICSS (656,632), as will
removal of the reward on pressing (191,634,635). This led to the
formation of the "anhedonia" hypothesis which states that neuroleptics
reduce the performance in lever pressing tasks by reducing the reward¬
ing value of the reinforcer (634). More support for this involvement
comes from experiments with 6-OHDA : lesions of the MFB with 6-OHDA
also lead to reduced pressing rates for ICSS (181). Lever pressing
to self-administer drugs is also attenuated by DA antagonists (644),
but not by NA blockers. Neuroleptics will also reduce lever pressing
for food reward, and will do so in similar doses to those that reduced
the other pressing behaviours (512).
Very low doses of neuroleptics induce a higher rate of pressing
throughout a session when pressing for amphetamine (504,644,495).
This increases the total amount of drug given, and argues strongly
along with all the above data in favour of neuroleptics decreasing the
rewarding effect of the reinforcers. The animal will increase drug




It has been suggested that the reduction in lever pressing on
the administration of a neuroleptic is mediated purely by sensori¬
motor deficits rather than by a reduction in reward (181). In one
study, it was shown that the rats did have the motivation to feed, as
shown by free feeding measurements (181), in the presence of a dose
of neuroleptic that reduced lever pressing. Also, using a variable
interval schedule (so that ICSS and food rewarded pressing rates were
the same), there was no increase in response rate before the fall in
rate, as happened when the reward was stopped on execution of the
behaviour (181). The same happened with 6-OHDA lesioned animals.
Evidence against the effect of neuroleptics being caused by a block in
the rewarding impact of the result of lever pressing also comes from
experiments that show that the effects of pimozide and extinction are
additive (381,461). If the action was due to the removal of reward,
there would be expected to be no further effect of pimozide on top of
extinction. Also the effects of pimozide treatment fail to transfer to
the extinction case as also would be expected if it was acting by reduced
reward (381). However, another study has in fact shown this transfer
effect (634). Using a differential reinforcement of low rates paradigm,
pimozide failed to cause a decrease in responding (381). This was
taken as evidence that the rats could press slowly, but because of the
deficit in performance caused by the drug they could not press quickly.
The fact that rats can press slowly, but not quickly, means that the
effect of the drug could no longer be seen at low pressing rates.
Therefore reduction in performance would not be seen in studies with
low responding rates throughout (461). In one such study, although
the deficits in rate were not so clear, the fact that there was a reduction
in rate before the first reward was given supports a motor deficit
53.
involvement (461). It also argues against a reduced reward effect
in the presence of the neuroleptic, as the rate falls before the reduction
in reward could be detected by the animals. In reviewing the literature
in the discussion of this paper the author concludes that the deficit
cannot be only in reward, nor can it be a single motor fault. The
explanation given is that the deficits in performance are due to a
reduced ability to initiate movements (461).
A certain amount of confusion arises in the literature over what
constitutes a motor deficit. In the paper quoted advocating an impaired
motor ability, the definition of a deficit uses the concept that the
affected animals cannot maintain a high pressing rate (461). The
other studies mentioned, advocating the involvement of some other
mechanism, defines the motor deficit as an inability to perform at a high
rate at all (190a,635). This is obviously going to lead to differences
in interpretation.
From all the above data it is clear that unresolved conflict has
arisen from the results of the lever pressing experiments as to the
reason for the reduction in pressing rate caused by neuroleptics and,
by inference, what the role of DA is in the nigro-striatal pathway.
The evidence for and against a reduction in the reward value of the
reinforcers was reviewed in 1978 by Wise (631) and again more recently
(633). In these reviews, Wise clearly favours a block of reward
rather than a motor deficit and states that a difference in interpreta¬
tions could come from the different nature of the reinforcers used.
Food and amphetamine or apomorphine, when used as a reinforcer,
are temporarily satiating, that is, the reinforcer temporarily saturates
the rewarding mechanisms, and the animals will not respond again until
the mechanism is no longer saturated. ICSS, however, is not satiating
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in that the rewarding effect ceases immediately the stimulus stops
and therefore the rat can reach much higher, or even maximal,
pressing rates, this would lead to an almost immediate fall in pressing
rate when reward is withheld or a neuroleptic given (assuming it did
act by a reward reduction mechanism). This difference accounts for
the increase in rate of pressing for drug self-administration on treat¬
ment with a neuroleptic (641,642) and the lack of increase in some ICSS
experiments (191). However, in most of the ICSS experiments, the
response rate is usually initially normal until the rat "realises" that the
rewarding effect of the particular behaviour is no longer present.
There are exceptions to this too, however: in one experiment, using
a variable ratio design, the pressing rate was seen to fall before the
first response had been given (461).
The problem of different reward values in the different experi¬
ments can partly be overcome by making the animals run along an alley
before pressing for ICSS (190a). When rats are given neuroleptics
in this experiment, no impairment of the running before reaching the
lever was seen.
In the recent review (633) Wise has put forward a revised form
of the "anhedonia" hypothesis already mentioned (634). This hypothesis
suggests that:
"The most subtle and interesting effect of neuroleptics
is a selective attenuation of motivational arousal which is
a) critical for goal directed behaviour, b) normally induced
by reinforcers and associated environmental stimuli, and
c) normally accompanied by the subjective experience of
pleasure."
Because of the conflicting evidence and opinions on the role of
DA and neuroleptics in the nigro-striatal pathway, it is clear that other
experiments than the ones already described must be considered.
Evidence from some of these is now discussed.
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Neuroleptics cause greater disruption of ICSS than they do of
open field exploratory behaviour (511). This suggests a specific role
for neuroleptics in blocking ICSS but not for a general inhibition of
movement. Neuroleptics also interfere with the acquisition of some
tasks. Pimozide will cause rats to learn to press more slowly for
food than in the control state (633). Rats will not learn the best way
to escape from an underwater Y-maze if they are treated with neuro¬
leptics or if they have bilateral 6-OHDA lesions of the DA system
(484,486). This evidence has been used to suggest a learning deficit
in the animals, as the motor problems have been overcome by forcing
the animals to swim. Using a conditioned stimulus to train rats to lever
press it was shown that rats which were given haloperidol during the
conditioning period did not learn to press for the conditioned stimulus.
This must be an effect of reduced reward value of the reinforcer or
learning as no motor response was demanded from the animals during
the conditioning period and so a motor deficit caused by the neuroleptic
cannot be involved. It seemed that the effectiveness of the primary
reinforcer, amphetamine, in rewarding the rat was reduced by the
haloperidol (126). Acquisition of other classically conditioned responses
is also affected by neuroleptics (30,31,185). For example, neuroleptics
interfere with the learning of foot shock avoidance, but do not interfere
with foot shock escape (185). Also, although the rats failed to learn the
task while under the influence of the neuroleptic, if the animals were
tested after the effects of the drug had worn off, they were no different
from controls that had had saline for the same time that the others had
had neuroleptics for (185). This suggests that the rats had leanred the
task and that the deficit was an inability to initiate movements, rather
than a reward or a simple motor deficit or a learning deficit. Amphetamine
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enhances passive avoidance behaviour after acquisition and increases
extinction time on removal of the stimulus and haloperidol has the
opposite effect (352). These effects were noted at doses well below those
that caused a deficit in exploratory behaviour, again arguing against
a motor deficit. As with the operant behaviour experiments, the effects
of extinction and neuroleptics were additive and indicates that it is
possible some factor other than a block of reward is involved, but as the
exploratory behaviour was not affected, a gross motor abnormality could
not have existed.
Rats lesioned with KA also show behavioural changes. Rats
lesioned bilaterally with KA show an increase in locomotory behaviour,
but only in the dark (179). Apomorphine stereotypy is not enhanced,
but amphetamine stereotypy is (179). Using a passive avoidance test,
KA lesioned animals have been shown to take longer to learn and they
show less retention than controls. They showed no deficit in locomotory
behaviour, so they were unlikely to be suffering from a gross motor
deficit (179,528). The learning deficit may have resulted from an
inability to suppress the step down response rather than a learning or
retention problem and so the experimental design is possibly not ideal
for investigating the cause of the deficit caused by the lesion. In a
lever pressing task for food, the controls and lesioned animals learned
at the same rate, but the KA lesioned animals responded more during
extinction trials. This again could reflect an inability to suppress
certain behaviours.
Electrolytic lesions of the anterior striatum impair delayed
alternation but does not affect visual discrimination (418a). KA lesions
also cause these changes (147). KA acid lesions of the anterodorsal
striatum also impair the ability of the rats to acquire a spatial alternation
task (179).
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As the KA lesions destroy the cells post-synaptic to the nigro-
striatal ones, it would be expected that they would mimic the effects
of the 6-OHDA lesions. From the above it does seem that this is the
case and supports a role for the DA pathway in these behaviours.
In summary, the data seem to support a role for neuroleptics in
blocking the rewarding effect of the reinforcers and indirectly for a
role for DA in reward. However, there is also evidence in favour of a
motor deficit and a learning deficit, and it is highly probable that DA
has multiple effects in the brain. It also seems that at least some of
the effects of DA on behaviour are mediated by the nigro-striatal pathway.
Induced or inherent nigro-striatal asymmetry
Unilateral damage to the nigro-striatal system is not nearly so
debilitating to the animal as a bilateral lesion, but does still cause
changes in behaviour. These are easier to study because of the less
akinetic behaviour of the animals.
Animals with a LH or SN lesion, either electrolytic or 6-OHDA,
show a strong sensory neglect on the side of the body contralateral to
the lesion (368,380). This neglect gradually recovers from about 1
week after the lesion onwards. It seems that the lack of orientation
to sensory stimulation in the lesioned animals is not due to a motor
deficit as the different sensory modalities recover at different rates,
tactile stimuli never fully recovering (175,368). During recovery the
rat will orientate to one stimulus type but not to another. The sensory
inattention, produced by a 6-OHDA lesion, can be reversed by apo-
morphine and reproduced again by administration of neuroleptics (378).
In one study of sensory inattention, some animals showed no recovery
of response to touch after 4 months whereas some recovered after about
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1 month (377). The extent of recovery was correlated with the extent
of the DA depletion measured at the end of the experiment. In the
spontaneously recovered animals, the neglect could be reinstated by
giving the animals a-methyl-p-tyrosine. Partial recovery of the
asymmetries caused by unilateral 6-OHDA lesions of the nigro-striatal
path could also be achieved by giving the animals a transplant of
embryonic SN tissue (41,42,159), or by injecting a DA cell suspension
into the striatum (161). These procedures cause a reinnervation of the
cells by DA axons and these seem to function in some way similarly to
the removed DA pathway even although there is no actual input from
the SN.
Experiments have also shown that the sensory neglect can, to
some extent, be reversed by conditioning (545). The arousing effects
of a noxious tail stimulus on the EEG of the animals is removed by the
lesioning of the DA pathway (544). If the stimulus is applied along
with a conditioned stimulus, the arousing effect is again seen despite
the lesion. It seems therefore that conditioning can amplify sensory
signals and cause a response to the signal to go via a route not involv¬
ing the SN DA system (545).
As well as causing sensory neglect, unilateral lesions of the
nigro-striatal DA pathway result in a strong rotatory response to apo-
morphine (contralateral) or amphetamine (ipsilateral) (592,593,595).
The former is due to a greater action of the drug on the lesioned side
which has become supersensitive as a result of the lesion. The latter
is suggested to be due to the release of DA from the intact terminals.
This is evidence in favour of a motor function of the nigro-striatal
system.
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Unilateral lesions also lead to changes in operant behaviour.
Recent experiments in this laboratory have shown that the assumption
that the effect of a lesion on behaviour will be the same, whichever side
of the brain it is given on, is not necessarily correct (590). It was
shown that a 6-OHDA lesion on the side of the brain that was ipsilateral
to the paw the animals chose to use most often in the pressing behaviour,
was far less disruptive to the lever pressing than a lesion contralateral
to the rats "preferred paw", that is the one the rat chose to use most
often. Figure 6 shows the results of these experiments (adapted from
590). The group operated contralateral^ to the initially preferred paw
show a decrease in total performance in each 30 min session and they
also have a tendency to use the initially "unpreferred" paw more than
the other one. This is not seen in animals operated on the side
ipsilateral to the preferred paw or in controls. Eight weeks later, the
performance level has returned to normal, but the paw preference remains
changed.
Several other studies have recently used unilateral 6-OHDA
lesions to study ICSS (84, 348,460). In these the lesions are placed
ipsilateral to the ICSS electrode in experimental animals and contra¬
lateral to it in the control animals. These studies produced results that
to some extent were conflicting. In one, only transient deficits in
pressing were seen when the lesion was contralateral to the electrode,
whereas longer disruption was observed when the lesion was on the
same side as the electrode (348). This experiment supports a role for
the DA system in reward processes. Another of these studies observed
equal disruption when the lesion was both ipsi- and contralateral to the
ICSS electrode and concluded that DA was not involved in reward and















FIGURE 6: Effect of ipsilateral and contralteral 6-OHDA lesions in
the MFB on pressing behaviour.
The vertical axis represents the number of presses totalled over two
sessions at each of the three times. Presses with the preferred paw
are shown on the upward axis and those with the other paw are shown
on the downward one. Presses not with an individual paw are not shown.
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FIGURE 7: Diagrammatic representation of a typical NMA lesion that
resulted in a change in paw use and turning in response to
apomorphine. Some lesions were larger than this, but this
example indicates the area of damage common to all the
effective lesions. The more posterior part of the lesion
seemed to be needed for the turning response, whereas the
anterior part was also necessary for the change in paw use.
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by the lesion (460). The third study found transient disruptions when
the lesion was made on either side, and these recovered in 8-10 days
(84). These also concluded that DA could not be important in mediating
the effects of ICSS. The differences could possibly be explained if
these lesions were made contralateral^ or ipsilaterally to an inherent
preference of the animals.
That rats do have inherent discrepancies between their DA
systems has been extensively reported by Glick and coworkers (219—
227, 297-299,656). Rats normally have a 10-15% difference in the
levels of DA in the two striata (656) and this difference is correlated
with the side preference of the animals in a T-maze, passive avoidance
test. The higher DA levels correlate with the side contralateral to the
preferred side. Rats sometimes show spontaneous turning behaviour
when tested in a rotameter (225) although the levels are far lower than
those induced by apomorphine in the lesioned animals. Amphetamine
increases the asymmetry in DA levels (223) and it will cause circling
in the rotameter in a direction contralateral to the higher DA level
(219,220,222,227,297). Apomorphine will also cause rotation in rats
and cats (298,299). Glick's laboratory has shown that out of 602 rats
there appeared to be a right sided population bias (226).
In a differential reinforcement of low rates design (DRL), better
performance is related to a greater side preference (220) as was the
time taken to learn a passive avoidance task (519).
When unilateral caudate lesions are made, it appears that the
rotation in response to the drugs is reduced or reversed if the lesion
is contralateral to the initial direction of turning, but will enhance it
if the lesion was ipsilateral to the initial direction of turning (298).
Similarly lesions ipsilaterally to the rats preferred side in a T-maze
62.
will enhance the side preference and facilitate passive avoidance
learning (519).
Although Glick's work has concentrated on side preference, he
has also considered paw-preference. In a bar pressing task for water
reinforcement, most rats showed a consistent side preference (222).
High pressing rates were correlated with greater side preference and
there was a correlation between side and paw preference: 75% used
the same paw as lever (224). In relation to preference, subtle differ¬
ences appeared on different reinforcement schedules, depending to
some extent on the relation between paw and side preference (220,222).
This is discussed in detail in the discussion.
Stimulation of the caudate nucleus during the performance of
a task will also cause a change in side preference, leading to a "strong
overattention" to the opposite side to the stimulation (655). This
supports the hypothesis that asymmetry is due to the overactivation of
one striatum.
Another group, has also studied paw preference in rats. They
have shown that an injection of 6-OHDA into the side of the brain
ipsilateral to the side the animals preferentially reached for food with,
caused little effect on the reaching behaviour. On the other hand,
a lesion contralateral to the preferred limb caused a decrease in
responding and also a tendency to use the other limb (546). This is
similar to the experiments on paw-preference already described from
this laboratory (590).
If the initial acquisition of the task was made 1 month after the




In this chapter the performance deficit seen in Uguru-Okori and
Arbuthnott's experiments (590) is further investigated, with a view
to further elucidating the nature of the deficit. The results
described already were repeated and extended, and other disruptive
procedures were administered to the animals in an attempt to reproduce
the performance deficits seen in unilaterally 6-OHDA lesioned animals.
The first hypothesis tested was that a motor deficit on one side
was sufficiently disruptive to cause a performance deficit as the animals
started to use the other paw. In order to do this various motor lesions
were given to the animals. These were neurotoxic lesions (NMA and KA)
in the striatum, electrolytic lesions of the striato-nigral pathway in
the crus cerebri and temporary, peripheral paralysis of the preferred
forelimb with a local anaesthetic. The effects of these procedures on
performance and preference were studied after each procedure.
The second hypothesis tested was that, because of the motor
impairment of the preferred limb, the rats had to relearn the task with
the other paw and that this was what caused the drop in pressing rate
while the rats were in the process of changing paw use. To test this,
the rats were trained to use the initially unpreferred paw and the
pressing rate was monitored while the rats were swapping.
As well as the above, the effect of unilateral 6-OHDA lesions
on the initial acquisition of the task was investigated, as was the
effect of an ipsilateral lesion on forcing the rats to use the initially
unpreferred paw. Further analysis of the relation between paw and
lever preference was also carried out.
The results presented here show that neither of the hypotheses
are valid and that none of the procedures used mimicked the effect of
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6-OHDA in reducing total pressing rate although they all (except the
ipsilateral procedures) caused a change in the paw preferentially used.
6-OHDA lesioned rats all learned to press with the paw ipsilateral to
the lesion, and the animals lesioned before training could not be
retrained to use the contralateral paw after the initial training had
been completed. Some of these results have already been presented
(253).
3.2 Behavioural methods
In most experiments, rats were pretrained to press for food in
the standard Skinner box. The experimental procedures were then
carried out, the animals replaced in the box and retested. In some of
the 6-OHDA experiments, the operation was carried out before any
training. In the case of the animals trained to swap paws the procedure
was, of course, carried out in the box. The effects of the various
procedures on learning or performance were then determined.
Initial training procedure
Male albino Wistar rats weighing 150-200 g were used in all experi¬
ments except where stated. The size was chosen so that the animals
would be the correct weight (200 g) for the coordinates when they
were ready for the operation. Rats to be given no pretraining were
started at 180-200 g.
All animals were daylight reversed for at least 10 days before
the start of the pretraining sessions. They were kept 14 hours in
daylight and 10 in the dark, and all training was done early in the dark
period. Also they were food deprived for 24 hours followed by a short
feeding period, 1 hour, at the start of the next 24 hours, at the end
of which the training procedure was started. This stopped the animals
from being too hungry to learn the task properly when they were
placed in the box, yet hungry enough to maintain interest throughout
the entire first session.
The training procedure consisted of placing food pellets (45 mg,
Campden Instruments Ltd) in the food hopper and crushed food pellets
on the two identical levers of a Skinner behaviour box (Campden
Instruments Ltd). The rats were placed in the box and manually shaped
until they had learned to press for the pellets. The shaping consisted
of giving the rat pellets by remote control while it had its head in or
near to the food hopper, until it learned to associate the noise of the
pellet dropping with the actual arrival of food. Once this association
was made, the emphasis in the shaping was gradually changed from
giving pellets when the rat's head was in the hopper, to when the rat
approached the lever with his paw. Eventually the rat pressed the lever
and earned the pellets. Criterion was said to have been reached when
20 presses by the rat were immediately followed by food retrieval in an
associating manner.
Criterion was reached within 2 or 3 hours in the box. Initial
session length varied from 30 minutes to 1 hour, so this was in three
or four sessions. Occasionally a rat would learn to press in less than
30 minutes. After acquisition of the task, four 30-minute sessions were
recorded. Note was taken of the total number of successful presses
and how these presses were divided between the two paws, both paws
or "other" presses such as with the nose.
No other feeding was given other than in the training sessions
unless the weight of the rat fell below 80% of its control weight. This
only very rarely occurred, but when it did the rat was allowed to feed




The methods for making all the lesions described are given in the
general methods section, only the specific points relevant to the
behaviour are mentioned here.
In all cases where lesions of the central nervous system were
made, the animals were allowed to feed freely for 24-48 hours before
the operation. They were also allowed at least 1 week to recover from
the acute effects of surgery before being food deprived again.
In all cases where there was pretraining, the side of the brain
which was operated, depended on the paw preferentially used by the
rat. The lesion was then performed either ipsilaterally or contra-
laterally to this paw, depending on the experiment.
The retesting procedure involved placing the rat in the Skinner
box and observing its performance as in the initial four sessions.
Three or four sessions were recorded.
In one group of 6-OHDA lesioned animals the operations were
performed before any pretraining. In this group the animals were left
for 4 weeks before the initial training procedure was given. This
meant that this group was larger in size (250-300 g) than the others.
In another group of 6-OHDA lesioned animals, operated ipsilaterally
to their preferred paw, they were retested for three sessions before
the experimental procedure was carried out, in this case the injection
of local anaesthetic to the preferred forepaw (see later).
The contralateral 6-OHDA lesioned group was also retested 4 and
8 weeks later to observe any change in performance. At 4 weeks
three sessions were recorded, and at 8 weeks five sessions were recorded.
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- Local anaesthetic injections:
At an interval after the pretraining sessions, the rats were
injected with 0.3 ml lignocaine hydrochloride (Xylocaine, Astra
Pharmaceuticals Ltd) in a 2% solution. This was put into the flexor
muscle of the preferred forelimb. The animal was then returned to its
home cage until it could not support its weight on that paw and the
withdrawal reflex on pinching had disappeared. This generally took
from 3-5 min. The animals were then retested, and the procedure
repeated three or four times, one session per day. After the last
session the animals were tested for full recovery. Some of the animals
were tested again 8 weeks later to see if the original preference had
returned.
- Retraining to use the other paw:
Two days or 1 week after pretraining one group of rats was
replaced in the Skinner box and retrained to use the initially unpreferred
paw. This was done by not rewarding the rat on use of the preferred
paw and removing the lever just as the rat was about to press. For
this experiment, the automatic reinforcing mechanism was disconnected
and all pellets were given by remote control. This allowed for more
operator bias in this experiment than the others. In order to be able to
do this the Skinner boxes were modified to have retractable levers.
Reward, however, was given on use of either both paws or the other
paw. Reinforcement on both paws was needed to prevent an extinction
response. Five sessions were recorded here. Lever withdrawals were
counted rather than preferred presses in this case.
Some of this group were also tested 8 weeks later, to observe
whether or not the original preference had returned.
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- Controls:
One group of animals was pretrained and then left for a week
before being retested. This was to assess the effect of a gap on the
performance. Another group was pretrained as described, but the
initial weight was higher, 250-300 g, to act as controls for the larger
6-OHDA lesioned group.
Analysis
As the pressing rates are not normally distributed it was decided
to use non-parametric statistics. The most usual tests were the
Wilcoxon Rank Sum test and Spearman Rank Correlation test. The
tests were always done on the total of the specified type of press over
the relevant time period, for each rat. In some instances a paired
t-test was used. Although the numbers themselves are not normally
distributed, the differences nearly always are, thus allowing the use
of the paired t-test. When more than two sets of data were being
compared with each other, a Kruskal-Wallis one-way analysis of variance
was used, along with a critical range method for multiple comparisons
to tell which pairs did differ (see 90). Further details of which test
was used in a given case is reported in the Results section (Section 3.3).
3.3 Results
Before the results from the experiments are given, the develop¬
ment of the NMA lesion is described, as are the details of the other
lesions used. The results from the lever pressing experiments are then
presented in the following order: firstly, the results from the initial
training procedure are covered, followed by the effects of the various
experimental procedures on the pressing behaviour. Finally, a compari¬
son of the different procedures is given.
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Development and description of the NMA lesion
Although NMA has been reported to cause similar neurotoxic
lesions to KA (see Section 3.1), details of the lesion making procedure
were not available. Therefore in order to achieve a successful lesion,
several combinations of doses and injection volumes were tried before
the lever pressing experiments were started. NMA has been reported
as being less potent than KA, and so the first dose attempted was just
greater than that used for the KA lesions (2.5 ag) and injected in
the same volume (0.2 |il). This dose caused virtually no damage to the
brain apart from the injection track itself. The other doses tried at
a preliminary stage were 5 ag and 10 ag in volumes of 0.4 al and 0.8 al
all at a rate of 0.1 al/min. 5 ag in either volume caused a small
lesion, close to the injection site, although in one case there was more
widespread damage, including nearly half the striatum. 10 ag in either
volume caused a satisfactory lesion. 0.4 al gave a greater extent of
gliosis and cell loss than 0.8 al, but it was not quite as extensive.
The 0.8 al volume spread further than the 0.4 al one, but did not cause
as severe damage, presumably due to the lower concentration. 10 ag in
0.4 al was chosen as the first dose to try in the lever pressing experi¬
ments, as it caused widespread damage and extensive cell loss within
the area of the lesion. It also caused the rotation of the animals in
response to 2 mg/kg apomorphine in a reasonable number of cases.
In a number of these test animals, as well as in all the animals used for
the pressing experiments, GAD was measured in both SN to see if the
lesion had caused a depletion in the lesioned side. However, when SN
from both sides of the brain in control animals were assayed, the
variation between the two sides was great (see Table 1). Because of
this it was decided not to use the biochemistry as a diagnostic parameter
of the lesion, but only to use it in support of other evidence.
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GAD in substantia nigrae
(nmol/mg protein/hr)






TABLE 1: Levels of GAD in the SN of control rats.
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The results from the first batch of rats used in the pressing
experiments were not very consistent with respect to the histology,
the turning behaviour and the pressing behaviour. Some of the
lesions seemed small on examination and it was decided to use double
the dose (20 ug in 0.8 |il) for the later set of experiments. Also as
some rats swapped gradually, it was decided to leave the rats for 2
weeks after the operation before retesting to see if this made any
difference. This did lead to more consistent results. However, the
extent of damage caused by the different doses and recovery times
did overlap to some degree and the results of the experiments are com¬
pared with the extent of histological damage rather than the dose used
or time before retesting. A description of the histology, behaviour and
biochemistry is given below and an attempt is made to correlate all the
data in a meaningful manner.
In total, 48 rats were injected with NMA. In 34 GAD was measured
in both SN and in 27 of these, the paw preference of the rats in the
Skinner box was tested before and after the lesion. In the animals
that were tested for paw preference, the injections were all given on
the contralateral side to the animals' preferred paw. In all, 23 rats
turned more than 75 times in response to 2 mg/kg apomorphine, and
another 2 turned only 40 times but had a marked asymmetrical posture.
All but 2 of these 25 turning rats had the same histological profile
after the lesion. This consisted of a large lesion, covering about half
or more of the nucleus and based medially and posteriorly in the
nucleus, with a possible ventral tendency. The minimum extent of the
lesion was from the anterior commisure or just anterior to it, right back,
almost to the globus pallidus. The medial part of the striatum was always
damaged, but the lateral rim was not always affected. One exception to
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the above was one of the rats given the lowest dose of NMA, and virtually
no damage was seen in the nucleus apart from the needle track.
Four rats with a similar profile to the above did not turn in
response to the apomorphine. Two of these, however, did swap paws
after the lesion and 1 responded inconsistently to the apomorphine, and
was therefore not included in any further analysis. In response to the
first challenge with apomorphine, it turned about 50 times ipsilaterally
to the lesion, however at the next test session, it turned similarly in
the other direction. The last of these 4 rats possibly did not have quite
as posterior a lesion as the others.
In all, 16 rats changed the preferred paw in the Skinner box
after the lesion. Ten of these swapped immediately on retesting, and
6 swapped more gradually over two or more sessions in the box. All
the rats that changed the paw preferentially used for pressing
immediately had a similar lesion. This was similar to that described
above for the "turning rats", but they also had a considerable antero¬
lateral component, extending right to the front of the nucleus. Moving
posteriorly in the brain the lesion appears to shift medially, leaving an
outer rim, continuous with the tail of the striatum. This lesion is shown
diagrammatically in Figure 7. The rats that took longer to swap paws
also had a lesion like this, but it did not extend quite as far anterolateral^
as the others.
All but 3 of the rats that swapped paws also turned in response to
the apomorphine. Two of the exceptions showed the same histological
lesion as described for the turners and swappers, but the third showed
extensive septal damage, and it appeared that the injection had gone
through the lateral ventricle. This animal was excluded because of this
despite the fact that it did swap paws and had a drop in nigral GAD on
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the lesioned side. The relationship between turning response to apo-
morphine and paw swapping is shown in Table 2.
Of the rats that turned, only 5 did not show a decrease in GAD
in the SN from the lesioned side, when compared with control. 4 of
these had comparable histology to those that did show a decrease, and
2 of this 4 did swap paws. One was not tested for preference.
On the other hand, 5 rats showed a decrease in GAD in the SN
ipsilateral to the lesion, but did not turn. Three of those, however,
swapped paws and the other 2 were not tested for preference. Of the
2 rats not tested, 1 had a small pallidal lesion, possibly counting for the
drop in GAD in SN, and the other had a dorsal, slightly anterior lesion.
Three rats with decreased GAD neither turned nor swapped paws.
One of these belonged to the group with comparable histology as the
turners, and another showed contradictory responses to apomorphine as
has already been mentioned. This leaves only 1 rat with a drop in GAD
and no other asymmetry, except the lesion. However, in view of the
variable control biochemistry this is not necessarily important. Despite
the variability of the biochemistry, most animals with extensive lesions
do show a decrease in GAD, although some did show a decrease with
little evidence of histological damage. Changes in GAD levels are shown
in Table 3, along with details of turning and swapping.
Of the rats that did not turn only the 4 already mentioned resembled
the turning group. All the others had small or misplaced lesions which
did not result in a change in pressing behaviour. It is interesting that
the one pallidal lesion did not result in turning or swapping. Electrolytic
lesions of the globus pallidus have been reported to cause a block in the
use of the contralateral paw (359). This is possibly due to damage of













TABLE 2: Relationship between rats that turned in response to
2 mg/kg apomorphine and those that swapped paws
after an injection of NMA into the striatum contra¬
lateral to the initially preferred paw.
* a) did not turn, but showed "turning" histology;









Intact Lesioned side as apomorphine)
side side % control ipsi /contralateral
194 220 113 52/39 - (c)
353 110 31 14/13 - (c)
187 210 112 142/11 - (c)
212 70 33 160/32 - (a)
149 80 54 167/21 - (b)
260 144 55 3/17 - (c)
144 144 100 110/0 No -
190 102 54 129/0 Gradually (b)
365 72 20 198/6 Gradually (b)
43 46 107 10/16 No (c)
165 75 46 (303/37) Immediately (b)
196 153 78 8/0 No (c)
221 189 86 198/2 Gradually (b)
154 180 117 176/6 No (a)
140 164 117 77/7 No (a)
131 135 103 43/13* Immediately (b)
113 184 162 38/7 No (c)
264 55 21 11/12 Gradually + (c)
216 161 75 6/23 Immediately (b)
217 229 106 27/12 No (c)
173 32 18 54/0 or 0/74 No (a)
237 231 97 0/54 or 45/1 No (a)
244 128 57 23/8 No (c)
194 61 31 191/1 Immediately (b)
78 44 56 153/0 Immediately (b)
132 115 87 21/9 No (c)
240 118 49 132/0 Immediately (b)
92 35 38 181/3 Immediately (b)
322 177 55 40/0* Gradually (b)
212 92 43 178/2 Immediately (b)
230 133 58 19/4 Gradually (b)
174 138 79 79/0 Immediately (b)
231 237 103 124/1 Immediately (b)
TABLE 3: GAD levels in the SN, turning behaviour and swapping
behaviour in all rats measured after an injection of NMA into
the striatum contralateral to the initially preferred paw. For details see
text. The figure in brackets is artificially high due to "oscillations" about
the counting point in the rotometer.
(a) "turning only" histology; (b) "swapping" histology; (c) other histology.
t This rat was excluded as the injection appeared to be into the lateral
ventricle. - Implies the information was not available. * Low turning rates,
but with a distinct asymmetric posture.
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lesion in the front of the striatum, not extending behind the anterior
commisure, resulted in neither turning nor paw preference changes.
Also an animal with anterior lesion which was placed medially with no
lateral damage did not swap paws.
It seems therefore that, in order for a rat to turn in response to
apomorphine, the lesion must be placed in the posterior two-thirds of
the nucleus more medially than laterally. For the paw preference to
alter, this lesion must continue forward, moving to the lateral anterior
striatum.
The results from the paw preference experiments in NMA lesioned
animals are shown in Figure 19. All rats which swapped paws except
the rat with the septal lesion are included.
NMA is much less potent than KA and also much less eleptogenic,
yet it seems able to produce very similar lesions. The animals are much
less ill after NMA injections.than they are after KA injections. A com¬
plicated sequence of motor behaviour results on recovery from the
halothane anaesthesia. The rats tend to circle gently, with the lesion
on the inside, from time to time. This is interspersed with periods of
normal behaviour and also, small forelimb twitches and occasional
convulsions. The twitches were on the contralateral side to the lesion,
and during the convulsions, the rats twisted violently in a contralateral
direction. After the convulsion the rat would go back to circling gently
ipsilaterally. This contrasts with the behaviour of the KA rats which
run in violent contralateral circles and have violent convulsions leading
to unconsciousness The NMA rats do not lose consciousness and are
relatively normal between twitches or convulsions. The KA rats are
unwell for several days, often with bleeding from the nose and urinary
tract. However, the NMA rats recover well from the operation.
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FIGURE 8: The photograph shows possible damage to the internal
capsule fibres near to the injection site of an NMA lesioned
striatum. An apparent loss of myelin has occurred in the
bundles, as shown by reduced blue staining. There is
possibly a slight shape change in the bundles as well.
Fibres are normal in front of and behind this point as far
as the luxol fast blue, cresyl violet staining method can tell.
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FIGURE 9: Histology of an NMA lesioned striatum (A) stained by
the luxol fast blue and cresyl violet method, compared with
a control striatum (B).
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FIGURE 10: Illustration of the blue "halo" effect seen in the striata
of rats injected with NMA and stained with the luxol fast
blue, cresyl violet method. Gall loss can bo g;ooii in this
area, but there is less gliosis than in the centre of the
luainn.
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Associated with the reduced level of convulsions, the NMA
lesioned rats do not have the non-specific damage resulting from the
convulsions that the KA rats often have.
Histologically, the NMA lesion is similar to the KA lesion, with
gliosis, cell loss and shrinkage of the striatum. Also, in most cases
the internal capsule fibres are spared although in one case interesting
changes in these were noted. The fibres appeared to change in shape
and the blue staining was much less. This was only seen near the
injection site, and the fibres are normal just behind this, showing the
fibres are still there. This is shown in Figure 8 and discussed later.
In many cases a blue "halo" was seen round the edge of the lesion.
The blue was darker than that of the myelin and in this area, although
cell loss was apparent, gliosis was not marked either. Figure 9 shows
a NMA lesion and the control side of the brain, and Figure 10 shows an
example of the halo.
Description of the other lesions
- Kainic acid lesions:
Histologically these lesions resemble those already described for
the NMA treated rats, and those already described in the literature
(see Section 1.6). Only the posterior portion of the striatum was
available in these rats as the anterior portion had been used for GAD
and CAT estimation. Ideally, the brain was divided down the injection
track, but due to shape changes and drying on freezing, not all the
posterior half of the lesion was examinable. Therefore in some animals
little or none of the lesion could be examined histologically. Because of
this, the type of correlation between all the measurements done in the
case of the NMA lesioned rats could not be done with the KA ones.
However, only one rat showed any differences from the NMA group. All
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the others could well have been similar to the NMA ones. The exception
swapped paws without turning and without the "turning" histology as
mentioned in the previous section. This might imply that the posterior,
medial lesion may not in fact be essential for the reversal of paw
preference, and the fact that all those in the NMA group did show
this as well as the anterior lesion was purely fortuitous.
The levels of turning in these rats was much lower than the NMA
group. This may have been due to the fact that these rats were less
healthy. Despite this one rat turned at a phenomenal rate and was
stopped after 5 minutes with an injection of haloperidol as it was going
to damage itself. In the 5 min the rat spun round 164 times. This
animal was killed as it was extremely jumpy and was virtually impossible
to handle. It would not settle in the box for starting at the tiniest
movement or sound, and would not lever press. Histology was examined
from this animal and both ventricles were seen to be enlarged. Non¬
specific damage from convulsions was clearly seen in the lateral and
ventral cortex, as well as the specific KA lesion in the striatum.
The details of the behaviour, biochemistry and histology for the
animals used are given in Table 4. Of the animals that swapped paw
after the operation, only one turned well. Another three had similar
histology to the one that did, but the other one did not. The lesion in
this rat was purely anterior, and may mean, as commented on already,
that the turning profile is not essential for swapping paws. The
biochemistry on the striatal tissue was much more consistent than that
on the SN and so is more useful in describing the lesions. The levels in
both striata of control animals are given in Table 5.
Figure 11 shows an example of a KA lesion and its control side.
This is not from an animal used in the paw preference experiments as
KA contralateral toinitially preferredaw
GAD
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GAD in striatum CAT in striatum
(nmol/mg protein/hr) (nmol/mg protein/hr)
Left side Right side Left side Right side
77.4 239.7 279.7 460.1
70.6 77.3 442.6 162.2
95.0 75.0 385.5 131.4
71.8 97.3 - -
69.0 126.6 282.4 367.9
52.1 77.5 146.0 217.9
107.9 79.7 154.5 136.3
95.8 185.0 137.1 94.3
85.3 77.8 176.3 127.6
73.1 100.9 94.3 148.2
109.6 134.6 335.8 266.1
56.9 173.9 318.4 433.5
TABLE 5: Levels of GAD + CAT in the striata of control rats.
FIGURE 11: Histology of a lesion caused by KA and stained with luxol




























TABLE 6: DA levels in the striata and turning behaviour of
rats after unilateral injections of 6-OHDA into the
MFB ipsilateral to their initially preferred paw.
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TABLE 7: Number of turns in response to 0.3 mg/kg in 6-OHDA
lesioned rats. Swapping behaviour for these rats
is shown in Figure 15.
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some of the nucleus was used for biochemistry in all of these animals.
This photograph comes from an animal destined for electrophysiology,
but that had to be killed 4 days after the operation as it had broken
a leg turning in the cage. Full degeneration may not have occurred in
4 days, but significant gliosis is seen.
- Electrolytic lesions in the eras cerebri:
These lesions were described only on the basis of histology and
turning. A typical lesion is shown in Figure 12. All these rats turned
100 times or thereabouts in 30 minutes to 2 mg/kg apomorphine.
- 6-hydroxydopamine lesions
All 6-OHDA lesioned animals turned more than 150 times in 45 min
to 0.3 mg/kg apomorphine, some much more. These rats turned contra¬
lateral^ in contrast to the other lesions all of which turned ipsilaterally
to the operated side.
The group operated ipsilaterally to the preferred paw also had
levels of DA measured in the striatum. The values for this group and
those for the control group used in this experiment are given in Table 6.
The turning figures, for the other rats used in the pretraining experi¬
ments, are given in Table 7.
Results from the initial training procedures
In total 131 rats were trained to lever press for food. All the rats
used learned to press and all but three did so within 3 hours in the
Skinner box and a few in as little as 30 min in the box. Of the 3 rats
that took longer than this, the longest time was 5 hours.
The total number of presses in each 30 min varied a lot, tending





FIGURE 12: Histology of an electrolytic lesion of the striato-nigral
pathway in the crus cerebri, stained with the luxol fast
blue, cresyl violet method. The dotted line indicates the
extent of the lesion.
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to as many as 250, or occasionally more. Most sessions were in the 100
to 225 range. In the later sessions rats often pressed faster than this
if the experimental procedure applied did not affect the total rate.
The maximum in any session was 330.
The rats needed no supplementary feeding during the week.
They all ate enough during the training sessions to maintain 80% body
weight during one week of training. It seems likely that the rats had
nearly reached the maximum pressing rate by the end of the initial
training period. It would seem that an animal having eaten 200-250
pellets is quite full and unlikely to press for much more food. Despite
this, very little drop in pressing rate was seen after the first few
minutes in the box. 30 min therefore seems to have been the ideal
duration for the test sessions.
All but 4 of the 131 rats showed a "paw preference" in the lever
pressing behaviour. That is they used one paw consistently more than
the other. The 4 exceptions pressed often with both paws or showed no
real preference for one or other paw. Three other rats changed
preference during the pretraining procedure, or showed signs of doing
so. Similarly, the rats showed a lever preference. Only 3 rats did not
have a strong preference, and another 6 tended to change which lever
they used more often during the training sessions.
Eighty out of 131 rats used their left paw rather than the right
and 51 used the right rather than the left. Seventy rats tended to use
the left lever and 61 used the right one. Rats were assigned to the
above groups using the total number of presses in the last four sessions
with the preferred paw or with any other combination of presses. Those
without a strong preference were included although their degree of
preference was very low. Seventy-three rats pressed with the same lever
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as their preferred paw, and 58 used the opposite lever to the preferred
paw.
Using a Students paired t-test, it was shown that the rats do
have a significant lever preference and a significant paw preference
(P <0.001). It was also shown, using a Spearman Rank Correlation test,
that there was a significant correlation between the lever preference
and the paw preference (P <0.01). To do this the number of presses
with the right paw was compared with the number on the right lever,
and similarly for the left side. Therefore each rat had two comparisons
made on its behaviour. The correlation coefficient was R = 0.19 which is
very low and although this was significant due to the large number
(262), it might suggest a low correlation level. This is supported by a
plot of all the figures used in the correlation, shown in Figure 13,
where a large number of points are not on the straight line. The left
and right values are both plotted on the same axes in the graph.
It was also shown using a chi-squared goodness of fit test that
the sample of rats had a slight left bias in paw preference (P <0.025),
but no bias in which lever was preferentially used (P >0.1). The
expected values used in the chi-squared test were those that would have
resulted if the sample had been divided equally between the right and
left hand side.
For the experimental procedures, no rats were used that did not
show a clear paw preference at the start of the procedure.
- Initial training of 6-hydroxydopamine lesioned rats:
These animals were given the initial training procedure 4 weeks
after an injection of 6-OHDA into the MFB . All 7 successfully lesioned
animals, as determined by their response to 0.3 mg/kg apomorphine,

















FIGURE 13: Scatter diagram showing the correlation between lever
and paw preference. Two points are plotted for each rat:
one for the number of presses with the right paw on the
right lever and one for the number of presses with the
left paw on the left lever. There is a highly significant
correlation between the two preferences (P <0.01).
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controls the rate of learning proved to be significantly slower (P <0.01
on a Wilcoxon Rank Sum test). The times taken to reach the criterion
level of 20 consecutive presses followed by immediate food retrieval,
is shown for lesioned and controls in Table 8, and a plot of the number
of presses in each 30-minute session is shown in Figure 14. In this,
sessions at the start which were not 30 min (these were either 60 min
or 15 min) are corrected arithmetically to be equivalent o a 30-minute
session. As well as being slower to criterion, the rats also appeared
to attain a lower maximum pressing rate, although this did not reach
significance. The mean control maximum was 210.4 and that of the
lesioned group was 186.4. The lesioned rat that has values among the
control ones did take a longer time to criterion that the controls. This
does not show well in the graph due to the correction procedure.
However, this lesioned rat did seem to learn faster than the other ones
and reached a higher level.
The rats rotated spontaneously in a direction ipsilateral to the
lesion while they were in the Skinner box, especially in the earlier sessions
or after being disturbed. This may have resulted in the slower learning
rate. These animals were also noted to have a high negative correlation
between paw use and lever use (P <0.02) whereas the overall level for
control rats was a positive correlation. The respective correlation
coefficients are +0.19 for the controls and -0.71 for the lesioned animals.
There would therefore appear to be a much stronger correlation in the
lesioned group. It certainly seemed so watching the animals. The rats
tended to use the lever contralateral to their preferred paw (and the
lesion) because of the tendency to circle: once the rat had learned to
press, it moved very quickly to the food hopper, this movement was












TABLE 8: Time taken to reach criterion (20 consecutive presses
followed by food retrieval) in minutes, to the nearest
15 minutes. The two groups are significantly different
(P <0.01) on a Wilcoxon Rank Sum test.
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FIGURE 14: Graph showing the rates of acquisition of the lever
pressing task in rats lesioned 4 weeks previously with
6-OHDA in the MFB and in weight matched controls.
The lesioned rats were significantly slower to reach
criterion (20 consecutive presses in 30 min) than controls
(P <0.01).
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anyway than against it. The rats appeared to have no problems in
going against their tendency to circle when they moved to press the
lever.
No such correlation was seen in the NMA treated animals or in
the LA treated group at 1 week or at 8 weeks.
Effects of experimental procedures administered contralateral!)/ to
the initially preferred paw
Figures 15 to 21, situated on the following pages, show the effects
on pressing behaviour of the various procedures. In these diagrams
the vertical axis represents the number of presses in each session and
the horizontal axis represents the sessions. In the preference graphs,
the positive vertical axis represents presses with the preferred paw
and the negative axis, all other presses. In each case the statistics
are performed on the total number of the relevant type of press in the
appropriate number of sessions, for each rat. The tests are made on the
same number of sessions before and after the procedures, using the
required number immediately before and after the procedure if uneven
numbers of sessions are plotted in the graphs. The effects are
described in detail in the figure legends and summarised at the end of





17 Local anaesthetic injections
18 KA lesions
19a NMA lesions - immediate swappers
19b NMA lesions - gradual swappers
20 Crus cerebri lesions
21 Training controls
FIGURE 17: Effect of local anaesthetic injections into the preferred
paw on pressing behaviour •
Using a Kruskall-Wallis one way analysis of variance, it is shown that
the total pressing rate does vary in the three groups of testing sessions
(P <0.0005). Using the critical range method for multiple comparisons
it is shown that the total rate during local anaesthesia is not different
from control, but that the total rate 8 weeks later is increased both
from control and the local anaesthetic level (P <0.01). Using the same
statistics, the number of presses with the preferred paw is significantly
different in the 3 groups (P <0.001). The use of the initially preferred
paw is reduced in the local anaesthetic sessions, and that of other
presses is increased (both P <0.01). The number of presses with the
preferred paw is not different from control during the retesting sessions
at 8 weeks, indicating a reversal of paw use. However the use of the
initially unpreferred paw at this time is not significantly different from
the local anaesthetic level, indicating the reversal to original paw use
is not complete. Only 9 rats were tested at the 8 week time and as
the multiple comparison test needs equal n the statistics were only done
on those 9 rats throughout. However, another 5 rats are included in
the graph at the 2 earlier times. In summary, the local anaesthetic
injections result in a change in paw preference, that partially reverses







































FIGURE 16: Effect of a 1 week break in training on pressing
behaviour.
A 1 week gap does not impair the pressing behaviour at all. In
fact, using a paired t-test it can be shown that the rate is greater
after the week's break than before it (P <0.001). Also, the number
of presses with the preferred paw increases with no increase in the
number of other presses. This indicates an increased preference.
FIGURE 19: Effect of NMA lesions contralateral to the preferred paw
on pressing.
A. Rats that swap paws immediately. These rats do not show any
change in total pressing rate on a paired t-test. However, the
number with the initially preferred paw decreases and other
presses increases (P <0.001).
B. Rats swapping paws gradually. Using a paired t-test before
and after, it can be seen that there is no change in total pressing,
and very little change in the number of presses with the initially
preferred paw (0.1> P >0.05). However there is a significant change
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FIGURE 18: Effect of KA lesions contralateral to the preferred paw
on the pressing behaviour.
These lesions cause a swap in paw preference, almost but not quite
immediately after the operation. Using a paired t-test, the total
pressing rate is not affected, but there is a decrease in the number
of presses with the preferred paw (P <0.01) and an increase in other
presses (P <0.02).
FIGURE 19: Effect of NMA lesions contralateral to the preferred paw
on pressing.
A. Rats that swap paws immediately. These rats do not show any
change in total pressing rate on a paired t-test. However, the
number with the initially preferred paw decreases and other
presses increases (P <0.001).
B. Rats swapping paws gradually. Using a paired t-test before
and after, it can be seen that there is no change in total pressing,
and very little change in the number of presses with the initially
preferred paw (0.1> P >0.05). However there is a significant change
























































Total Presses Paw Preference
FIGURE 20: Effect of electrolytic lesions in the crus cerebri, contra¬
lateral to the preferred paw on pressing behaviour.
There is a significant increase in the total pressing rate
after the operation (paired t, P <0.01) and also an increase
in the number of "other" presses (P <0.001), and associated
with this a decrease in the number of presses with the
initially preferred paw. The total overall rate of this group
is lower than any of the other groups (see text for discussion
on this point). These results have already been reported
elsewhere (206).
FIGURE 21: Effect of training the rats to use the initially unpreferred
paw.
The rats show no change in total pressing rate, either during the
retraining sessions or 8 weeks later when they are retested (Kruskal-
Wallis one way analysis of variance.) However, using the same test
it is shown that the preference is different between the different
groups. Using the critical range method for multiple comparisons,
it was seen that the number of presses with the initially preferred paw
was significantly reduced during the retraining period when compared
with control (P <0.01). The number at 8 weeks was not different
from either control or the retraining period, indicating partial recovery.
Similarly, the number of other presses is increased during the re¬
training procedure (P <0.01), but here the number at 8 weeks is still
different from control (P <0.05), but not from that during the re¬
training. In summary, retraining causes a change in paw use during
the procedure, with no change in total pressing rate. The change in
paw use has partly reverted by 8 weeks after the retraining. The
statistics are only performed on the rats which were tested at 8 weeks










































FIGURE 22: Effect of lesions ipsilateral to the preferred paw on
pressing behaviour.
A. KA lesions.
B. Electrolytic lesions of the crus cerebri.

































FIGURE 23: Effects of ipsilateral and unsuccessful 6-OHDA lesions
on pressing behaviour. In the lesioned animals the
lesion itself had no effect on the pressing behaviour.
When local anaesthetic was given, however, the rats did
not change to the other paw. Other combinations of
pressing were used: both paws, paralysed paw and nose.
However, the unsuccessfully lesioned animals did swap
paws as those in Figure 17 did.
Each column represents the total presses over two days.
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- Summary of the results from the contralateral experiments:
From the Figures on the previous pages, it is apparent that the
only group of rats with a deficit in total performance are the 6-OHDA
lesioned group. All the other experimental groups that swap paws do
so without an accompanying drop in performance. It seems that motor
disruption on one side is enough to cause a rat to change its preferred
paw, but will not affect it enough to reduce total rate. If anything,
there is an increased rate and preference in control animals. This
increase is not seen in any of the other groups except the contralateral^
operated crus cerebri lesioned animals. The crus lesioned animals were
given a slightly different training procedure, in that they were allowed
1 hour free feeding after the training sessions and therefore may not
have been as hungry. This may have led to the much reduced pressing
rate in these animals, which was slightly less evident after the lesion.
Apart from this the learning curves seem to be disrupted by the experi¬
mental procedures.
Effects of experimental procedures administered ipsilaterally to
the initially preferred paw
A few animals were operated ipsilaterally to the initially preferred
paw: 5 KA lesions and 2 crus cerebri lesions. The effects of these
procedures are shown in Figure 22. In order to do a paired t-test,
the 7 rats were combined and it could be shown that there was no
significant effect on the pressing of these animals, either in total rate
or preference. This is important as it shows that the operation itself,
or the injection of KA or application of current is not sufficient on its
own to cause a change in behaviour.
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Results of training or forcing animals lesioned ipsilaterally to
the initially preferred paw, to swap paws
Attempts were made to retrain the 6-OHDA lesioned animals that
learned to press after the operation to use the paw contralateral to
the lesion (and the paw they had learned to use). This proved an
impossible task. When no reward was given on the use of the paw
ipsilateral to the lesion, the rats occasionally attempted to use the
contralateral paw. These attempts were usually unsuccessful, with the
rat often completely missing the lever. They could just manage to press
if they approached the lever with the contralateral side of the body
pressed against the wall, possibly using it for support. It was also
impossible to count lever withdrawals (corresponding to "wrong"
presses) accurately and presses with the other paw. This was mainly
due to human limitations. As food was being given and levers with¬
drawn by hand, the operator had to watch the rat closely to ensure
the correct reinforcement was given, and to give the reinforcement or
to remove the lever. It was difficult to note the number of presses
made as well. The only clear observation was that no, or very few,
presses with the contralateral paw were successful. The rats would
continue to attempt to use the ipsilateral paw even though reward was
being withheld. The noise of the food dispenser may have acted as
a secondary reinforcer preventing extinction.
Another group of rats was operated ipsilaterally to the preferred
paw after pretraining. After recovery these rats were retested for
two sessions to ensure they were still pressing as before. They were
then given an injection of local anaesthetic into the preferred forelimb.
As with the retraining of the 6-OHDA lesioned animals, not one was
persuaded to use the paw contralateral to the lesion. Some stopped
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pressing, and some continued to try to press, generally unsuccess¬
fully, with the paralysed paw or some other part of the body such as
shoulder or nose. These animals were compared with controls which had
had unsuccessful injections of 6-OHDA, as determined by the turning
response and DA levels in the striatum at the end of the experiment.
These rats did swap paws as expected. The results of the turning and
biochemistry is shown in Table 5 earlier in this Chapter, and the
pressing behaviour is shown in Figure 23.
3.4 Discussion
Review of results
Rats were shown to have a preference for which lever and which
paw they used in a lever pressing task in the Skinner box. The two
preferences were positively correlated.
6-OHDA lesions in the MFB on the side of the brain contralateral
to the initially preferred paw of the animal led to a change in which
paw was used. The change in preference remained stable over an 8-week
period. A drop in performance which had recovered by 8 weeks after
the lesion was also noted.
None of the other procedures used led to a drop in performance,
but all the contralateral procedures led to change in paw use. The
ipsilateral procedures did not affect the pressing behaviour. After
8 weeks the rats given local anaesthetic in the preferred paw and those
trained to swap paws had partially reverted to the original paw use.
Rats lesioned with 6-OHDA before the initial training procedure
took longer to learn the task than did weight matched controls, but the
total rate was not significantly lower than in the controls. All learned
with the ipsilateral paw. Rats given ipsilateral 6-OHDA lesions could not
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be persuaded to change paws by a local anaesthetic injection into the
preferred limb.
NMA was shown to be as effective as KA in producing neurotoxic
lesions of the striatum. It is less potent than KA, but also far less
toxic to the animals and therefore higher doses can be used to obtain
enough damage. Using these lesions, an area of the striatum that must
be destroyed for a swap in paw use to occur has been delineated.
Paw and lever preference
- Control animals:
Inherent asymmetry in operant behaviour has been extensively
studied by Glick and co-workers (220,222,224, Section 3.1). Both paw
and lever (i.e. side or spatial) preferences were studied as were the
effects of amphetamine on these preferences. A fixed interval (15 s)
schedule (FI 15) resulted in animals with both a paw and a lever
preference, however a fixed ratio (30) schedule (FR 30) led to rats with
a lever preference, but that used both paws alternately on the levers,
enabling a higher pressing rate and therefore higher reward (222).
In a DRL schedule all rats had a consistant lever preference and 8 out
of 12 had a preferred paw (220). The degree of lever preference was
correlated with the pressing rate, rats with a high lever preference having
the highest pressing rates (222). In the FI 15 and FR 30 schedules, if
the lever preference was the same as the paw preference, amphetamine
administration led to an increase in the degree of preference for the
lever. However, if the two preferences were different, the preference was
reduced or even reversed. The total rate was reduced by amphetamine
in both cases. These rats were also seen to rotate to amphetamine in
a direction related to the lever preference (222). In other studies,
amphetamine has been shown to cause rotation in a direction correlated
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with DA levels in the striatum, and to the side preference in a T-maze
(223,299,656). The asymmetry in the DA content of the striata of the
rats has been used to explain the existence of the side preferences
(222,224). It can also be used to explain the differential effects of
amphetamine: DA release caused by the amphetamine will amplify the
asymmetry and increase the preference when the paw and side prefer¬
ences are the same. If the two preferences are different, more presses
are generated with the lever corresponding to the paw preference.
Glick and Jerrussi (222) point out that the lever preference is more
stable if it is linked to the paw preference and also that the paw
preference is retained with and without the drug. This implies, along
with the decreased preference on amphetamine administration in animals
with a differential preference, that it is the paw preference rather than
the lever preference that is determined by the DA asymmetry, and that
the side preference is less dependent on the DA balance. If this is the
case it is odd that a correlation between DA levels and side preferences
and rotation was obtained. However, it is difficult to explain the
differential effect of amphetamine in animals with opposite paw and lever
preferences if this is not the case.
The experiments described in Section 3.3 resemble the FI 15 group
of rats rather than the FR 30 group, despite the fact that the animals
were trained on continuous reinforcement schedule. As food pellets
are used as reward in these experiments the pressing itself is not actually
rate limiting: a combination of eating and pressing is. Both paw and
lever preferences were seen in these rats as with the FI 15 (222) and
DRL (220) schedules. The reason that a paw preference is not seen in
the FR 30 animals is probably because a higher rate can be achieved
pressing with alternate paws and in this type of schedule higher pressing
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rates lead to greater reward. In the schedules requiring lower rates,
it does not really affect the reward if they press slightly slower and so
the animal will use the paw it finds easier to use.
In the experiments described in Section 3.3 there are far fewer
rats without a preference than in the other studies quoted. Here only
4 out of 131 do not have a preference, but in these studies 1 out of 12
(222) and 4 out of 12 (220) are seen. This may have been due to the
criteria used to decide what the paw preference of a rat is. These papers
give no details of this. In some of the rats described in this study it
was very difficult to see which paw the rat was using and constant
shifting of position of the observer was necessary. This may not have
been possible when the rats were observed by videotape. Also, in some
cases the first paw to touch the lever did not necessarily activate the
food dispenser and food was not given until the rat pressed more strongly
with the other paw. Also after one paw had initiated the food dispensing
mechanism the other was often placed on the lever. In each case the
paw that caused the activation of the food dispensing mechanism was
designated as the paw used.
Glick and co-workers' studies (220,222) do not have enough numbers
to allow an extensive correlation of the paw and lever preferences to be
done. This study has correlated the two preferences in 131 rats.
There is a significant correlation between the two. However, in a large
number of individual cases, there is not a correlation (see Figure 13).
The overall correlation of paw and lever preference (but with differences
in individual cases) possibly explains why a correlation between side
preference and DA levels was seen by Glick and co-workers, although it
seems to be the paw preference that is primarily determined by the DA
imbalance.
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- The effect of lesions on lever and paw preference:
Electrolytic lesions of the caudate nucleus led to a change in the
side preference in a T-maze (519) and in the paw preference of rats
in a lever pressing task for sucrose reward (256). In the former
experiments, paw preference was not mentioned and in the later experi¬
ments conditions were manipulated to obtain a set number of responses
with each lever. When rats were only allowed to use the left paw on the
left lever and the right paw on the right lever (359), electrolytic
lesions of the globus pallidus led to a blockade of lever pressing with
the paw contralateral to the lesion. In these experiments lever access
was restricted as it had previously been shown that which lever was
used did not affect the effects on pressing (256). Further evidence
for the fact that it is the paw preference that is primarily determined by
the DA imbalance comes from the fact that it did not seem to matter
which lever was used in these experiments. Another experiment has
shown that lesions in the entopeduncular nucleus will also affect
laterality (360). In this experiment pallidal and LH lesions had no effect.
Ablations of cortex have shown that the effects of electrolytic
caudate lesions are not caused by damage to corticofugal fibres as
these lesions have no effect on paw use (256,359). However, a more
recent experiment has shown that cortical ablations lead to a reduced
strength and rate of pressing, especially in the contralateral paw (479).
This might be expected as the pyramidal motor system will have been
extensively damaged. Although the deficit was most pronounced on
the contralateral side there is an effect on the other side too; these rats
will therefore not swap paws. The rats lesioned in the crus cerebri in
the experiments described in Section 3.3 do not show a drop in perform¬
ance as might have been expected. However, they do swap paws,
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presumably due to damage to the striato-nigral pathway. The lack of
effect on performance may mean that the pyramidal motor system is not
of vital importance in the behaviour of rats, or that the lesions did not
affect the corticofugal fibres.
Glick (226) has suggested that there is a frontal cortical influence
on striatal asymmetry and suggests this as a reason for the increase
in asymmetry higher up the phylogenetic scale.
The electrolytic lesions of the caudate nucleus, the globus pallidus
and entopeduncular nucleus could have damaged the DA fibres as they
travel from the SN to the striatum. If this were the case, 6-OHDA
lesions would be expected to cause the same effects. Such lesions in
the SN or striatum block reaching behaviour with the contralateral paw
(546). These rats also show a relative increase in the number of reaches
with the ipsilateral paw. Similarly, in this laboratory, 6-OHDA lesions
in the MFB have been shown to lead to a large drop in the use of the
contralateral paw even as long as 8 weeks after the lesion (590). There
is a slight increase in the use of the ipsilateral paw immediately after
the lesion (there is an overall reduction in pressing rate at this time)
and a complete swap of paw use by 8 weeks after the lesion (when the
overall rate has returned to the control level). These experiments do
mimic the effects of the electrolytic lesions in as far as there is a block
of pressing with the contralateral paw. However, in these experiments
(546,590) there also appears to be an increase with the ipsilateral paw.
In the electrolytic lesion experiments, the experimental design restricts
the swapping over of paw use as pressing is restricted to right paw
on right lever and left paw on left lever. There is no opportunity to use
the other paw on the lever. It is possible therefore that the effect of
the electrolytic lesions in blocking the use of the contralateral paw is due
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to the loss of DA from one side and the slight differences result from
differing extents of DA depletion.
The experiments described in Section 3.3 also show the swap in
paw use after 6-OHDA lesions in the MFB . Also all rats that were
initially trained after the lesions learned to press with the ipsilateral
paw. These results can also be explained by a reduction in the DA
content of the contralateral striatum.
It was noted that in the 6-OHDA lesioned animals after they have
recovered from the deficit in total pressing rate there is a strong
negative correlation between paw use and lever use; that is, all rats
operated contralaterally on the left side pressed on the right lever with
the left paw and vice versa. This difference in paw and side preference
cannot be explained on the basis of DA imbalances. However, a rather
teleological explanation can be given from observation of the rats. The
shaping process involves the animals learning to associate the noise of
the food dispenser with the arrival of food pellets. Even after the task
is well learned, the rats will still respond to the noise. The response
seems almost reflexive: the rat rushes to the dispenser immediately
on hearing the noise. To some extent this occurs when the rat presses
the lever normally. The 6-OHDA lesioned animals tend to circle ipsi-
laterally (with the lesion on the inside) in the Skinner box, especially
at the start of a session. Whenever the lesioned rat presses the lever,
and "reflexively" dashes to the food hopper, it will move in this
ipsilateral direction. Therefore, if it presses the ipsilateral lever it
needs to turn a full circle to reach the centrally placed food hopper.
The rat soon learns that this takes a long time and begins to use the
contralateral lever from which there is only a short distance to the
centrally placed food hopper. The rats appear to have no difficulty in
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moving against the tendency to circle in order to use the contralateral
lever.
Specific lesions of striatal cell bodies with the neurotoxin NMA
and temporary lesions of the preferred forelimb (during anaesthesia
and 8 weeks after the paralysis) do not show this strong negative cor¬
relation between paw and lever preferences. However, these rats do
change the paw preferentially used. This indicates that the use of the
initially unpreferred paw does not necessarily lead to a change in the
relation between paw and lever use. The negative correlation seen in
the 6-OHDA lesioned animals seems to be related to the strong tendency
for spontaneous circling, not seen in the other groups of animals.
The NMA lesions and peripheral paralysis, along with KA lesions
of the striatum, electrolytic lesions of the crus cerebri and training
experiments designed to cause a change in paw use all lead to a change
in the preferred paw when given contralateral^ to the initially preferred
paw. Ipsilateral procedures had no effect on the paw pressing behaviour.
This indicates that all these procedures (excluding the training experi¬
ments) lead to a motor deficit on the side contralateral to the lesion.
This will be further discussed later in this section.
The above discussion strongly indicates that the function of the
nigro-striatal system is not bilaterally symmetrical and that the effect
of unilateral lesions to the system will depend on which side of the brain
is operated. Also, it is clear that not all rats show the same direction
of asymmetry. Glick has shown a population bias towards the right side
(226), whereas the experiments described in Section 3.3 suggest a
left bias. It seems that the paw preference is the stronger indicator of
this asymmetry and that the side preference is secondary although it
does correlate with the DA asymmetry in the control animals. The
116.
divergence of paw and lever preference after 6-OHDA lesions in the
MFB might provide an insight into the behavioural mechanisms involved
in these tasks.
Performance and the effect of lesions
Neuroleptics have been reported to cause performance deficits as
have bilateral 6-OHDA lesions. Most studies using unilateral lesions to
study performance have not taken the inherent asymmetry of the
animals into consideration (see Section 3.1). The only experiment
reported that has done so is that by Uguru-Okori and Arbuthnott
(590). This study shows a large performance deficit in animals lesioned
with 6-OHDA contralateral to their initially preferred paw. Animals
lesioned ipsilaterally did.not have this deficit. At 8 weeks after the
lesion the total pressing rate had returned to normal, but the paw
reversal remained.
The 6-OHDA experiments described in Section 3.3 also show this
deficit at 1 week after the lesion. By 4 weeks after, the rate has
partially recovered and by 8 weeks it has fully returned to the control
value. The reversal in paw use is also seen. None of the other
procedures carried out mimicked this effect on performance although
all the contralateral procedures led to a swapping of paws. These
procedures included lesioning the cell bodies in the striatum with NMA
or KA, electrolytically lesioning the striato-nigral pathway in the crus
cerebri and peripheral lesions with local anaesthetic. Training the rats
to use the other paw also lead to the reversal of paw use with no drop
in total rate.
The lack of effect of all these procedures, except the contralateral
6-OHDA lesions on total performance implies that DA depletion leads to
more than a motor deficit in the lesioned animals. That there is a motor
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deficit in these animals is implied by the fact that they change their
paw use at all and also by the tendency to circle spontaneously and
in response to DA agonists. That the deficit is not just motor and
that there is likely to be another component to the effect of the lesion
is shown by the fact that the other procedures affecting the motor
system and leading to a change in paw use do not affect the total rate of
performance whereas the 6-OHDA lesions do.
From Figure 23 it seems that animals operated on the side ipsi-
laterally to the initially preferred paw might have a deficit in perform¬
ance after the lesion. This is due to the training conditions during
this experiment. The experiment was done as part of a teaching course,
but the initial training was done beforehand by a single observer.
Most of the post-operative sessions were observed by the class of
students. Although the design randomised the division of rats into
those trained by students and those not, it was clear that the rats
trained in the presence of the class had a lower rate than the others.
Because of this less emphasis was placed on the absolute number of
presses and attention focused on the proportion of the various types
of presses.
Despite the problems of being part of a teaching course, this
experiment does show that these lesioned animals could not be persuaded
to use the contralateral paw, even when the ipsilateral one was paralysed
with local anaesthetic. The control rats press most often with the
unanaesthetised paw whereas the lesioned rats still press most often
with the anaesthetised one and sometimes with both paws or the nose.
They rarely press with the paw contralateral to the lesion. This implies
that the lesion is more disruptive to the animal than the local anaesthetic
is. The significance of this is considered later.
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Learning and 6-OHDA lesions
Although there has been difficulty in designing experiments to
study learning in bilaterally 6-OHDA animals due to the lack of spontan¬
eous movements, one experiment has suggested that these lesioned
animals do have difficulty in learning tasks. A lack of acquisition
in a brightness task was shown to exist in experiments which forced
the animals to move by placing them in an underwater Y-maze (484).
Bilaterally, lesioned animals did not seem able to learn the task, even
although they did swim through it. This was used as evidence for a
learning deficit.
The experiments described in Section 3.3 also suggest that these
animals have a reduced learning capacity. These animals were trained
4 weeks after the lesion and so had partially recovered from the
performance deficit observed immediately after the lesion. These rats
did learn to press for food, but did so more slowly than controls.
Also, all learned the task with the paw ipsilateral to the lesion. The
reduced learning rate may have been related to the high degree of
spontaneous turning exhibited by these animals in the Skinner box.
In this case, the decreased rate of learning would be due to the motor
problems that are present in these animals. Alternately there may
indeed be a learning deficit.
Rats trained to use the initially unpreferred paw, learn to use it
with no deficit in total performance. If the rats needed to learn to use
this paw after a motor lesion, a learning deficit might result in the drop
in performance seen.
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The nature of the performance deficit caused by
unilateral 6-OHDA lesions
The nature of the deficit in performance caused by 6-OHDA
lesions of the nigro-striatal system will give an insight into the role
DA plays in that pathway. Various possibilities have been suggested
for the role of DA in the system. It has been suggested that DA in
this system only mediates motor behaviour. It has also been suggested
that DA in this pathway is involved in the motivational state of the
animal, and that motor deficits are only secondary to this. The third
possibility is that DA serves a role in learning behaviour. The arguments
for all these possibilities are considered in Section 3.1.
The working hypotheses used in the experiments described in
Sections 3.2 and 3.3 are (i) that a motor deficit in the animals on one
side is sufficient disruption to lead to an overall pressing deficit and
(ii) that after motor disruption on one side the animals must relearn the
task with the other paw and that this results in a drop in total pressing
rate.
The first hypothesis was tested by giving the rats lesions to the
motor system contralateral to the initially preferred paw and then
comparing the effects of this to those of the 6-OHDA lesions. As
discussed in Section 3.3 these motor disruptions lead to a change in
paw usage, but there is no drop in performance as is seen in the 6-OHDA
lesioned rats. This indicates that a lesion that paralyses one side,
does not of itself lead to a drop in performance as the rat will continue
to press at the same rate but with the other paw. However, as the rats
do swap paws in both the 6-OHDA and other experimental cases, it
would seem that the lesions do make it difficult for the rats to use the
contralteral paw, and this is in all probability due to a motor deficit
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especially when considered along with the rotation occurring after
unilateral 6-OHDA lesions. However, it is clear that there is another
component to the deficit caused by the lesion as well as the motor one.
This is because of the drop in performance seen after 6-OHDA that is
not seen after the other disruptions of the motor system.
To test the second hypothesis, rats were retrained to press the
lever with the other paw. They managed to learn the variation in the
task with no difficulty and there was no deficit in the pressing rate.
As the 6-OHDA lesioned rats did show a deficit, it might be that there
is a deficit in learning. A learning deficit is supported by the fact
that rats lesioned before the initial training procedure learn to press
more slowly than controls. However, this could be explained by the
high levels of spontaneous turning distracting the rats from concen¬
trating on the task.
Another possibility is that a mechanism for generalisation has been
lost and that previously acquired knowledge cannot be applied to other
situations easily. Rats given local anaesthetic into the preferred fore-
limb will change the paw used with no sign of having to relearn the
task, they appear to be able to apply knowledge already learned. This
would support the loss of a generalisation mechanism rather than a
learning deficit.
The final suggestion for the role of DA in the nigro-striatal path¬
way is that it is involved in motivational or reward behaviour. This
postulation is less easy to investigate than the others and this thesis
does not shed much light on the problem. It does seem, however, that
there is another component to the deficits as well as the motor one, and
although this could be a learning or generalisation problem, as suggested
above, it could be a deficit in the motivational drive of the animals.
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There is strong evidence that neuroleptics block reward behaviour
and this would support a motivational deficit caused by DA depletion.
This explanation is clear enough for a bilateral lesion, but an overall
deficit resulting from a unilateral DA deficit is more complicated.
However, the DA asymmetry reflected in the existence of side prefer¬
ences could also be reflected in other asymmetries, or more correctly
other behavioural asymmetries could be reflected in the DA asymmetry.
The side of the brain with most DA, may well have developed in relation
to motivation in such a way that the other side of the brain is unnecessary
and so becomes redundant. When the system with the higher DA is
removed and the position is reversed, the other side of the brain takes
time to assume its role in motivating the animals. In support of this
it is seen that the effects of 6-OHDA lesions do recover with time - both
the performance deficit seen in this study and the severe aphagia,
adipsia and akinesia seen in the LH syndrome. However, the motor
deficit does not seem to recover as the paw preference remains and the
rats still turn in response to agonists for long periods of time. This is
further evidence for separate motor and other behavioural deficits.
This type of lateralised function is known to exist for example the
dominance of one hemisphere for speech in humans (257). Also in
humans a condition of unilateral neglect exists that may resemble the
sensory neglect seen in LH lesioned rats (270). Therefore the concept
psycho!ogical
of lateralisation of abuU'itut functions is not completely new.
It is strange that rats lesioned ipsilaterally to the preferred paw
still will not use the paw contralteral to the lesion when the ipsilateral
paw is paralysed with local anaesthetic. This might imply that the
deficits caused by the 6-OHDA on the contralateral side of the body are
more disruptive than complete paralysis of the forelimb. If the deficit
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had two components, a peripheral motor paralysis might be expected
to be less disruptive than a lesion causing a motor deficit as well as
another deficit. If motivation is supported by one side of the brain,
a lesion ipsilateral to the preferred paw should not affect this aspect
of the functioning of the system. However, the rats still cannot be
persuaded to use the paw contralteral to the lesion by using local
anaesthetic. It is possible that the central lesion to the motor system
causes more damage than a peripheral one, for example by affecting a
greater degree of musculature, and this accounts for the failure of these
rats to swap paws. Alternately there might be a some "other" function on
this side of the brain. This is very possible as lateralisation of function
is reported never to be complete (257).
The differences in effect of the KA and NMA on one hand and of
6-OHDA on the other, must also be discussed. As the KA and NMA
remove most of the cell bodies in the area the nigro-striatal pathway
projects to, the KA and NMA lesions would be expected to mimic the
effects of 6-OHDA as DA released in the striatum will not be able to have
any effect. This does not happen: the deficit in pressing rate is not
seen after the neurotoxic lesions of the striatum. There could be two
explanations for this. Firstly, the KA and NMA might not destroy a
sufficient portion of the striatum to cause the deficit in performance, but
enough to cause a change in paw use. The other explanation is that the
deficit is not caused by the destruction of the DA terminals in the
striatum but of those in the nucleus accumbens. The fibres in the MFB
that are destroyed by the 6-OHDA also project to this nucleus as well
as to the striatum. It is possible that the motor components of the deficit
caused by 6-OHDA are caused by loss of the DA in the striatum, but
that the drop in performance seen is due to DA loss in the nucleus
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accumbens. This agrees with the hypothesis put forward by Iversen
in 1977 (283). Here Iversen proposed that the mesolimbie DA system
provided motivational arousal and that the striatum provided motor
arousal.
The evidence for this comes from the fact that the two areas have
different functions with respect to DA. Because of the similarity of
the two areas, the differences will arise from the different connections
of the two systems. The nucleus accumbens is connected to areas of
brain that are supposedly involved with "emotive" behaviours whereas
the striatum is part of the exptrapyramidal system and as such is
involved in the processing and execution of movements. Because of
this Iversen (283) suggested that the nucleus accumbens was involved
in the motivational arousal necessary for movement to occur and that the
striatum is involved in the carrying out of the movements.
The difference in function in the two areas is that DA in the
nucleus accumbens mediates locomotion, whereas the striatum mediates,
the stereotypy caused by amphetamine. The evidence for this comes
from experiments using lesions along with direct injections of drugs into
the brain. Amphetamine which releases DA from the terminals, results
in increased locomotion and in a pattern, of stereotyped behaviour,
including biting, gnawing and licking (283,321). The hyperactivity
seen on the administration of amphetamine appears to be mediated by the
nucleus accumbens as 6-OHDA lesions of this area block this component
of the response to amphetamine, but not the stereotypy. Lesions of
the striatum, however, abolish the stereotypy, but do not affect the
hyperactivity (283,319,320). Injection of DA into the nucleus accumbens
will lead to increased locomotion (465,467), and injection of haloperidol
into the nucleus accumbens blocks the effects of systemic d-amphetamine
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on locomotion (466). These experiments suggest that the nucleus
accumbens is involved in motor behaviour to some extent, although
Kelly (319) suggests that the locomotor activity is not really a motor
phenomenon, but an indicator of an increased state of arousal of the
animals. The fact that manipulations of this nucleus can affect 6-OHDA
induced turning supports this. Turning induced by lesions of the
caudate nucleus is blocked by further lesions (with 6-OHDA) in the
nucleus accumbens (320,482), and it has been suggested that the meso-
limbic DA system might in fact amplify the striatal asymmetry (320).
The mesolimbic and mesocortical DA systems certainly seem to be
necessary for the normal exploratory behaviour, as 6-OHDA lesions
of these will reduce exploration in a novel environment, and this effect
can be reversed by apomorphine (187). The authors of this study
concluded that mesolimbic and mesocortical DA was necessary for normal
exploratory behaviour and that the system might facilitate optimal
sensorimotor integrations.
It seems from the above that DA in the nucleus accumbens is to
some extent involved in the initiation or expression of motor behaviour.
It could be that the deficit caused by removal of limbic DA is responsible
for the drop in pressing rate seen after 6-OHDA but not after KA or
NMA in the striatum.
In conclusion it seems that there is a motor deficit in rats given
6-OHDA into the MFB. There also appears to be another deficit, possibly
in the learning ability of the rats, but also possibly in the motivational
state of the animals or of the generalisation ability of the rats. The
second aspect of the deficit is most likely to be mediated via the lack of
mesolimbic DA rather than striatal DA whereas the motor deficit is
mediated by striatal DA.
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NMA and KA lesions of the striatum
The lesions caused by NMA described in Section 3.3 resemble the
KA lesions. The histological profile is similar although the NMA
diffuses less through the brain tissue than the KA does. This may
contribute to the reduced toxicity of the compound when compared with
KA. Although extensive lesions were observed with NMA, the motor
abnormalities were not as severe as those seen after KA injection.
Bleeding from the nose and the urinary tract was never observed in
NMA lesioned animals, whereas it was quite common in the KA lesioned
animals. Also none of the NMA lesioned animals died from the effects
of the neurotoxin, whereas several of the KA rats did, or had to be
killed because they were so unwell. The lower level of toxicity of the
NMA suggests that it is a much better tool to use for lesioning cell
bodies than KA is.
The differences in motor behaviour seen on recovery from the
anaesthesia is very noticeable. KA injected rats, after a period of
ipsilateral circling, will run contralaterally for long periods after the
injection of KA (239,288 and Section 4.3), having full convulsions
every so often. These convulsions involve full body twists and rearing
in the direction contralteral to the side of the lesion. After these
convulsions the rats are unconscious for a few minutes. On regaining
consciousness the rats start running in contralateral circles again.
The NMA lesioned rats tend to circle ipsilaterally most of the time, but
more slowly and under control than the KA lesioned animals. From time
to time these rats also show signs of convulsive activity. However,
these are minor and often only consist of contralateral forepaw twitches
or a few body twists in the contralateral direction. The NMA injected
rats do not lose consciousness after these convulsions. It is interesting
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that the convulsive activity is expressed in a contralateral direction,
but the increased locomotion is ipsilateral. In the KA rats, the ipsi-
lateral and contralateral phases are completely separated. Taylor et al
(585) have reported that rats injected with NMA only rotate ipsilaterally,
and not contralateral^ at all. The explanations given for this is that
the different glutamate analogues may have differential actions on
different glutamate receptors. However, it may possibly reflect the
action of the KA on the cell firing patterns in the striatum and SN.
James and Taylor (288) have shown that ipsilateral circling
produced by KA is associated with a decrease in the firing of SNC
cells and an increase in SNR cell firing. Conversely, the contralateral
rotation was associated with an increase in SNC cell firing, and a
decrease in SNR cell firing. Braszko et al (49) have shown that 1 hour
after KA injection, the firing rate of the DA cells had increased. This
time corresponds to the time when James and Taylor (288) see ipsilateral
rotation and a decrease in DA cell firing. Twelve hours later, when
James and Taylor see contralteral circling, and an increase in SNC
firing rate, Braszko et al see fewer cells firing; Braszko et al also
show that at this stage GAB A will cause the SNC cells to start firing,
but that glutamate will not. The authors suggest that the excitatory
input from the striatum has increased the firing of the DA cells so much
that they have entered depolarisation block (see Section 4.4). The
differences between these two studies (49 and 288) is difficult to explain.
At a time when one study shows an increase in DA cell firing, the other
shows a decrease. The dose used in each case is similar (2.13 |ig in 288
and 2.5 |ig in 49) but the volumes may be different. Braszko et al (49)
used a volume of 1 ul while James and Taylor do not report what volume
was used. As a larger volume will spread further in the brain and it
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might have different effects than a lower volume. The more widespread
the area of action, the greater the area excited by the neurotoxin.
However, if it does not spread far, there will be greater excitation in
a more limited area. These differences could lead to different time
courses and extents of effects seen. It is possible that in the case of
Braszko et al (49), the cells are entering depolarisation block sooner
than in the other case and that the acute effects wear off sooner leading
to increased firing at the later time.
It is not clear whether changes in firing rate of the DA cells will
be reflected in the circling behaviour of the animals. If the input to
the SNR from the striatum is being maximally stimulated, the DA input
to the striatum would not be expected to influence the output, if the
striato-nigral pathway only mediates the output from the striatum.
However, if this pathway also mediates the feedback, or part of the
feedback control of DA cell activity (see Section 4.1) it might be
expected to affect the output from the striatum and hence the motor
behaviour of the animals. An oscillation in the system might explain the
alternation from ipsilateral to contralteral in the NMA lesioned animals.
The large excitatory effect of the NMA in the striatum leads to activation
of the DA cells which then reduces activity in the striatum, and also the
circling would reduce. The oscillation might also result from phases
of depolarisation block in the cells. When the DA cells stop firing the
inhibitory influence they exert will also be stopped. This could lead to
the convulsive contralateral activity. Once the cells recover, they start
firing and replace the inhibition in the striatum and stop the convulsive
phase of rotation. Also it is possible that the more potent KA will
excite the output so much that the effect of the DA input is not seen,
whereas NMA which is less excitotoxic, might allow the expression of
changes in DA cell activity.
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Functional subdivision of the striatum
Various reports have suggested that there is a functional division
of the striatum. Injection of the DA agonist, 2-(N ,N-dipropyl)-amino-
5,6-dihydroxytetralin at various sites in the guinea pig striatum produces
different behavioural responses (102). Hyperactivity could be obtained
without biting in lateral positions, the more dorsal the placement the
better. Biting was obtained from ventromedial regions where the hyper¬
activity response was more variable. In rostral areas only weak biting
occurred, but hyperactivity resulted. Lesions in anterior and medial
positions have been reported to impair delayed alternation retention (147),
but to leave visual discrimination unaffected.
Local application of crystalline DA or amphetamine onto the ventral
anterior striatum, decreased the efficiency in a DRL task (418a) and
affected LH self-stimulation (420). It was suggested that this area of
striatum was involved in the modulation of behavioural arousal and as
such functioned similarly to the nucleus accumbens and differently from
the rest of the striatum. Although the authors say it is not the case,
this may be due to spread to the nucleus accumbens as the ventral
anterior striatum is very near to this nucleus. The lesion that was
effective in producing a change in paw use in Section 3.3, seemed to
include this region although it was possibly more lateral and dorsal as
well. No deficit in performance in the lever pressing task used here was
seen. The difference may be that the DA implants were bilateral and
so a swap of paw use would not be possible and a deficit in performance
would occur. It is worth noting that here it is an excess of DA that is
resulting in the performance deficit and not a lack of it. This emphasises
the fact that a correct DA balance is necessary for normal function, not
just the presence of DA.
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The problem of separating motor and motivational or other effects
after bilateral lesions of the striatum again make interpretation difficult.
The existence of an area that must be damaged to result in a
change of paw use supports the conclusion that the striatum is function¬
ally divided, as does the existence of an area that must be lesioned for
turning in response to apomorphine to occur. Because of this sub¬
division, care must be taken in interpreting data from lesions of this
area. Details of which areas are affected and how great the extent of
the lesion is, are important.
Lesions and turning behaviour
Unilateral destruction of the nigro-striatal DA pathway leads to
spontaneous ipsilateral rotation in rats, which is much amplified by
amphetamine. Apomorphine causes a contralateral rotation (592,593).
The turning is attributed to the imbalance in the DA systems. The
turning behaviour is mediated by the striato-nigral pathway and then
by one or more of the ventromedial thalamus, the midbrain reticular
formation or the superior colliculus (see Section 4.1). It is reasonable
to assume that lesions of these pathways should affect the rotation in
6-OHDA lesioned animals as the effects of DA are mediated by these
pathways. Also in control animals these lesions should cause rotation
when the system is challenged with apomorphine. This has been reported
in several studies (206,208,540). Rotation in KA lesioned animals has
been reported and suggested as a model for studying intact DA receptors
(540). Animals with lesions in the crus cerebri have also been reported
to turn in response to apomorphine, and also these lesions, made ipsi-
laterally to a 6-OHDA lesion, will block the turning effect of that lesion
(206). KA lesions of the ventromedial thalamus will reduce the turning
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to apomorphine after 6-OHDA lesions (208) and lesions of the midbrain
reticular formation and superior colliculus will result in turning to
apomorphine (208).
The turning rates in the 6-OHDA lesioned rats tends to be higher
and turning is elicited by a much lower dose of apomorphine than the
other lesions (0.3 mg/kg cf 2 mg/kg). Also all the 6-OHDA lesioned
rats exhibit high rates, whereas only some of the other lesioned ones
do. The turning in response to apomorphine was shorter in duration
in the striato - nigral lesioned animals and so the testing sessions were
30 min instead of 45 min. The different behaviour of the 6-OHDA
lesioned rats in response to apomorphine reflects the supersensitivity
that has developed to DA after the lesion (540). This does not occur
in the case of the striatal lesions. The reason for the less consistent
turning in these animals may be that the lesion has not affected a large
enough portion of the area of striatum involved in turning (see above).
The lesions affecting the input will get most of the striatum and therefore
will be sure to have reduced the DA input to this area.
As well as being elicited at a lower dose, the turning behaviour
emitted by the 6-OHDA lesioned rats is much more compulsive than that
of the other lesions, and is observed spontaneously, long after the lesion.
Spontaneous rotation is not seen in the crus lesioned rats and is not
seen after the acute effects of the neurotoxins have worn off. The
compulsive element of the turning seen in the 6-OHDA lesioned animals
may be due to the limbic component. The asymmetry is provided by the
lesioned striatum but the increased locomotion leading to the continual
circling results from the imbalance in the nucleus accumbens. That the
turning response seen in 6-OHDA lesioned animals is a two component
system has been suggested in the literature by Pycock and Marsden (482).
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These authors suggest that as well as a striatal imbalance, mesolimbic
stimulation is necessary for rotation to occur.
CHAPTER IV
An Electrophysiological Study into the
Functioning of the Nigro-Striatal Pathway
132.
This Chapter is divided into four main sections. The first is
an introduction covering the relevant background information and the
rational behind the experimental designs. The second section describes
the methods used, the third gives the results and finally the fourth
section discusses these results.
4.1 Introduction
The SNC contains DA cells which send projections to the ipsi-
lateral striatum (see Section 1.2). The electrical activity has been
recorded from these cells in several species (62,132,153,156,243,250).
The cells are spontaneously active with a characteristic action potential
shape (6,235,250).
DA released in the striatum as a result of the firing of the DA
cells, leads to a response in the post-synaptic striatal cells. There is
some controversy about the nature of this response. Many results
have shown a predominant inhibition in response to iontophoretic DA
(29,44,93,124,163,178,231,383,392) or nigral stimulation (92,93,178,231).
In some studies, however, comparison of the effects of nigral stimulation
with those of iontophoretic DA are conflicting (93,392). In some studies
there are also excitatory responses (35,36,44,92,93,178,392) and in
others, especially those using intracellular recording show only excit¬
atory responses, or at least EPSP-IPSP sequences, to nigral stimulation
(280,281,342,344,345,562) or iontophoretic DA (342,562). The effect
of iontophoretic DA and nigral stimulation is blocked by chlorpromazine
(CPZ) (646). One suggestion has been that the two types of response
were due to existence of an excitatory and an inhibitory receptor for
DA in the striatum (431). There is a lot of evidence for the existence
of more than one receptor for DA (see reviews by Kebabian and Calne,
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315, and Seeman, 543), but the explanation for the excitatory and
inhibitory effects of DA are not likely to be as straightforward as this.
More likely explanations involve faster conducting non-DA pathways
(see Section 1.2) or polysynaptic or collateral pathways involving
stimulus spread to other brain regions (627).
The evidence in support of multiple DA receptors suggests there
is a DA-AC receptor (or D1 receptor) on the post-synaptic cells and
another type or types (D2) situated on the pre-synaptic terminals,
not only of the DA neurones, but also of other afferents to the area,
e.g. from the motor cortex (50,409,539). The D1 type is thought to
mediate the effects of released DA on the post-synaptic cells and the
D2 type possibly modulates transmitter release from the terminal it is
situated on. However, recent reports have suggested that the D2
receptors may be situated on the same, or other, post-synaptic cells
as the D1 ones and may also mediate a post-synaptic effect (294,587).
Feedback control of DA turnover?
The activity of the DA cells is under a tight feedback control:
any alteration in the DA equilibrium will result in a change in activity
designed to offset the disturbance. This effect was first described in
1963 by Carlsson and Lindqvist (65). They showed that, after mono¬
amine oxidase inhibition, the accumulation of O-methylated metabolites
seen was enhanced by the neuroleptic drugs CPZ and haloperidol.
The suggested explanation was that blockade of the DA receptors
resulted in a compensatory activation of the DA neurones themselves.
They also suggested that the increase in neuronal activity did not
result in a depletion of transmitter levels because the increase in
activity was accompanied by an increase in synthesis. At this stage,
no further details were given on a possible mechanism for this effect.
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The convenient existence of the striato-nigral pathway immediately
led to its being proposed as a mediator for the proposed feedback effect.
It was suggested that the activation of post-synaptic receptors by DA
led to the alteration of activity in the DA cell bodies by way of the
striato-nigral fibres.
Since the idea was first proposed a large amount of data has
accumulated in favour of the feedback loop hypothesis (FLH). However,
in recent years, mostly since 1975, data has also been accumulating that
would suggest that the FLH might only be a small part of the mechanism
involved in regulating the metabolism of the DA cells. Firstly, the
evidence in favour of the hypothesis will be covered and then the
evidence against it will be dealt with.
- Evidence in favour of the feedback loop hypothesis:
The relation between an increased DA synthesis and increased
impulse flow does seem, at first sight, to exist. The activity of the SN
DA system is reflected in both the cell firing rate and the turnover of
the transmitter. Increased impulse flow in the DA axons leads to an
increased activity of TOH, the rate limiting enzyme in the synthetic
pathway for DA, possibly by affecting the affinity of the enzyme for
its substrate or its cofactor (518).
Stimulation of the SN leads to an increase in DA levels and turnover
in the striatum (25,77,349,424,433,533). Similarly, drugs that increase
DA turnover in the striatum, such as the neuroleptics haloperidol and
CPZ (10,34,241,432,433,434,436,625) also increase the firing rate of
the DA cells (5,60,62,624). Conversely, those drugs reducing turnover
in the striatum such as amphetamine and apomorphine (62,436,517) also
decrease firing rate at a comparable dose (5,54,56,57,59,62,614). The
effect did seem to be mediated by the nigro-striatal pathway as an
intact DA system seemed to be needed for the effect to occur ( 11,435).
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The effects of stimulating the striato-nigral pathway also seemed
to agree with a role for that pathway in the mediation of the feedback
control of the DA cell activity. Stimulating the striatum led to an
inhibition of firing rate in the DA cells (87,153,448) as does the local
application of GABA or GABA agonists such as muscimol (71,448).
Stimulation of the post-synaptic DA receptors in the striatum with
apomorphine also leads to a reduction in cell firing in the SNC. The
GABA antagonists picrotoxin and bicuculline reduce the effects of
stimulation (87,153,448) and GABA agonists (448) on DA cell firing.
Biochemically it has been shown that intra-nigral muscimol blocks
the effect of haloperidol on striatal TOH and that this effect is antag¬
onist by bicuculine (244) and that GABA antagonists can cause an
increase in DA metabolites in the striatum (248).
Lesions of the striato-nigral pathway have been reported to
reduce the effects of the DA agents on DA turnover in the striatum (318)
or the effect on cell firing rate (56,347).
As well as the straightforward effects of GABA just described,
some paradoxical effects have been obtained in response to GABA-ergic
agents. These have been seen to cause increases in the DA cell firing
rate (234,374,437,616,619). Also there appears to be a lack of direct
reciprocal relations between the nigro-striatal and the striato-nigral
pathways (198,343). An attempt to reconcile these observations with
the FLH suggests that an inhibitory GABA interneurone might exist -
the existence of interneurones has been proposed in the SN (194,246,
305,541) - that is itself inhibited by GABA released from the striato-
nigral pathway, or by exogenous GABA placed in the SN. This
"double inhibition" leads to the paradoxical excitations of the DA cells
(234,619). There is evidence that GABA does inhibit SN cells in general
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(111,112,172,197,232,394,648,650,651), although in these experiments
the type of cell recorded from was often not specified.
For a FLH involving striato-nigral GABA to be feasible the
postulation of an interneurone is essential at some point. In order
for DA receptor stimulation which results in the inhibition of the post¬
synaptic cell, to lead to an inhibition of DA cell activity, the inhibitory
striato-nigral path would have to be excited if only two neurones were
involved. The postulation of a nigral GABA interneurone simplifies this
problem. Another approach to this problem has been to propose a
striatal interneurone. One candidate is ACh. DA agents are known to
affect the ACh systems in the striatum: DA agonists inhibit ACh cells,
and so, by reducing release, increase the levels of ACh (25,76,77,547,
548,563). This decreased release of ACh could in turn lead to decreased
activity in the GABA output neurones from the striatum. DA does reduce
GABA release in the striatum (74) and this could be a reflection of
reduced GABA release from collaterals of the output cells or of other
cholinoceptive cells in the striatum.
Figure 24 shows diagrammatieally how a feedback loop might act
to cause a post-synaptic receptor mediated effect via the SN pathway.
However, if SP, also thought to exist in the striato-nigral pathway
(see Section 1.2), were involved in the feedback, the DA cells would
be excited and therefore no interneurone need be postulated. However,
the evidence that it is the GABA-ergic component in the pathway that
is important is so great it seems unlikely that SP is involved.
- Evidence against the feedback loop hypothesis:
No evidence against the FLH was produced until 1971 when it was
shown that CPZ still had an effect on turnover in striatal slices. The






FIGURE 24: Diagrammatic representation of possible mechanisms for
the feedback control of DA turnover, involving the
striato-nigral pathway.
1. A loop involving a striatal ACh interneurone, a striato-nigral
GABA cell and a nigral interneurone, probably containing GABA.
2. A loop involving a striatal ACh cell and a striatal GABA cell
along with a striato-nigral GABA cell.
3. A loop involving a striatal ACh cell, and a striato-nigral SP cell.
4. A loop involving direct action of a DA cell on a striato-nigral SP
cell.
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by CPZ (169). This implied that a local factor might be involved in the
regulation of DA release. Then in 1973 it was postulated that the
SNC DA cells might also have DA receptors of their own (54). Ionto-
phoretic DA into the SN was shown to reduce the firing rate of the DA
cells. This suggested that an intra-nigral mechanism might also be
involved. At this stage the local mechanisms were not thought to be
a threat to the FLH. A more direct challenge to the FLH was made by
Bedard and Larochelle (27). These workers cut the striato-nigral
fibres and noted that there was no reduction in the effect of neuro¬
leptics on HVA in the striatum. Therefore, they postulated, the striato-
nigral pathway could not be involved in the feedback control of DA
turnover. Later, this was supported by the work of Garcia-Munoz
et al (207) who lesioned the striato-nigral pathway and showed that there
was no difference in the effect of haloperidol on DA turnover. The DA
receptors on the DA cells themselves have since been christened
"autoreceptors" by Carlsson in 1975 (64) although he was more specific¬
ally referring to the ones on the pre-synaptic terminals in the striatum.
Since these early reports a large body of evidence has accumulated
to suggest that local mechanisms involving only the striatum or only
the SN may be involved in the regulation of the DA activity. This
evidence will now be discussed.
Although lesions of the nigro-striatal pathway abolished the effects
of DA agonists and antagonists on DA turnover, acute axotomy itself
increased greatly the turnover of DA (9,618). Inhibition of impulse
flow with y-hydroxybutyrate (GHB), a general CNS depressant (554)
or its precursor y-butyrolactone, both of which have a specific action
on the DA system (514) also leads to an acute enhancement of turnover
in the striatum (212,449,517,618), but not in the SNC (458a). The
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inhibitory action of GBH on cell firing possibly involves its conversion
to GABA, especially as it is inhibited by picrotoxin (516). It may also
have an endogenous inhibitory function as GBH is found naturally
in the brain (515). The reason for this response to GBH is unclear.
This paradoxical response to axotomy and GBH implies that DA
release in the striatum is not completely impulse dependent as earlier
results may have suggested. In fact it may have been because of the
increase in basal firing and release that the effects of dopaminergic
agents were no longer seen after lesions of the nigro-striatal path.
The increase in DA synthesis occurring on the cessation of impulse flow
seems to result from a decreased sensitivity of the enzyme to the end
product inhibitor, DA (64). The mechanism causing the change must
exist in the striatum as the nigro-striatal connection has been destroyed.
Other evidence also suggests the existence of an intra-striatal mechanism
for the regulation of DA synthesis.
Firstly, the effect of neuroleptics (169,170,284) and DA agonists
(169,170,284,400,565) on release is still present in slices. Other agents
can also affect the release of DA in slices. ACh will still cause an
increase in DA release (216), as will GABA (162,214,567,572) or a
GABA-transaminase inhibitor (573) and glutamate (505). The glutamate
effect is blocked by intra-striatal KA and so implies an involvement of
the striatal cells in the response. However, other workers have shown
that the effect of glutamate is not blocked by tetrodotoxin (TTX),
an agent blocking action potentials, suggesting that the effect is pre¬
synaptic (213). The explanation may be that the KA lesions had some
non-specific damage to terminals. ACh will also increase DA release
from striatal synaptosomes, but GABA has no effect on synaptosomes.
This implies that ACh may act directly on the terminals to affect DA
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DA release. These pre-synaptic ACh receptors are thought to be
nicotinic (215,217), although both muscarinic and nicitonic receptors
have been shown to decrease in the striatum after 6-OHDA in the SN
(130).
The fact that ACh and GABA are still effective in slices and ACh
in synaptosomes suggests that their role in a FLH may not be quite as
outlined in Figure 24. Also as the effects of DA drugs are still seen
in animals with KA lesions of the striatum (24,142,144) or brain tran¬
sections leaving DA paths largely intact, but severely reducing the
GAD levels in nigra (640) and that cell firing is still altered by halo-
peridol and amphetamine in animals with small lesions in the crus cerebri
(206) implies that the striato-nigral pathway may not be necessary for
a feedback control of DA turnover. Also ACh or GABA interneurones
in the striatum may not be necessary, and the mechanism of action for
the DA drugs may be a purely pre-synaptic one. This is supported
by work with TTX in which the effects of apomorphine and haloperidol
are not affected, implying that an action potential is not needed for the
effect on release (284). However, the effect of GABA on DA release is
TTX sensitive implying it does involve the mediation by an action
potential (214). This is in agreement with the synaptosome work.
GABA also decreases the release of ACh, possibly acting via an
indirect effect on DA release (358,572).
As well as ACh affecting DA release, DA can affect ACh release
as has been mentioned in the previous section (76,247,248,563), in
favour of a FLH. This is also true of GABA (74). The reciprocal
nature of these interactions is extensively reviewed by Lloyd (371)
and argues against a simple feedback loop. A loop may be involved but
the total mechanism cannot be as simple. Alternately, the ACh and GABA
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involvement in the striatum may be coincidental to the feedback
mchanism and represent other influences on the system. Figure 25
shows the postulated mechanisms that may be involved in an intra-
striatal feedback mechanism.
As well as evidence for a local striatal effect there is also evidence
for an intra-nigral effect on the control of DA cell activity. This
concept was first tentatively suggested by Aghajanian and Bunney in
1973 (6,54). They showed that the local application of DA in the SN
caused a slowing of the DA cells. In this experiment, amphetamine
had little effect and the, later christened, DA autoreceptors were not
thought to have a significant role in the control of cell activity. In
1975 Groves et aI again put forward the idea. This time a lot more
emphasis was placed on a role for the DA autoreceptors in the control
of cell activity, as an alternative to the FLH (242). In this paper the
hypothesis that the dendrodendritic synapses, that were proposed on
the observation of varicosoties in the DA dendrites containing DA (39),
could regulate the DA cell activity. Synaptic vesicles had been demon¬
strated in these varicosities as early as 1973 (252). A small number of
"autapses", that is collaterals synapsing with the parent cell have also
been seen in the SN (312). To test the hypothesis that dendritically
released DA could control DA cells by acting on DA autoreceptors,
Groves et al (242) infused amphetamine into the SN and striatum and
recorded the activity of the DA cells at the same time. These direct
injections led to strong depression of the firing rate of the DA cells,
and was consistent with a local mechanism of control. Since 1975 much
evidence has accumulated in favour of this hypothesis.
It was shown that the inhibitory effect of amphetamine on the SNC
cells was blocked by a-methyl-p-tyrosine (243). DA release was shown
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FIGURE 25: Diagrammatic representation of intrastriatal mechanisms
for the feedback control of DA turnover.
1. A striatal ACh cell feeds back onto the DA terminal.
2. A striatal ACh cell feeds back onto the DA terminal by way of
a GABA interneurone and a collateral from a striato-nigral GABA
cell.
3. DA acts directly on its own terminals.
4. A second nigro-striatal DA cell affects the terminals of the first
one.
* represents the site of action of all the mechanisms.
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to occur in the SN (78) and to be increased by amphetamine and the
uptake blocker benztropine (415,451). Nerve ending particles can also
be prepared from DA dendrites and these can be shown to release DA
(269). DA levels were shown to decrease and the metabolite levels
increase after stimulation of the MFB resulting in the antidromic
activation of the DA cells (350,351) also K+ stimulation leads to release
(118,211). Uptake of endogenously applied DA can also be shown to
occur in SN (118) and release appears to be greater in the SNR, which
contains most of the dendrites (118). This is consistent with a role
for dendritically released DA.
DA or amphetamine applied locally into the SN does result in
decreased release of DA in the striatum as would be expected if nigral
DA had a regulatory function (427,428). Similarly, neuroleptics,
applied to the SN, will increase DA in the striatum (428). Iontophoretic
DA, directly into the SN, will reduce DA cell firing rate (8).
DA can also affect GABA-ergic function in the SN. A large GABA
input to the SN comes from the striato-pallidal area (see Section 1.2)
and there is also some intrinsic GABA or output GABA cells. Different
groups have reported different effects on GABA release. Reubi et al
(494,495) showed an increase in evoked GABA release in SN slices
whereas Arbilla et al (14) failed to do this. In fact if large doses of
apomorphine were used a slight decrease was observed. In the intact
animal, using push-pull cannulae, biphasic results were obtained on
GABA release (599). Apomorphine and DA behaving in an opposite
manner. This is possibly due to complications from the descending
GABA pathway in the whole animal. It can be shown that DA can excite
SNR cells which is unusual for this inhibitory transmitter (522). It
also seems that DA can affect the release of GABA from the GABA nerve
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terminals when these are stimulated by K+ (566). The exact significance
of this is unclear, but it may be involved in the action of the striato-
nigral cells on the DA cells. Despite some confusing evidence, it seems
that DA does affect GABA in the SN and this suggests a transmitter or
modulatory role for DA in the SN.
The existence of DA autoreceptors, both in the striatum and the
SN has been demonstrated by autoradiography combined with lesion
and binding studies (409). The DA autoreceptors are thought to be of
the D2 non-cyclase linked type of receptor, both in the striatum and in
the SN. Spiperone binding studies combined with various lesions show
this in the SN (483,492) and the striatum (205,492,539).
Biochemistry has also suggested the existence of a DA-AC in the
SN (316,463,478), later shown by lesion studies to be on the terminals
of the striato-pallido-nigral fibres (203,411,462,478,483,560). Similarly
in the striatum the DA-AC receptor has been shown to be on the post¬
synaptic cells (186,205,539).
Figure 26 shows the postulated feedback mechanisms in the SN.
The current concensus of opinion on the FLH seems to be that it
may exist, but that the main function of the striato-nigral pathway is
as an output for the striatum and it only secondarily affects DA cell
activity, and the feedback control of DA synthesis is in fact controlled
by one or more local mechanisms in the SN or the striatum.
A compromise hypothesis was suggested by Bunney and Aghajanian
in 1978. They suggest that control of DA cell activity is mediated by
both the striato-nigral pathway and the autoreceptors in the SN (58).
Skirboll et al suggest an interesting point by saying that if the pre¬
synaptic DA receptors were more sensitive than the post-synaptic ones,
low doses of DA agents could possibly result in a net excitatory rather
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FIGURE 26: Diagrammatic representation of intra-nigral mechanisms
for the feedback control of DA turnover.
1. DA from the dendrites of the DA cells, acts on the striato-nigral
GABA terminals to affect an interneurone, which then affects the
DA cells.
2. Direct lateral (or auto) inhibition between the DA cells.
3. Dendritic DA affects an interneurone, possibly containing GABA,
which affects the DA cells via another GABA interneurone.
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rather than inhibitory effect (553). This might help to explain some of
the conflict in the literature.
An alternative role for the striato-nigral pathway
The unilateral activation of the nigro-striatal DA system leads to
contralateral rotation in rats (15) and this is correlated with DA release
in the striatum (17). After a unilateral 6-OHDA lesion in the nigro-
striatal system rats will turn ipsilaterally when challenged with apo-
morphine (see Chapter III). Lesions of the striato-nigral pathway will
block this behaviour (140,206). Picrotoxin and GABA agonists will
also affect the DA dependent turning behaviour of rats, but in a rather
complicated way (see review by Pycock, 481). Whether the DA effects
are enhanced or blocked appears to depend on where in the SN the drugs
are acting (18,489). It seems that the SNR acts as an output station in
the processing of DA mediated effects in the striatum, and that the
GABA in the striato-nigral pathway mediates this effect (96,140,206,443).
There is still controversy over where the output goes after the SN
(see review by Pycock, 481). It may go via the ventromedial thalamus
(208,291), the midbrain reticular formation (139,208,408) or the deep
layers of the superior colliculus (128,139,208,282), although there is
some evidence against the latter (110,335,490) (see also Section 1.4).
Other possibilities for the post-synaptic mediation of the feedback
control of DA turnover
Other polysynaptic pathways could conceivably be involved in
the feedback control of DA turnover, not involving the striato-nigral
path. The crus lesion described (206) does not get the projection from
the tail of the striatum to the more lateral parts of the SN (55,588).
However, GABA and DA are mostly located in the main body of the
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nucleus (277,584) and so the effect is unlikely to be mediated by the
lateral fibres. Also the effects of apomorphine and haloperidol on DA
cell firing are not affected by lesions getting this part of the striato-
nigral pathway (206).
Of the other inputs to the SN (see Section 1.3), the one from the
raphe nuclei is the most likely to be involved. Stimulation of the DRN
and MRN leads to the inhibition of the nigral DA cells (152,154). It is
suggested that 5-HT could cause a tonic inhibitory influence on the DA
cells. Lesions of the raphe nuclei also lead to a drop in nigral 5-HT
and an increase in striatal dopamine (154). DA agonists have been shown
to increase 5-HT levels in the rat brain (491), so the mechanism might
conceivably work. The fact that the striatum also receives an input
from the median raphe (422,601) suggests the possibility of complex
interactions. In further support of a role for 5-HT in the control of
DA turnover, 5-HT is also known to be involved in turning behaviour
(103,286,287,402,481,613) which may be related to DA dependent
rotation, although there is evidence to suggest a non-DA dependent
involvement of 5-HT in rotation (440). It is even possible that DA and
5-HT have opposing roles in the control of DA cell activity (115).
However, it is difficult to see how this feedback loop would be
completed. It would have to be a very complex circuit.
Another interesting possibility that has not been investigated is
that the proposed non-DA nigro-striatal pathway (see Section 1.2) may
be involved.
Experimental rational
In the experiments described in this Chapter, an attempt was made
to study the control of the activity of SNC DA cells using electro¬
physiological methods, and paying particular attention to an intra-nigral
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mechanism of control. Firstly, it was thought that if DA could be
released from the dendrites by antidromically driving the cells from the
striatum, it might be possible to see the effect of the released DA on
the firing of the cells by constructing peristimulus histograms (PSTHs).
In these, the cell firing is time locked to the stimulus so that short -
term (several ms) changes in activity can be examined. Such high
currents were required to drive the cells antidromically, that what
appeared to be interference from the striato-nigral pathway masked any
possible effect from antidromically released DA. Complicated sequences
of responses resulted from what were presumed to be GABA and SP
from this pathway. In order to avoid this interference, lesions of the
striatum were made and the effect of driving observed. The earliest
lesions used KA injections into the striatum and on examination did not
appear to clarify the picture at all. At this stage it was assumed the
lesions had not been extensive enough to damage enough of the striatum
to prevent the effect and other types of lesion were tried: electrolytic
lesions of the striato-nigral fibres where they pass through the crus
cerebri, distinct from the ascending DA fibres (206,588). These lesions
and other neurotoxic lesions of the striatum (using NMA) also did not
affect the pattern. The significance of this is discussed in Section 4.4.
If there is an intra-nigral, DA mediated, lateral inhibition it seemed
odd that picrotoxin, a GABA antagonist should block the effects of
amphetamine on the DA cell firing, as had been reported (234). In the
drug experiments first of all we tried to repeat the experiments with
picrotoxin on the effect of amphetamine on DA cell firing. After this,
the existence of a mechanism by which dendritically released DA could
act via GABA was investigated. DA could act on the striato-nigral
terminals to reduce the release of GABA. This would then lead to the
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excitation of inhibitory, interneurons themselves possibly GAB A
containing, which would then cause the inhibition of firing in the DA
cells. This is similar to the hypothesis of Grace and Bunney (234)
where they also propose a GABA interneurone in the SN which is
affected by the release of striato-nigral GABA. In their view, DA was
acting in the striatum, while in this view, it is acting in the SN.
To examine this possibility further, we tried to see if the DA
feedback obligatorily involved GABA cells or whether the effect on DA
cell firing could still be seen after blockade of GABA receptors with
picrotoxin. If so, no further effect should be seen with haloperidol
after the administration of picrotoxin (which of course will speed up the
cells on its own). Haloperidol should not affect the action of picrotoxin.
The same rational was used in studying the effects of drugs on the
PSTHs. It was hoped that this would show whether any antidromic
effect was mediated via GABA receptors or not.
This is further discussed in Section 4.4, after the methods used
and the results obtained are given in detail.
4.2 Electrophysiology methods
The spontaneous activity of the dopamine cells in the SNC was
recorded extracellularly. These cells were driven antidromically from
a stimulating electrode in the striatum. Records of spontaneous activity
and PSTHs were made from each cell. The activity of cells from both
control and striato-nigral lesioned animals was recorded. The effects
of several drugs on the firing of control cells were also studied.
Surgical procedure
All experiments were performed on male albino Wistar rats, ranging
in size from 220-300 g. Anaesthesia was induced in a plastic box, with
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a 4% mixture of halothane (Fluothane, ICI Ltd) and medical air.
A tracheal cannula (outside diameter 2.1 mm, Portex Ltd) was inserted
to facilitate breathing. Anaesthesia was then maintained at 1%, with
a flow rate of 200-300 ml/min. The tracheal cannula was connected to
a Y-piece, along one arm of which the anaesthetic was supplied. The
anaesthetic was removed along the other arm by suction.
In drug experiments a cannula (outside diameter 0.63 mm, Portex
Ltd) was placed in the femoral vein of one leg, to allow the injection of
drugs. If necessary, another cannula (outside diameter 0.75 mm, Portex
Ltd) was placed in the adjacent femoral artery to allow the recording
of blood pressure. The intravenous cannula was perfused with normal
saline at a rate of 150 nl/hr to prevent the cannula blocking. Blood
pressure was recorded on a Devices chart recorder, via a transducer
(0-75 cm Hg, Type 4-327-L221, Bell and Howell Ltd). The cannula and
transducer were filled with normal saline in which was dissolved 50 units/
ml heparin sodium (Pularin, Duncan Flockhart Ltd). On flushing the
cannula, care was taken to get as little heparin as possible into the
circulation of the animal as this could lead to death from bleeding.
After this the rat was laid on a heated blanket (Thermega Ltd)
and put in the stereotaxic frame (David Kopf small animal frame) using
blunt earbars, tip angle 45°. The tooth bar was set at 2.4 mm below
the earbar zero. A midline incision was made to expose the skull and
the muscles at the back of the neck. Two burr holes, 2 mm in diameter
were drilled with a dental drill to insert the stimulating and recording
electrodes. Before inserting the electrodes the dura matter was removed
with fine forceps and the brain surface covered with liquid paraffin to
prevent the cortex from drying out.
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Two approaches were used to position the nigral recording
electrode. The first of these was to insert the electrode at 46° to the
vertical. The co-ordinates used for this approach were as follows:
4.5 - 5.2 mm posterior to bregma
6.8 - 7.0 mm lateral/oblique to bregma
6.0 - 8.0 mm ventral/oblique from brain surface
Because of the angle of the electrode, the lateral and ventral
measurements are also at 45° to the axis of the frame, hence the use
of the term "oblique". The more lateral and anterior measurements were
used in the bigger animals.
The second approach was to insert the electrode in vertically at
the following co-ordinates:
4.5 - 5.2 mm posterior to bregma
1.5 - 2.0 mm lateral to bregma
7.0 - 8.0 mm ventral from brain surface
Again, the more lateral and anterior values were used in the
larger animals.
The latter approach allowed more electrode penetrations in each
animal before the brain became too damaged to record from. However,
in this way, fewer cells could be recorded on each penetration because
of the smaller size of the SN when approached from above.
The striatal stimulating electrode was placed in various sites
both in the head of the striatum and further back towards the tail.
The co-ordinates for two of the sites are given below.
0.5 mm anterior or 1.0 mm posterior to bregma
2.5 mm or 4.0 mm lateral to bregma
4.5 mm ventral from the brain surface.
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The position of the electrodes was verified histologically at the
end of each experiment, as described in Section 2.1.
In the animals lesioned with neurotoxins, the stimulating electrode
was placed as near as possible to the centre of the lesion by inserting
the electrode at the same co-ordinates as were used for the injection
of the neurotoxin.
Animals which were given picrotoxin were given injections of
gallamine triethiodide (Sigma) intravenously. A dose of 16 mg/kg was
used and was repeated every 45 min or as necessary. Because of the
paralysis induced by the gallamine, these animals were ventilated
artificially, using a Bioscience air pump, model No. B15-51190-1.
The ventilation rate was set at 60 cycles/min and the volume (2-5 ml)
set to maintain the blood pressure as near to control as possible.
Cells which were recorded from animals with an unsteady blood
pressure were not used. Slight decreases in blood pressure did occur
on the injection of any solution. Also, during surgery on the head,
fluctuations in blood pressure occurred which steadied after the
operation. Figure 27 shows sample blood pressure traces.
Stimulating procedure
Concentric bipolar stimulating electrodes (Rhodes Medical
Instruments Ltd) were used throughout. These had an outside diameter
of 0.5 mm. Stimulating pulses were generated by an isolated stimulator
(Digitimer Ltd, Type No. 2533), supplying a constant voltage from 0 V
to 100 V. Pulse lengths varied from 0.2 ms to 0.5 ms, with a very
occasional longer pulse of 1 ms. The frequency of stimulation was
either 1/1.1 s or 1/1.3 s. The currents involved were later calculated
from a calibration curve, plotted from resistance measurements made at
the end of an experiment. The currents used varied from 40 jjA to 3000 uA.
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FIGURE 27: Sample blood pressure traces.
A. Control, with variations due to operating on the head.
B. Before and after the start of ventilation.
C. The effect of the injection of 0.3 ml saline.
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The timing of the stimulating pulse was controlled from another stimulating
unit, capable of generating several pulses to control all the equipment
(D 100, Digitimer Ltd). All connections are shown in Figure 28.
A typical stimulating site is shown in Figure 29, both in a control and
an NMA lesioned striatum. In the lesioned animals, the stimulating
electrodes were placed as near as possible to the centre of the lesion.
This was done by using the same co-ordinates as for the injection and
noting where in the burr hole the needle was positioned. In one experi¬
ment, an attempt was made to estimate the extent of stimulus spread.
This was done by inserting an array of four electrodes, all of the same
type as used in the other experiments, into the striatum of the rat.
Measurements were then made on the stimulation strengths, and other
parameters needed to drive the same cell antidromically from the different
stimulating sites.
Recording procedure
Recording electrodes were made from double barrelled thetaglass
(Clark Electromedical Instruments Ltd, TGC 150). These were pulled
on a Forth Instruments microelectrode puller, and had a resistance of
45-60 Mohms, as measured on a voltohmeter (W.P. Instruments Ltd,
model No. F-29). The electrodes were filled with 2% pontamine sky blue
dye (Gurr Ltd) in a 0.5M solution of sodium acetate (BDH), filtered and
adjusted to pH 7.7.
The recording electrode was moved through the brain by a micro-
drive unit (Forth Instruments Ltd) using remote control. While the
electrode was being moved through the brain to the correct area, it was
moved at 100 am/s, 2 am at a time, and while searching for cells in the
substantia nigra, the electrode was moved at 4 am/s. Each electrode
could generally be used several times. At the end of the experiment,
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FIGURE 28: Interconnections of the equipment used in the recording
experiments. The Biomac computer and the Ferranti
computer were not used in the same experiments. Details
of the use of the various pieces of equipment are given
in the text.
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FIGURE 29: Histology of typical stimulating electrode placements
stained with luxol fast blue and cresyl violet.
A. In a control animal.
B. In a NMA lesioned animal. The electrode tip can be seen in the
centre of the lesion.
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or sometimes during the experiment, the position of the electrode tip
was marked by ejecting some dye from the tip with negative current
(10 uA for 7 min). This left a blue spot in the brain, the position of
which could be determined under the microscope. Figure 30 shows a
typical electrode placement.
The electrode was connected via a silver wire to the gate of a
field effect transistor (F.E.T., Radiospares Components Ltd, No. 2N3819)
which was used as a voltage follower and was supplied by two 6 V
batteries in series.
The signal was recorded differentially, using a silver wire in the
neck muscles as a reference electrode. An earth electrode was attached
to the skin at the edge of the incision.
The whole animal, includingtheF.E.T. was enveloped in aluminium
foil to reduce radiofrequency interference to a minimum.
The signal from the preamplifier was fed into a differential
amplifier (Tektronix 5A22N) and then into channel 1 of a dual beam
storage oscilloscope (Tektronix D.13). In this amplifier the signal is
filtered to remove excess noise. The upper limit is 3 kHz and the lower
limit is 1 kHz. From the differential amplifier, the signal was fed to a
spike processor (Digitimer Ltd, D100), where the nerve action potentials
were quantified and the signal digitised. The levels at which the
potentials were counted could be set by a window discriminator in the
spike processor and these levels could be monitored on channel 2 of
the oscilloscope. The digitised signal was then passed on to the data
collecting system, described later. The signal could also be used to
trigger the D100 for performing a collision test or constructing post-pulse
histograms (PPHs). These are also described later in this section.
Again, these connections are shown in Figure 28.
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FIGURE 30: Histology of a typical recording electrode position.




To show that a cell was being antidromically driven, that is being
driven backwards towards the cell body and not trans-synaptically,
each one was tested for collision and if this did not occur, the cell was
rejected. Collision is when a spontaneous spike travelling from the
cell body to the terminals meets and cancels out an action potential
caused by stimulation and which is travelling from the terminals to the
cell body. This is one of the most reliable tests to see if a driven
potential is antidromic or not. To perform this test, the D100, set in
single cycle mode, was used to trigger the stimulator when it itself
was triggered from a spontaneous spike, via the spike processor. The
time interval between the spontaneous spike and the stimulating pulse
was increased from zero until the driven spike could be seen again. The
time interval when the driven spike was just not seen, was taken as the
collision time.
Another test used for antidromicity was the following frequency
of the response. This was done by applying two stimuli closer and closer
together until only one response was seen. The frequency at which two
responses could still be seen, was taken as the following frequency.
A frequency of greater than 100 was taken as support for antidromicity.
Data collection
- Spontaneous activity:
The output from the spike processor was fed into a chart recorder
(Servoscribe, or Bryans B600). The number of spikes summated over
10 s intervals was plotted, and changes were noted as an increase or
a decrease in this level.
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- Interval histograms:
In the earlier experiments, the signal from the spike processor
was sent to a Biomac 1000 computer (Data Laboratories Ltd) which
constructed interval histograms (IHs) and displayed them on a screen.
This could then be output to a chart recorder (as above).
The later histograms were constructed by a microprocessor
computing system, built in this department and based on the Ferranti
F100-L system. The D100 was adapted to send a signal to the micro¬
processor system which was programmed to display the completed histo¬
grams on a graphics display unit (G.D.U.) (Tektronix 4006-1). This
information could then be stored on magnetic tape (TandbergTDC 3000
Digital Cartridge recorder), or a hard copy could be taken (Tektronix
Hard Copy Unit, 4613). From either of these the actual values forming
the histograms could be determined.
- Peristimulus histograms:
Again, the early experiments used the Biomac 1000 to construct
the peristimulus histograms, and output them to a chart recorder as
above. In constructing these, the D100 was used to co-ordinate the
triggering of the oscilloscope, the stimulator and the Biomac. In some
cases the pulse was delivered at the start of the histogram, and in
others it was delivered 200 m into the histogram in order to provide
a control period at the start. The overall lengths of the histograms
varied: 40, 80, 640 or 1280 m. The shorter ones were for demonstrat¬
ing the antidromic response and any early effects, whereas the longer
ones showed the later effects, up to about 1 s after the stimulus. The
1280 m ones proved more satisfactory as all effects were not always over
by 640 m. However, this meant that the highest frequency of stimulation
was one stimulus every 1.3 s (0.77 Hz).
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The next set of experiments was done using a Scope Raster-
Stepper (W.P. Instruments Ltd, model No. 140A) to construct the
PSTHs. Here the histogram was recorded on film as a pattern of dots,
built up on a second oscilloscope screen. These were later counted and
conventional histograms drawn from these values. In these experiments
the D100 was used to trigger the second oscilloscope, via the raster-
stepper, as well as the other equipment. In this case, histograms were
either 50 or 1000 msin length. Again the shorter ones are to show
antidromic and early effects and the longer ones to show effects up to
800 msafter the stimulus. In the longer histograms the stimulus was
applied at 200 rnf. Here the stimulation frequency used was one every
1.1 s (0.9 Hz).
The last experiments again used the microprocessor system. The
D100 was also modified to trigger the computer at a set time in the
stimulating cycle. It also triggered the oscilloscope, the stimulator and
the raster-stepper which was used to monitor the histograms as they
were building. Again the histograms could be displayed on the GDU
and could be stored on tape or as a hard copy.
All data on tape could later be reread or calculations performed on
it, by another microprocessor computer, the Ferranti F100-L Development
system.
Experiments on spontaneous activity
The spontaneous activity of all cells was routinely recorded. The
effects of several drugs on the spontaneous activity was observed.
The effect on the interval histograms was also investigated. All drugs
were applied intravenously through a cannula in the femoral vein.
The exact doses of the drugs varied and details are given in the results
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section, but the drugs used are listed here, with the range of doses
used: haloperidol, 0.05-0.2 mg/kg (Serenace, Searle, 5 mg/ml ampoules
diluted in saline); picrotoxin, 1.5-4 mg/kg (Sigma); apomorphine,
0.1-0.4 mg/kg (Macfarlane Smith Ltd); amphetamine, 1-2 mg/kg (Koch
Light Laboratories). For a single stage injection the volume of injection
was 1 ml/kg.
Experiments on peristimulus histograms
Measurements made on the antidromic activity were as follows:
antidromic threshold, antidromic latency, collision time and following
frequency.
For each cell a series of histograms were made at different stimula¬
tion strengths, to observe the full range of effects of stimulation on
that cell and to obtain thresholds for all effects. For each cell one or
two control PSTH's were constructed, using the same procedure, but with
the stimulator switched off. This was used in the analysis of antidromic
effects. Another type of control histogram was the PPH. Here the
stimulator is also switched off and the computer is triggered by a spon¬
taneous spike. The D100 was left on single cycle so each histogram
was 1 s long plus an interval while the system waited for the next
spontaneous spike.
This was done both on control cells and on cells from animals with
a lesion in the striato-nigral pathway, either in the striatum or in the
fibres as they travel to the substantia nigra.
The effects of picrotoxin and haloperidol on the PSTH's were also
studied by constructing the histograms before and after intravenous
application of the drugs. This was only done on control cells.
PSTHs taken from the biomac or the raster-stepper were




- Analysis of post stimulus histograms:
A non-parametric approach, using Wilcoxon Rank Sum tests,
was used to estimate the effects of lesions on the antidromic threshold
and the various other thresholds measured, the antidromic latencies and
the firing rates. The mode and range of the antidromic latency were
also plotted as these were more meaningful than the mean.
The estimation of any excitations or inhibitions in the PSTHs was
done by eye in the preliminary experiments, but it was felt that numerical
values and a consistant quantitative analysis of the data was needed.
In order to do this a control period was used to calculate a mean value
for the number of spikes in a 20 ms period in each cell. This control
period was either a complete 1 s histogram constructed as the PSTHs
were, or the control 200 ms at the start of one or more of the PSTHs.
The mean number of spikes in 20 ms was then used to calculate
limits above and below which the number in a test period could be said
to differ significantly from the control one. To find these limits, the
following equation, based on a Poissonian distribution for the spontaneous
activity was used. The distribution of firing rates in the control histo¬
grams did not differ signficiantly from Poissonian distribution, so this
approach seemed valid.
A i = mean control firing in 20 ms; summed over 50 sweeps.
A 2 = limits between which the mean firing in a test period of
20 ms was considered normal
11 = the number of 20 ms periods used to obtain A x
t2 = the number of 20 ms periods in the test period, used to
find the test mean firing value
Z = a constant, 1.96, giving 95% confidence limits.
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An example is given below to show how this operates in practice,
and what problems can arise in the application of the method.
Mean value of spikes in 20ms in control period = 4.9
Number of 20 ms periods used to obtain the above = 50
Values of 20ms bins in the histogram to be tested:
13 14 9 8 55 31 7 2 4 4 0 0 0 0
7 19 40 8 19 32 63 0 0 2 0 13 7 20
11 17 12 12 12 9 8 2 5 11 8 10 14 12
The limits calculated from the above equation are:
for t2 = 3, 2.9 - 8.12
for t2 = 1, 2.04 - 11.54
The values above were summated over 60 ms periods and the average
for 20 ms found. This was done forward and backward from the point
of stimulation, and this leads to the omission of the first and last
numbers. Below are the results of this averaging and how they
compare with the calculated limits, an excitation indicated by a +,
an inhibition by a -, and no difference by a o.
10.3 == o 22.3 == +
11.7 =: 0 13.7 == +
9.7 == o 0.7 == -
55* = + 1.3 :
(* see later - these
31* == + h-* to : O three are still un-
7* r: - 13.7 == +
combined 20 ms bins
3.3 =: - 9.7 =: O
0 = - 6.0 == -
8.7 =: o >—4 o 11: O
This histogram has a short strong excitation, followed by an inhibition
and then a sequence of effects lasting up to Is.
The choice of sample time is important. 2.0 ms was convenient
for several reasons. Firstly, it was the minimum period of resolution
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that could be obtained from the raster-stepper patterns on the
oscilloscope; secondly it is a long enough time to have a reasonable
number of spikes in each bin, even in the slowly firing cells; and
thirdly, and almost incidentally, in the PSTHs constructed on the
computer using 50 sweeps this number corresponds to the firing rate
of the cell in Hz. The number in 20 ms and firing rate, of course,
did not correspond in the histograms taken from the raster-stepper
oscilloscope pictures, where 64 stimuli were used.
The length of bin used to calculate the mean firing must be the
same in both the control and test cases, although this need not have
been 20 ms as was used throughout in these analyses. In the example
quoted above 20 ms spells were used in the control period, and as
60 ms test periods were used, t2 had to equal 3.
It was decided to use 60 ms test periods as this seemed the best
compromise between losing information by having too long a sample time
(that is aliasing), or to obtain many spurious effects from having too
short a sample time. Also a shorter test period would have resulted
in unrealistic limits and any effect would have been difficult to show.
It was also thought best to use 95% confidence limits as this ensured
there was a significant effect, while not expecting too much of the
data. It is unlikely that the histograms themselves are more than 95%
consistent.
Although it was decided to use 60 ms periods for the analyses,
the first 60 ms after the stimulus required a different treatment.
Very often this was complicated by the presence of a large stimulus
artefact, leading to very high count in that bin. Also, above antidromic
threshold, the antidromic spike was often included in this bin. This
meant that the analysis of the first 20 ms, and even occasionally the
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second 20ms, was difficult. Therefore, in order to keep the other
bins in line in the analysis of a series of PSTHs, lower values of t2
were used in the 60 m after the stimulus. Sometimes a very short
early excitation, lasting only about 2.0 ms would be seen in this bin.
If this happened, it was treated with a value of t2 equalling 1.
The PSTHs constructed from the oscilloscope raster-patterns were
already in 20 ms bins and the numbers from these were grouped and
averaged by hand. These values were then compared with limits
calculated on a programmable calculator (Hewlett Packard 97). Early
data from the F100 computer was collected in 4 ms bins and then
reduced to 20 ms bins. The summated values were obtained on line.
These values were recorded on the hard copy unit and processed as
above. The later data from this system were stored on magnetic
tape and processed later entirely by the F100 development system.
This gave comparisons with the limits on a printout similar to the
example above, leaving the values around the stimulus as 20 ms bins,
allowing later examination by hand.
The data obtained in this way were drawn as single lines, a
space indicating an inhibition, a thin line a period of normal firing
and a thick line an excitation (see Figure 46). This allowed easy
comparison between cells and between different histograms from the
same cell.
- Analysis of the action of drugs on peri-stimulus histograms:
The PSTHs taken after the intravenous administration of drugs
were analysed as above. Any changes in the response to stimulation
caused by the drug were then described qualitatively.
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- Analysis of the action of drugs on the spontaneous activity:
In the cases of single drug administration, a paired t-test was
done on the mean firing rate before and after the drug application.
However, due to low numbers in the other groups where more than
one drug was administered each cell was described individually and
any overall effect was discussed qualitatively, with no further attempt
at analysis.
4.3 Electrophysiology results
Recordings have been made from a total of 281 DA neurones in
the SNC. An outline of all the data recorded is given in Tables 9
and 10. Not included in these tables aire cells that were recorded
from but that no experimental procedures were performed on. Most
of these however, are included in Table 13, showing the distribution
of types of antidromic response (see later in this Section). Information
from many of these neurones is used more than once in the rest of
the Chapter.
Tables 9 and 10 summarise all the data that has been described
and discussed in the rest of the Chapter. Also discussed are the
basic properties of the cells in each group, for example the antidromic
latency and firing rates of the units recorded.
All stimulus strengths are quoted in coulombs, to avoid the
problem arising from different pulse lengths (see Section 4.2).
Activity and antidromic driving of the dopamine cells
All subsequent sections will deal with data collected from action
potentials (APs) both firing spontaneously and affected by orthodromic
and antidromic activation from the striatum. The basic properties of
the recording of these APs is described here and will be assumed in














1 These are from cells which were lost before
more than one, or possibly two, PSTHs could
be recorded.
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All APs studied in this Chapter were shown histologically to be
recorded from the SNC. An example of a typical recording site is
shown in Figure 30. These units are thought to be the DA neurones
that project to the striatum as they were all antidromically driven from
the striatum and had shapes and firing rates corresponding to those
previously described (250). All cells resembled the Type I neurone
of Guynet and Agahjanian.
The firing rate was usually constant for long periods of time,
varying from unit to unit, from 0.9 to 9.8 Hz. The shape of the AP,
however, varied during the course of an experiment, and bore no
relation to the antidromic latency of the action potential. The shape
change was probably due to the electrode edging closer to or further
away from the cell, or possibly due to some extent of damage to the
cell caused by the electrode. The most noticeable change in shape
involved separation of the initial segment (IS) spike from the full
somato-dendritic one (SD). Figure 31 shows examples of the shapes of
extracellularly recorded DA cell APs.
All the units used were thought to be DA cells on the strength
of the above characterisation. It was unlikely that any were axons,
but the possibility does exist. All units are referred to as cells from
here on.
The measurements quoted below include information from the
preliminary data and the later studies. The antidromic latencies from
each group of animals is given in Table 11, as is the firing rate.
The mode and the range are given as well as the mean in the case of
the antidromic latency, as the distribution was skewed, as shown in
Figure 32.
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showing the skewed distribution of antidromic
SNC DA cells on striatal stimulation.
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A Wilcoxon Rank Sum test showed that there was no significant
difference in the antidromic latencies of cells from the control and
lesioned groups of animals (P >0.1), but that there was a difference
between the control group and the partially lesioned group (P <0.01).
Where there was a latency variation (see later) the value occuring
most at antidromic threshold was used. This was generally the longest
value.
Using both a Students t-test and a Wilcoxon Rank Sum test,
the firing rate of the control and partially lesioned groups did not
differ significantly (P >0.1). Those from control and lesioned groups
of animals did differ (P <0.002).
The collision test method was used to verify the antidromic
nature of the driving in all cells used. The collision time was taken
as the longest time interval between a spontaneous spike and the
stimulus that still led to collision, that is the cancelling out of the
spontaneous and driven action potentials. A longer interval than this
allows the spontaneous spike to pass the stimulation point before the
stimulus is applied and the antidromic pulse can be initiated. Figure
33 shows collision: three stimuli are applied, but only the two later
ones result in an antidromic response, the one with the shortest
interval from the triggering spontaneous spike does not give an anti¬
dromic response, i.e. it has collided.
Theoretically the collision time should be equal to the antidromic
latency plus the refractory period of the cell. However, in many of
these recordings, the collision time was equal to or even less than the
antidromic latency (the time from the stimulus to the onset of the
antidromic response). This was due to the triggering system used








FIGURE 33: Demonstration of collision on the oscilloscope trace.
Four stimuli are given and the resulting traces super¬
imposed. The time interval between the spontaneous spike
triggering the stimulus and the stimulus was increased by
1 ms each time. Only the stimuli with the longer intervals







FIGURE 34: Diagrammatic representation of the relation between
collision time and antidromic latency. The collision time
(12 ms) was taken from the time that the falling phase
of the triggering action potential crosses the lower window,
until the stimulus. The antidromic latency (15 ms) is
measured from the stimulus to the start of the initial segment
component of the antidromic spike. This leads to a
discrepancy (3 ms) approximately the length of the AP.
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phase of the action potential crossed the lower level set by the
window discriminator. Depending on action potential shape and the
level the windows were set at, this could be as much as 4 ms after
the start of the action potential. However it is the start of the action
potential that is taken for the antidromic latency measurement. This
leads to an apparent reduction of the collision time in relation to the
antidromic latency. Figure 34 shows this diagrammatically, using a
rather extreme example.
The following frequencies of most of the cells were also tested.
This was done by applying two stimuli closer and closer together until
only one response was seen. The frequency at which two responses
were just seen was taken as the following frequency. If the stimulus
artefact was large it could be difficult to see the first response.
It was possible to tell whether the cell was following at this frequency
by noting the latency of the visible response. This should be longer
than the latency in response to a single stimulus by the amount between
the two stimuli. Figure 35 shows an antidromic response following at
500 Hz.
A following frequency of greater than 100 Hz is taken as strong
evidence for an antidromic response.
The antidromic response to a series of stimuli either consisted
of the IS component, the whole SD spike or a mixture of the two.
Sometimes the SD spike is evoked, but it is split partially or fully
into the IS and SD components. Figures 36 and 37 show examples of
single and several superimposed responses. Table 13 outlines the
frequencies of the various types of antidromic response in all the





FIGURE 35: Example of a cell following a stimulation frequency of
500 Hz. The two stimuli are applied 2 ms apart and a
response to both is still seen.
FIGURE 36: Examples of the responses to single stimuli in SNC DA
cells on stimulation of the striatum.
A. IS component only.
B. SD component only.
C. A split response showing both IS and SD components.
The insert in each case shows the shape of the spontaneous AP.
179.
FIGURE 37: Examples of several superimposed responses in SNC
cells in response to striatal stimulation.
A, All IS components.
B . Mostly SD component.
C. Mixed IS and SD responses.
The insert shows the shape of the spontaneous AP in each case.
2ms in each case
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Animal group IS only IS >SD IS = SD SD > IS SD only Total
Control 65 66 22 18 5 176
Lesioned 13 19 5 4 6 47
Partially
lesioned
12 13 3 0 1 29
Total 92 104 33 25 12 267
TABLE 13: Division of driven APs into IS, SD and both components
of the spike. Data is from all three animal groups.
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In some cells the antidromic latency is not constant despite the
fact that collision occurs. Some cells show a distinct double or triple
latency whereas others show continuously varying latencies over several
ms. Sometimes the latency reduces as the stimulation strength increases.
Figure 38 shows examples of this "latency jump".
Stimulus spread
Four electrodes were placed in the striatum of one rat. The array
crossed the nucleus from the antero-medial portion to the posterior and
lateral portion, not quite reaching the edge. Each cell was driven from
one electrode and then the current necessary to drive it from the other
electrodes was measured. This was attempted on 7 cells. In 4 of these,
electrode 1 could drive the cell but electrode 2 could not. The other
three were driven by more than one electrode. The first was driven by
electrode 1 at a threshold of 112 nC, by electrode 2 with a threshold of
1500 nC. It was not driven by the other 2 electrodes. The second of
these was driven by electrode 1 with a threshold of 40 nC, by electrode
2 at 60 nC and by electrode 3 at 3000 nC. It was not driven by electrode
4. The third cell was driven by all 4 electrodes. Electrode 1 drove the
cell with a threshold of 60 nC , electrode 2 at 240 nC, electrode 3 at
400 nC and electrode 4 at 3000 nC.
From these crude experiments it can be estimated that even at the
highest stimulus strengths used, current spread was not much more than
6 mm and likely to be less. At the lower strengths the area of spread is
less, between 2 and 4 mm.
FIGURE 38: Examples of latency variations. Several superimposed
responses to stimulation of the same cell are shown in
each trace.
A. Two distinct latencies at the same stimulus strength.
B. Continuously variable latency at one stimulus strength.
C. Distinct latency jumps, the earlier response being elicited at a







- Preliminary stimulation studies:
In all these preliminary experiments only one PSTH was recorded
for each cell, either at or above the threshold for antidromic activation.
In some cases a note was made of the threshold for any other effects of
stimulation. These other effects were often complex and consisted of
a series of excitations and inhibitions of the normal firing in the period
after stimulation, often lasting up to 1 s after the stimulation. The
antidromic threshold had a mean value of 311 nC and this varied from
54 nC to 1500 nC. The mean "effect" threshold was 69 nC and this varied
from 40 nC to 200 nC. Plotting antidromic threshold and effect threshold
and using a Spearman Rank Correlation test, it was seen that the two
are only just correlated at the 95% level. The scatter diagram is shown
in Figure 39a, and Figure 40 shows examples of the PSTHs that were
obtained from striatal stimulation. These PSTHs were collected on the
Biomac 1000 and were printed out on a Servoscribe or a Bryans chart
recorder. It proved impossible to get accurate numerical values from
these histograms as the resolution was not good enough to separate the
individual columns. (Each PSTH is made up of 1000 columns.) When
printed at a faster paper rate, the PSTHs were unwieldy and it became
apparent that the response time of the recorder was not fast enough to
keep up with the Biomac output. If the output speed was reduced, the
time taken to print the PSTH became unreasonable while on line.
Despite the lack of accuracy in estimating the effects of stimulation,
due to the non-numerical nature of the data, it was clearly seen that a
complex response resulted from striatal stimulation. This complex response
was attributed to orthodromic activation of the striato-nigral pathway,





















FIGURE 39: Scatter diagram of the correlations between antidromic
threshold and effect threshold in the preliminary experiments.
A. Control animals. There is a significant correlation at P <0.05, but
not at 0.02.












40: Examples of PSTHs recorded on striatal stimulation from
SNC DA cells in control animals. These were collected
on the Biomac computer and printed by the chart recorder.
187.
100ms




FIGURE 41: Examples of PSTHs recorded on striatal stimulation from
SNC DA cells in KA lesioned animals. The data was
collected on the Biomac computer and printed by the
chart recorder.
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nature of the fibres. It was thought that if the striato-nigral pathway-
were lesioned by removing the striatal cell bodies with kainic acid,
the response patterns would be simplified, and an analysis of any
purely antidromic effect could be attempted.
Initial experiments with KA lesions, however, did not appear
to simplify the pattern very much if at all. However, using a Wilcoxon
Rank Sum test, a significant increase in the threshold for the other
effects was recorded (P <0.05). The mean was 143 nC with a range
of 40 nC to 400 nC. This time a plot of this against the antidromic
threshold (mean 828 nC, ranging from 60 nC to 2400 nC) showed a
stronger correlation on the Spearman Rank test (P <0.01). This is
shown in Figure 39b and examples of the PSTHs obtained from these
lesioned animals is shown in Figure 41.
In all, 11 lesioned animals were used and an assessment of the
extent of each lesion is given in Table 12. All animals were con¬
sidered to have large striatal lesions, either on the grounds of a
reduction of striatal enzymes or on histological evidence. The bio¬
chemistry was given slightly less weight in deciding on the extent of
the lesion as only the portion of the striatum anterior to the injection
site was assayed and this may have included normal tissue, whereas
the histology showed the tissue immediately at the injection site. An
example of a KA lesioned striatum, showing cell loss and gliosis is
illustrated in Figure 11 in Section 3.2.
- Preliminary experiments with picrotoxin:
From the results from six early cells it became apparent that 1.5
mg/kg was a threshold dose, sometimes being effective and sometimes
not, for both an effect on DA cell firing and for causing convulsions
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after the injection of the drug, so for later experiments, gallamine
paralysis and artificial respiration was used. Despite these problems
the experiments with amphetamine and picrotoxin described in a later
section of the results were successfully carried out.
To summarise, from these early experiments it became clear that
high currents were needed to drive the nigral DA cells antidromically,
and that these currents caused interference from other neurons acting
on the DA cells orthodromically. From the results from the KA lesioned
animals it seemed that the simplest possibility - that the striato-nigral
fibres may not account wholly for the effects of stimulation - might be
the case, although the threshold for these effects did seem to be higher
in the lesioned animals. More experiments were needed with carefully
assessed lesions. It was also obvious that some form of quantification
was needed as it was difficult to estimate the extent of effects consistently
and accurately by eye. The later experiments attempt to do this. Also
in all future picrotoxin experiments, gallamine paralysis was used.
Description of the lesions
The lesioned animals described above and in the rest of the
Chapter consist of several animals with electrolytic lesions in the crus
cerebri and several with KA or NMA lesions in the striatum. The KA
lesions have been already described. All the rats turned in response
to apomorphine, and had lesions identified histologically (see Section 3.3).
Table 14 shows the turning values for all the animals and the levels of
GAD in both nigrae of the NMA lesioned rats.
The partially lesioned animals also turned in response to apomorphine,
but histologically these lesions were not as extensive as those considered
as lesioned animals. The one partially lesioned NMA animal only differed
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mean that the lesion might not be extensive enough for the purpose of
the experiment, i.e. to ensure that current does not activate the striato-
nigral pathway.
Antidromic and effect thresholds
In order to follow up the difference in correlations between the
antidromic thresholds and effect thresholds (the lowest strength at
which an effect is seen) in the lesioned and control groups, hinted at
in the preliminary data, the same correlations that were done in the
preliminary section were done on the later data where more careful
measures of the effect thresholds were available. The Spearman Rank
Correlation Test showed strong correlations between antidromic threshold
and effect threshold in the control group (P <0.001), and the lesioned
group (P <0.01) but the partially lesioned group did not show this
correlation (P >0.1). Table 15 gives the mean values and the range for
these thresholds. The preliminary data was not used here as it was
less accurate. Figure 42 shows the scatter diagram of the correlation
of the two thresholds in the control animals.
The Wilcoxon Rank Sum test was used to see if there was any
significant difference in the antidromic or effect thresholds between the
lesioned group of animals and the controls and the partially lesioned
animals and controls. No significant differences were seen between
the antidromic thresholds of the control and either lesioned group, or
between the effect thresholds of the control and either lesioned group.
Post-pulse histograms
In order to control for the possibility that each time a SN DA cell
fires, there follows a set pattern of firing, PPHs were constructed.
If this set pattern exists, any effect would not be seen in histograms
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Control Lesioned Partially lesioned
Cells from animals animals animals
Antidromic 451 .1 362 . 6 514 .8
threshold (n = 142) (n = 32) (n = 28)
Effect 77 .8 58 .2 71 .1
threshold (n = 125) (n = 26) (n = 27)
All values are in nC.
TABLE 15: Mean values of the antidromic thresholds and effect
thresholds in each group of animals. There is no
difference between the control group and lesioned
groups. There is a correlation between antidromic
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FIGURE 42: Scatter diagram of the correlation between antidromic
threshold and effect threshold in the later control data
(see text for details). Here there is a significant correla¬
tion between the two thresholds (P <0.001).
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made up of randomly selected 1 s periods, as were the control histograms
used. The PPHs were constructed by starting each sweep in the control
histogram at a spike, triggering the system, set in single cycle mode,
with a pulse from the spike processor. This would show any inherent
fluctuations in the post AP period. A typical PPH is shown in Figure 43.
In all, these PPHs were obtained from 17 cells. These were analysed
in the same manner as the PSTHs, and in very few was there any trace
of any periods of firing above or below normal. There was usually a
short inhibition after the triggering pulse. The mean value of this was
46 ms (s.e. 12.4). The range of the inhibition was from 8 ms to 220 ms.
A single value of 220 ms and one of 104 ms caused an increase in the
mean which otherwise would have been much lower - without these two
values the mean inhibition was 30.9 (s.e. 4.6). The fact that the only
inherent pattern of firing linked to the firing of the cell is a short post-
spike inhibition, means that the large deviations from normal in the PSTHs
are indeed caused by the stimulation of the striatum and are not an
artefact caused by time locking the spikes. This result would have been
expected as the patterns were also seen, below antidromic threshold.
Because of this short inhibition, care should be taken in interpreting
short initial inhibitions, immediately after the antidromic spike as these
could reflect this functional "refractory period" of the cell.
Initial effects of striatal stimulation
The only immediately obvious classification of the PSTHs from the
206 cells recorded from all the groups of animals, was a division into
a group which had a short latency (<60 ms) excitation, which was short
lasting and relatively strong, and those which had not. Figure 44a shows
an example of an early excitation. An example of a cell with no early








FIGURE 43: Example of a PPH, showing1 the short post-pulse
inhibition in DA cell firing.
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FIGURE 44: Oscilloscope traces showing the early excitation resulting
from striatal stimulation.
A. Latency of excitation is greater than that of the antidromic spikes.
B . Latency of excitation is less than that of the antidromic spike and
shows the two effects superimposed.
Both traces show 5 superimposed sweeps.
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time interval within which excitation had to occur included was arbitrary,
but 60 ms seemed to be functionally relevant as this short lasting
excitation never started after 60 ms, although a few lasted longer than
the 60 ms. A total of 8 out of 67 cells (6 control, 1 lesioned and 1 partial
lesioned) with an early excitation had an excitation carrying on after
the 60 ms period, some up to a few hundred ms after.
Excitations starting before 20 ms after the stimulus were difficult
to measure as they tended to become tangled with the stimulus artefact
and the antidromic spikes. When this occurred, collision was also more
difficult to show, as spontaneous collision with the excitation occurred
before the antidromic spike could reach the electrode. This only
occurred to a significant extent in 3 cells one of which is illustrated in
Figure 44b.
- Peri-stimulus histograms with an early excitation:
The frequency of occurrence of the early excitation was determined
and a 2 x 2 frequency table was analysed with a chi-squared goodness
of fit test, comparing each of the two lesioned groups with the control.
The control group was used to generate expected values and the test
values were shown not to be significantly different from control in the
frequency of occurrence of the early excitation (P >0.1).
The threshold stimulus strength for the appearance of the early
excitation in each of the two test groups was compared with the control
group, using a Wilcoxon Rank Sum test and were shown not to differ
either (P >0.1).
As the effect was short lasting in most cases, it was decided not to
measure the length of the effect but only its extent, counting the number
of spikes above the mean predicted by the equation given in the analysis
section. Only the firing during the first 60 ms was included. The 3 cells
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whose early excitation tangled with the antidromic spike and stimulus
artefact were completely excluded from the analysis as an accurate
estimate of the extent of the excitation was impossible to obtain.
A stimulus intensity that was as close to twice the threshold for
the effect as possible was chosen for the analyses. Due to the limited
number of histograms from some of the cells this could not always be
done. Strengths varying from threshold to four times threshold were
used with only 4 cells out of 189 above this. Twenty-one cells had no
information on thresholds. These were included in the analyses of the
effect extent, but not of the effect threshold. Omitting these PSTHs
from the threshold effects leads to the differing n values in Table 16.
This table summarises all the above information and gives mean values
with standard errors for occurrence, threshold and extent of the early
excitation.
- Peri stimulus histograms with no early excitation
The other group of PSTHs either showed an initial inhibition of
firing when compared with control or showed a delayed effect, which
in most cases was an inhibition. In three cases, however, the delayed
effect was a late excitation. Two came from control animals and one
from a lesioned animal. Sometimes there would be an initial or delayed
inhibition occurring at a stimulus strength above that at which a late
excitation appeared. In a case like this the threshold for the appear¬
ance of the inhibition was used in this section, although in the previous
section where the antidromic and effect thresholds were compared,
it was the lowest threshold that was used, that is the threshold for
any effect at all.
As the inhibitions were much more varied than the excitations, the
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which this time was summed over the whole length of the inhibition.
The extent of the inhibition was taken as the number of spikes below
the expected number for that period, calculated from the control firing.
The same rules for choosing which stimulus intensities were chosen
for the analyses as in the previous section were used.
The three PSTHs which had delayed excitations as their only
initial effect, over all intensities of stimulation were not used in the
analyses, nor were another four cells which did not show a clear effect
over the stimulation intensities used. Hence only 90 of the 97 cells in
this group have been included in the analyses.
The mean values for the effects of this group of cells has also
been included in Table 16.
Later effects of striatal stimulation
The initial effects seen in the histograms were often followed by
a complex sequence of changes in firing, the most common effect being
a late excitation. Later inhibitions and even third excitations or
inhibitions were also seen. These later effects could be short lasting,
or they could last up to the end of a PSTH. Only one cell showed only
an initial effect at the stimulus intensities used and no cells did not
respond in some way to stimulation. Figure 45 shows the oscilloscope
pattern constructed with the raster-stepper and figure 45b shows the
histogram drawn from it. Figure 46 is an example of a PSTH constructed
by the F100 computer system.
Of the later effects, the most common one was a late, second
excitation illustrated in Figure 46. This was generally longer lasting
than the initial excitation and although occasionally could be, were not
usually as great in extent. It seemed to occur more strongly in cells
which also had an initial excitation, but this observation was not in¬
vestigated further due to comparative and quantification difficulties.
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FIGURE 45: Example of the oscilloscope pattern resulting from the
use of the raster-stepper to construct histograms. The
graph plotted from this scatter is also shown.
A total of 64 sweeps was made.
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FIGURE 46: PSTH constructed by the Ferranti computer, showing
a late excitation. The bars drawn under the PSTH
indicate whether or not the particular period of firing is
above control (■■), the same as control (—) or belou
control ( ). (See text for details of the analysis resulting
in these levels.) The PSTH is 1 s long. The star indicates




FIGURE 47: Sample PSTHs from control cells. The scale bar is the
same in each case and each PSTH is 1 s long. All are
taken from the Ferranti computer, but these are also




FIGURE 48: Sample PSTHs from cells from lesioned animals. See
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It was decided not to attempt to quantify the later effects at all
as they varied so much in latency and extent, also it would be very
difficult to choose which stimulus intensities to use and to justify
the choice, especially if a comparison with a different group of cells
was to be made. An attempt at a qualitative description is made below
and a few histograms with diagrammatic representation of the changes
caused by a change in stimulus strength are shown in Figures 47 and 48.
A larger collection of data is also demonstrated in Appendix B , as it
was felt it was useful and important to have more information than could
be conveniently coped with in the text.
On a qualitative basis, the series of histograms can be divided into
six groups:
1. effects generally get larger as stimulus strength increases;
2. the second effect decreases as the initial effect gets larger, as the
stimulation strength increases;
3. the initial effect decreases as the second effect gets larger, as
the stimulation strength increases;
4. the initial effect is split by the appearance of a new effect as the
stimulation strength increases;
5. very little change in pattern results from increasing stimulus
strength;
6. not enough information to classify.
Table 17 shows the numbers of cells that fall into each category.
It can be seen from the table that the most common effect is for the
patterns to increase as the stimulus intensity increases. This is true
for both classification groups and for both control and operated animals.
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The other four effects also have a similar distribution amongst the
various groups.
The above classification, or rather description, shows no correla¬
tion with the relative positions of the recording and stimulating electrodes
in the brain. Most combinations of effect grouping and histology
positions were seen.
The action of drugs on the effects of striatal stimulation
It was hoped to be able to compare PSTHs before and after drug
treatment by using a chi-squared test on each cell to see if the response
pattern was different after the drug and if so, to then examine the
PSTHs more closely to describe the effect, on a cell by cell basis.
However, if PSTHs taken at the same stimulation strength in the same
cell or two "off" periods are compared before and after a drug (allowing
for the change in spontaneous rate), they show as being significantly
different by this test (P <0.05). This was seen even when the two
patterns were identical when described by the equation given in Section
4.2. Due to this inherent variation in the PSTHs from one cell, it was
clear that the test was not suitable and it was decided, as in the previous
section, only to describe the effects from observation.
- Haloperidol:
Haloperidol at 0.05 or 0.1 mg7kg, caused little change in the pattern
of response to striatal stimulation, either above antidromic threshold or
at a lower strength, nearer the effect threshold. However, there did
appear to be a slight, but consistant reduction in the amount of
inhibition in the PSTHs. 0.05 mgYkg seemed to be a maximal dose as-
there was little difference in the effect of this dose and the higher dose.
Sixteen cells were used to construct the PSTHs above antidromic threshold.
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In 10 of these the reduced inhibition was in the form of a shortening
of the latency of a delayed excitation or the shortening of an initial
inhibition. In 1, there was a decrease in a delayed inhibition,
secondary to an early excitation. In 2, there was generally less
inhibition, and although in 1 the initial inhibitory component seemed
to be larger there was much less inhibition later in the PSTH. In the
final 3, there was very little change at all.
Only 13 cells were used to construct PSTHs near the effect threshold.
The same general pattern was observed as mentioned above, but the
effects, both before and after the drug are less than at the higher
stimulus strength.
Looking at the numbers in the bins in the PSTHs, rather than just
the pattern, did not alter the conclusions about the effects of the drug.
In some cells the delayed excitation was stronger or less delayed,
whereas in others it is weaker and prolonged. Figure 49 shows some
examples of histograms at antidromic threshold before and after halo-
peridol. The extent of significant effects is also indicated below each
PSTH (see legend to Figure 46).
It seems, therefore, that haloperidol may reduce the amount of
inhibition produced by striatal stimulation, although it proved impossible
to provide statistical support for this.
- Picrotoxin:
Picrotoxin at 2 mg/kg had a much more pronounced effect than
the haloperidol on the response to striatal stimulation. In 3 out of 7
cells recorded, picrotoxin caused the appearance of an early excitation,
not present before the drug. In 1 cell the threshold for an existing
early excitation was very much reduced. In another 2 cells the existing
early excitation is, if anything reduced, and later excitations are
H a I operi do!
mg/kg
FIGURE 49: PSTHs taken before and after haloperidol. All are taken
at just above antidromic threshold. See Figure 46 for
a description of the histograms.
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increased substantially. In one cell there was little change in firing rate
or the shape of the IHs, and correspondingly there was no change in
the response to striatal stimulation. This may have been because 2 mg/kg
was below the threshold dose for an effect in this animal. This dose
was chosen because it was known to be submaximal.
In the cells where the drug introduced a strong early excitation,
the later inhibition tended to be increased although this was not always
the case. Also where the early excitation was introduced by the drug,
a later secondary excitation was reduced in size, corresponding to an
increased inhibition, but contrasting to the increase in a secondary
excitation in the case where the early excitation was already present,
and reduced by the drug. Figure 50 shows examples of PSTHs taken
before and after picrotoxin. Figure 51 shows a strong excitatory response
to striatal stimulation not present before the administration of picrotoxin.
It seems therefore that picrotoxin causes an increase in the amount
of excitation resulting from striatal stimulation, although again it was
not possible to give statistical support for this.
- Haloperidol and picrotoxin combined:
Haloperidol, 0.1 mg/kg, given after 2 mg/kg of picrotoxin does
not seem to cause the same effects after picrotoxin as it does before.
This combination of drugs was tried on 4 cells. If anything, the amount
of inhibition is increased, going both by the patterns and by the numbers
in the PSTRs. The excitatory component of the response did not seem to
be affected. In one case, due to a high spontaneous firing rate, after
4 mg/kg picrotoxin apomorphine was added before the haloperidol (0.05
mg/kg). The apomorphine prolonged the inhibition and this was reversed
partly by the haloperidol, but not quite to the picrotoxin level. This is






FIGURE 50: PSTHs taken before and after picrotoxin. For description





FIGURE 51: Example of a strong excitation in response to striatal
stimulation after 2 mg/kg picrotoxin. No excitation was
present before the picrotoxin was given.
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It is possible that apomorphine is somehow competing with the picrotoxin
to reduce its effect. This is further considered in the Discussion.
PSTHs from the 4 discussed cells are shown in Figure 52.
If picrotoxin, 2 mg/kg, was given after 0.05 mg/kg haloperidol,
it seemed to cause the same changes as it did in the control case. In
2 out of 3 cells an early excitation was introduced where there was not
one before, and in the third an initial one was increased. The latter
effect is different from controls where early excitations already present
were reduced. Where the initial excitations were introduced, this may
have been due to the shortening of the latency of a later excitation. In
one case this would also mean the disappearance of an initial inhibition.
In the case where the early excitation was increased a secondary inhibition
was also reduced. In this particular PSTH there were no later excitations.
All these are shown in Figure 53.
It seems therefore that haloperidol does not affect the action of
picrotoxin on the effects of striatal stimulation.
The effects of drugs on the spontaneous firing of SN DA cells
- Amphetamine and picrotoxin:
In order to determine the effects of picrotoxin on the response of
the SN DA cells to amphetamine, the response of 16 cells to amphetamine
was first determined. A dose of 1 mg/kg was shown to reduce significantly
the firing rate of the DA cells (P <0.001, Student's paired t-test).
In a further 3 cells in which a higher dose was used (2 or 4 mg/kg)
inhibitions no greater than those observed above were seen. To test
whether this effect was reduced after picrotoxin, the drop in firing rate
resulting from a 1 mg/kg dose of amphetamine before and after a 1.5 mg/kg
dose of picrotoxin were compared using a paired t-test. In order to
FIGURE 52: PSTHs resulting from striatal stimulation taken initially
and then after picrotoxin followed by haloperidol (see
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FIGURE 53: PSTHs in response to striatal stimulation, taken initially
and after haloperidol followed by picrotoxin (see Figure













control for a reduced effect of a second injection of amphetamine, the
same was done on the drops caused by two consecutive injections of
amphetamine, 45-60 min apart, a time comparable to that between the
injections when picrotoxin was also used. There was a significant
reduction in the drop in firing rate caused by amphetamine after the
picrotoxin (P <0.001). Such a reduction in effect was not seen after
the second injection of amphetamine, when no picrotoxin was given in
between (P >0.1). The reduction of the amphetamine effect by picro¬
toxin is similar to that caused by haloperidol and confirms the observa¬
tions of Bunney and others (see Section 4.1) in support of the feedback
lopp hypothesis, that picrotoxin blocks the action of amphetamine on SN
DA cells.
It was decided that due to the variability in the control firing rates
of the cells used, the numbers in the different groups were too low to
attempt a quantitative analysis of the effect, but the traces shown in
Figure 54 are typical of all. Also included in this figure is an example
of the blocking action of haloperidol on the effect of amphetamine on the
DA cells.
- Picrotoxin and haloperidol:
In order to further investigate the interaction of DA and GABA, the
combined effects of picrotoxin and haloperidol were studied. Before
this was done, however, the effects of these drugs on their own were
investigated. Both picrotoxin and haloperidol were shown to significantly
increase the firing rate of the DA cells, again using a paired t-test
(P <0.001 in both cases).
It was decided not to attempt the quantitative analysis of the size
of the effects due to the high initial variability. Plots of the concentration
against firing rate, including the standard error, show how variable the
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FIGURE 54: Effects on the spontaneous firing of SNC DA cells of:
A. Amphetamine followed by picrotoxin and more amphetamine.
B. Amphetamine followed by a second dose of amphetamine.
C. Amphetamine followed by haloperidol and then more amphetamine.
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firing rates are and how difficult it would be to quantify the dose-
response effect realistically. These are shown in Figure 55, a and b.
It was decided to use 2 mg/kg of picrotoxin and 0.05 mg/kg of
haloperidol when used as the initial drug in the pair, and 2 mg/kg
picrotoxin and 0.1 mg/kg haloperidol when it was the second of the pair.
The initial doses were chosen as they seemed to be mostly submaximal,
although occasionally 0.05 mg/kg haloperidol did produce an effect, not
increased by the further addition of haloperidol. Also occasionally
0.05 mg/kg of haloperidol did not affect the firing rate and so another
0.05 mg/kg was added.
It can be seen from Table 18 that these two drugs, haloperidol and
picrotoxin, are additive, irrespective of the order they are applied in.
An attempt was made to compare quantitatively the effect of haloperidol
and picrotoxin on their own to the effect of each after the other. It was
shown that there was no significant difference between the control
effect of haloperidol and the effect after picrotoxin (P >0.1), nor between
the control effect of picrotoxin and the effect after haloperidol (P >0.05).
- Depolarisation block and the effects of apomorphine:
One of the biggest problems with the drugs increasing the firing
rate of the DA cells is that the cells do not appear to be able to fire
much faster than 10 Hz. A few may fire a little faster, and a few may not
reach this level, but it is an approximation of the level when firing
patterns change dramatically. This may mean that the sample of cells
used in the haloperidol and picrotoxin experiments above may not be
representative of the whole population, as in my experience the experiment
could not be done on a cell firing at 6 Hz or more to start with.
Examination of the interval histograms from these cells show that
the pattern of firing may have changed, while the mean firing rate has
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FIGURE 55: Dose response relation of haloperidol and picrotoxin,




0.89 0.54 0.80 0.97
0.95 0.04 1.42 1.05
0.62 1.63 0.45 2.09
-0.27 1.05 0.55 0.91
0.69 0.46
TABLE 18a: Changes in firing rate (Hz) caused by 2 mg/kg picro-
toxin, with and without 0.05 mg/kg haloperidol pre¬
treatment. There is no significant difference between
the two cases (Wilcoxon Rank Sum test).
After 2.0 mg/kg
No pretreatment picrotoxin
0.78 -0.08 1.16 -0.78
0.46 0.51 1.30 0.85
0.89 0.56 0.55 1.79
0.30 1.27 2.40
TABLE 18b: Changes in firing rate (Hz) caused by 0.1 mg/kg
haloperidol, with and without 2 mg/kg picrotoxin
pretreatment. There is no significant difference
between the two cases (Wilcoxon Rank Sum test).
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remained much the same, indicating that firing rate alone is not a good
indication of whether a cell has been affected or not. The usual pattern
is for the cell to start firing in short, fast bursts, leading to a biphasic
interval histogram, or even one with just a very early peak, depending
on the frequency of the bursts. Figures 56 and 57 show IHs from some
cells treated with haloperidol or picrotoxin. The main significance of
this for these experiments is that when the cells start bursting the size
of the action potential reduces towards the end of the burst, possibly
even below the level of the noise, meaning that not all the action
potentials will be counted, or that as the IS and SD components often
become more separated, each action potential is counted twice. Figure
58 shows an oscilloscope trace of a "bursting" cell. This bursting effect
was only seen extensively after picrotoxin, but a change in the IHs of
haloperidol treated cells did sometimes show similar changes.
An extension of this observation is that sometimes, after picrotoxin,
the cell will increase its firing rate greatly, increase the frequency of
overall firing of bursts and then reduce in size gradually or abruptly
until it cannot be detected over the background noise. It was supposed
that the cells were firing so fast that they had gone into depolarisation
block, and that a drug known to reduce the firing rate after a picrotoxin
induced increase (apomorphine) might restore the firing of the cell.
This effect of apomorphine in reducing the firing .rate of cells after
picrotoxin is marked and was observed in 3 cells one of which is illustrated
in Figure 59a. A complete cessation of firing was seen in 7 cells given
picrotoxin at 3 or 4 mg/kg. Apomorphine was tried on 6 of these and
some firing was restored. This was difficult to quantify and a description
of the behaviour of each cell is given in Table 19. Traces from two of
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FIGURE 56: IHs before and after haloperidol 0.05 mg/kg, showing a









FIGURE 57: IHs before and after 2 mg/kg picrotoxin, showing a
decreased mode and a shape change.
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FIGURE 58: Oscilloscope trace of a burst in cell firing after 2 mg/kg




FIGURE 59: Changes in the spontaneous activity of a cell caused by:
A. Administration of picrotoxin followed by apomorphine.
B. Administration of apomorphine after picrotoxin had caused the
cell to enter depolarisation block.
Initial firing- rate (Hz)
First dosef picrotoxin (mg/kg)
New firing rate (Hz)
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The fact that apomorphine can restore some form of firing would
support the concept that picrotoxin can cause a state of depolarisation
block in the DA cells.
As no haloperidol treated cells entered this apparent state of
depolarisation block, it was not possible to see if apomorphine would
do the same to them. However, it does seem that some effect of apo¬
morphine on the DA cells remains after 0.05 mg/kg haloperidol (see
Figure 60). As only 2 cells were tested with apomorphine itself it was
not possible to say quantitatively whether the reduction in firing rate
was reduced by haloperidol, as has been reported.
One cell appeared to be inhibited by amphetamine after a dose of
picrotoxin sufficient to cause bursting in the cell, although the total
rate was not very high (4 Hz). However, as the cell was bursting very
fast, with a mode in the IH of 10 ms, the amphetamine application could
have coincided with the onset of depolarisation block. If this was the
case, the amphetamine unlike apomorphine, did not restore firing. This
might have been expected from the results, mentioned earlier, that
picrotoxin blocks the effects of amphetamine.
In summary, therefore, it was seen in these experiments that
picrotoxin does block the effects of amphetamine, but not that of apo¬
morphine and that the latter may even restore firing after onset of a
depolarisation block caused by picrotoxin. It was also seen that the
effects of picrotoxin and haloperidol are additive, regardless of the order












FIGURE 60: Changes in spontaneous firing rate of SNC DA cells




All DA cells recorded from were characterised by antidromic
driving from the striatum. The threshold for antidromic driving was
correlated with that for any effect in both control and lesioned animals.
There was no difference in the antidromic thresholds, nor in the effect
thresholds nor in the extent of any of the effects measured, in any of
the groups of animals. The only effect of the lesions was to increase
the spontaneous firing rate slightly in the lesioned animals, and to
decrease the antidromic latency in partially lesioned animals.
The effects of picrotoxin and haloperidol in increasing the
spontaneous firing rate were additive, regardless of the order in which
they were administered. The effect of amphetamine was blocked by
picrotoxin, but that of apomorphine did not appear to be. Apomorphine
could even cause firing in cells that had entered depolarisation block
after picrotoxin. Haloperidol may have reduced the amount of inhibition
in PSTHs resulting from striatal stimulation. The effect of picrotoxin
was to increase excitations and to cause some excitations that were not
there before the administration of the drug.
Dopamine action potentials
Other workers have found that the APs from cells shown to be
DA ones are very homogeneous in nature (6,62,136,235,250). Cells
identified as DA ones by their position in the SNC, intense fluorescence
after iontophoresis of 1-DOPA (6,62) and/or by antidromic driving from
the striatum (136,235,250) all had similar characteristics. These
characteristics consist of a relatively slow firing rate with wide action
potentials. The APs have been described in some studies as typically
biphasic, ana greater than 2ms long in some studies (6,62), but in others
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they have been reported to be much longer, 4-6 ms, typically triphasic
with a late positive wave and a marked initial segment component (250).
The firing rate and pattern seems to depend on the anaesthetic used.
In animals that were anaesthetic free and gallamine paralysed, the firing
rate has been reported to be between 2 and 6 Hz and to be steady
(6,62). If chloral hydrate was used the rate seemed faster, 3-9 Hz
showing bursting patterns with a decrease in AP width and size during
the burst (6,62). However, a later study has shown that firing in
chloral hydrate anaesthetised animals was more variable between animals
and steady (0.5-8.0 Hz) (250). On the other hand, ketamine anaes¬
thetised animals have been reported to have DA cell firing rates of 3-6 Hz
(136).
Injection of 6-OHDA into the nigro-striatal path several days
before the experiments resulted in an almost complete loss of this type
of cell and this has been used as evidence that the type of AP described
above belongs to a DA cell (6,250). Experiments combining extracellular
recording with the intracellular injection of 1-DOPA show intense
fluorescence in this type of recorded neurone. This is not seen in non-
DA cells (235).
The APs described in the experiments in Section 4.3 all resemble
those mentioned above. In the halothane anaesthetised rat, there
appear to be a combination of the characteristics from the others. Cell
firing rate varies from 1-9 Hz, and shows bursting patterns in quite
a few cases. Many of the APs are wide, up to 6 ms, and have an initial
segment component. However, narrower ones are seen, although none
are less than 2 ms wide and not all have the initial segment component.
The shape and size of the cell often varied between the alternatives
during the course of an experiment and this has been attributed to the
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movement of the electrode towards or away from the cell, changing its
orientation to the soma.
From the above it was assumed that all the cells used in this study
are, in fact, all DA cells.
An increase in firing rate of SNC DA cells after striatal KA
lesions has been previously reported (531), although not all groups of
workers have seen this increase after the lesions (413).
In this study, although the range in firing rates was not different
in control and striato-nigral lesioned rats, the mean rate was more in
the lesioned group than the control group or the partially lesioned
group. The other characteristics were unaltered by the lesions. The
change in firing rate is probably due to the removal of a tonic inhibitory
input from the striato-nigral GABA projection (see Section 1.2).
Antidromic driving of substantia nigra dopamine cells
As has already been mentioned, all cells used in this study were
antidromically driven from the striatum. Guyenet and-Aghajanian (250)
have also identified SNC DA cells by means of antidromic driving from
the striatum. The DA cells, called by these authors Type I cells, were
only antidromically activated from the striatum and not from any of the
other areas tested and all fitted the description given above. Other
groups of workers have also antidromically activated DA cells from the
striatum (136,87,89,413). One of these groups of workers (136) also
found some SNR cells that were antidromically activated from the striatum
and some of these were also driven from the thalamus. The shape of the
APs of these cells was more like the non-DA, Type II cells of Guyenet
and Aghajanian, that is much narrower (less than 2 ms) and they always
responded with the full spike.
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From the antidromic latency the authors mentioned above calculate
conduction velocities of from 0.3-1.0 m/s, mostly averaging at about
0.5 m/s (87,189,136,413). This value corresponds well with the values
obtained in this study. Assuming a distance of approximately 4.5 mm,
the conduction velocities in this study ranged from 0.2-0.75 m/s. These
values are necessarily approximate as the exact distance and point of
activation cannot be ascertained. This value is consistant with that
expected from fine non-myelinated fibres that the nigro-striatal pathway
is reported to consist of (see Section 1.2).
The mean conduction velocity of the SNR fibres driven from the
striatum was 4.1 m/s, corresponding to a latency in the case of the
experiments described in Section 4.3 of just less than 1 ms. No antidromic
latencies this short were observed in this study. The shortest was 6 ms.
From this it was concluded that none of the cells used in this thesis were
of the fast conducting type.
The antidromic latency was shorter in the partially lesioned group
when compared with that of the controls. However, the lesioned group
showed no differences. The latency in the lesioned group, however,
was shorter than in the control cases, but the difference was not
significant. Intracellular studies have suggested that an inhibitory input
may lengthen the time between the stimulus and the IS component of the
antidromic spike (249), so the removal of a tonic inhibitory input to a
system may result in the shortening of the stimulus-IS interval. This
may be the reason for the shortening of the latency in this case. Removal
of a tonic inhibitory input would also be consistent with the increase
seen in the spontaneous firing rate in the lesioned group. The reason
that the lesioned group did not show a drop in latency and the partially
lesioned group did not show a drop in firing rate may have been because
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the operated groups are relatively small and the changes themselves
are small. Larger samples may have resulted in significant effects for
both measures in both operated groups.
Collision, the cancelling out of a spontaneous or orthodromically
driven spike by an antidromically driven one is thought to be the best
means of proving antidromicity. Other methods are a high frequency
response to repeated stimulation, a constant latency of response,
stability of the antidromic threshold and the shape of the driven AP
(367). AP shape is not a good indicator for antidromicity in SNC DA
cells. In many areas of brain, the antidromic spike will be split into
the IS and SD components, whereas the spontaneous or orthodromic
spikes are not. In the case of the SNC DA cells, the APs are split
under normal circumstances and so this test is not suitable. Stability
of threshold is also not very useful in this case. Normally in antidromic
driving, there is a stimulus strength that results in 100% invasion but
any lower strength will result in no invasion, i.e. it is all or none.
However, if the stimulating electrode is in a terminal area where one of
several points may be activated, not necessarily by the same stimulus
strength, this may result in not quite 1 : 1 responding at some stimulation
strengths. Also if the cells are spontaneously active, a stimulus arriving
during the relative refractory period needs to be higher to drive the cells
than otherwise. This will also lead to less than 100% response. Both
of these conditions apply to SNC DA cells. Variations in latency result
from several factors including the activation of different branches in
a terminal area (leading to distance latency jumps) and also it can take
a longer time for the AP to invade the cell in the relative refractory period
and so there are variations in the IS-SD time. Both these types of latency
variations have been reported for SNC cells driven from the striatum (89).
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These latency variations were also seen in the experiments described
in this Section 4.3, although only the stimulus-IS interval was measured.
The other two criteria, collision and following frequency, have both
been measured in these experiments, and collision is taken as the
definitive test, as various factors can affect following frequency, usually
in some way related to an increased membrane potential.
The principal of collision is that the cell can be antidromically
invaded after a minimal delay between a spontaneous or orthodromically
driven spike and the stimulus, the collision time. A delay any less than
this will cause the orthodromic and antidromic spikes to cancel out.
The minimum delay should be equal to the antidromic latency of the cell
plus the refractory period. In the experiment described in Section 4.3
the collision time was often equal to or less than the antidromic latency.
This would not be expected according to the above. Explanations for
this observation have been suggested (200). These reasons are based
on changes in the electrical properties of the axons but the reason in
this case is due to the method of triggering used - the stimulator was
triggered by the falling phase of the spontaneous spike, but the anti¬
dromic latency was measured to the first appearance of the IS spike
(see Figure 34).
Cells that did not collide were excluded from the results in this
Chapter. However, in some cases collision with a spontaneous spike
was difficult to demonstrate due to an early strong orthodromic excitation.
If any orthodromically driven spikes occurred after the stimulus, but
before the antidromic response, it collided with the antidromic pulse so
it was not observed. However, as the shape of the antidromic and
orthodromic spikes usually differed it was possible to estimate the collision
time if the test was repeated often enough.
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A very high stimulus strength has been reported to be necessary
for the antidromic activation of the SNC DA cells. Values of 100-250 |iA,
50-2000 |iA and 40-3000 |iA with pulse widths of 0.05-0.5 ms have been
quoted (87,89,136,250). These values compare well with those used in
the experiments described earlier (Section 4.3). These vary from 35-
3000 uA with pulse widths from 0.2-0.5 ms, with occasionally longer
pulses of 1 ms.
The antidromic thresholds were the same in all the groups of animals.
It might have been expected that the threshold would be lower in the
lesioned animals as an inhibitory input had been removed. That the
input had been removed was suggested by the increase in spontaneous
firing rate seen in the lesioned animals. This was not reflected in the
antidromic threshold. It is worth noting, however, that the thresholds
were of the same order in the NMA lesioned animals as in the control
animals. This implies that the lesion has not affected the axons in the
nucleus and supports the specific action of the neurotoxin on cell bodies
and not axons of passage.
Other studies have reported that the full SD spike is frequently
not generated by stimulation of the striatum and only the IS component
appears (87,89,250). Guyenet and Aghajanian (87) comment that the
few cells giving 100% SD responses also have thresholds for activation
lower than most. It is not clear why this should be so. It might be
thought that invasion of the soma leading to the full spike might be
easier if there was less inhibitory input, but the antidromic threshold
depends on the ease of activation of the terminal and not the cell body
so they would not be expected to be related. However, if there is a low
threshold for antidromic activation, less of the inhibitory striato-nigral
fibres will be activated and so the cell body will be less inhibited.
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The relation between the proportion of SD invasion and antidromic
threshold could be due to the coincidental existence of the reciprocal
pathways between the nuclei.
The relation between proportion of full SD spikes and low threshold
was not seen in the cells described here, however it was seen that few
cells exhibited the full SD spikes all the time. The usual response was
a combination of the two components.
In most studies, antidromic driving has been used primarily for
the purpose of identifying the cells as SNC cells, so the split into IS and
SD components is not important. In the experiments in this study, the
main purpose of antidromic driving, as well as for identification, was to
cause the release of dendritic DA in the SN. If only the IS of the cell
is driven, it is unlikely that much DA will be released from the dendrites.
However, as the desired effects are likely to be caused by a lateral
inhibition in the SN as well as, or instead of, auto-inhibition, it is likely
that sufficient DA cells will be induced to release DA on striatal stimula¬
tion . However, failure of the full SD spike could lead to a dilution of
any effect of antidromically released DA and may explain the lack of
effects described later in the discussion. Stimulation of the MFB does
result in the release of DA in the SN, therefore it is possible to get the
dendrites to release DA by this method (350,351). Problems and
variation arise when the effect on specific areas are studied. In this
case no relation was seen between the proportion of full SD spikes and
the pattern in the longer PSTHs (Table 17) so it is possibly not
important in view of the possible complications in the PSTHs from other
sources (see later).
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Later effects of striatal stimulation
The effects of striatal stimulation on SN cell firing have been
widely reported, but fewer studies have been done on identified DA
cells.
Complicated response patterns to striatal stimulation have been
reported in SNC DA cells (87,153,250,413). The effects can be seen
in PSTHs constructed during the 1 s period after striatal stimulation.
Series of excitations and inhibitions can be seen lasting as long as 1 s.
The most common response is an inhibition lasting several hundred ms,
but facilitations of firing do occur as the first effect of stimulation.
What appear to be rebound excitations also occur as well as distinct
late excitations and inhibitions. Occasionally, oscillatory sequences of
responses occur, returning to normal anything up to 1 s after the
stimulus. All these responses to striatal stimulation are also seen in
this study.
In two of the studies mentioned above, not all the cells are driven
antidromically from the striatum: in one, 68 out of 116 are (87) and
in the other, 14 out of 65 are (413). In the third, all are antidromically
activated, but only 12 cells are used to constructed PSTHs 1 s long
(250) and in the fourth no cells are antidromically activated (153).
Collingridge and Davies (87) explain the complex sequences as being
caused by inhibitory GABA and excitatory SP inputs from the striatum.
Even very late effects could be explained by the striato-nigral fibres
they suggested that
terminating on very distal dendrites, and^several hundred ms might be
needed for the effects of activation of these synapses to be seen in the
soma. Dray et al (153) suggest that the inhibition could be caused by
the GABA component of the striato-nigral pathway, but do not suggest
what the excitatory transmitter might be.
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Guyenet and Aghajanian (250) describe a long lasting suppression
of firing after the appearance of an antidromic spike, and use this as
further support in differentiating SNC and SNR cells. The SNR cells
show a much shorter inhibition after antidromic driving. Guyenet and
Aghajanian do not attempt to explain this observation.
Nakamura et al (413) observe excitations and inhibitions in non-
antidromically driven cells but do not try to explain these. The assumption
is that the inhibition is due to the GABA-ergic input from the striatum
as the inhibition in non-antidromically driven cells is reduced after KA
lesions of the striatum. They explain the inhibition seen in the anti-
dromically driven cells as being due to dendritically released DA. The
evidence in support of this is that this inhibition is not shortened by
striatal lesions (16 out of 97 cells from lesioned animals were antidromically
driven) but that it is shortened by intravenous haloperidol and ionto-
phoretic trifluoperazine. Nakamura et al (413) use the suppression of
firing after the antidromic spike reported by Guyenet and Aghajanian
(250) to support their observations on this "antidromic inhibition",
although Guyenet and Aghajanian themselves do not suggest this as an
explanation.
The results presented in this study do not agree with the existence
of a prolonged inhibition after every antidromic invasion. Antidromic
activation is followed by a number of types of response: inhibition
(short and long); facilitation (generally short) or a delayed effect,
either facilitatory or inhibitory. The numbers in this study are much
higher than those in these two studies (180 antidromically activated
control cells as opposed to 12 (250) or 14 (413). As a large number of
antidromic spikes were followed by the type of inhibition described by these
two groups it may only have been because of low numbers that this was
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the only effect seen. Also, in these two studies, a range of stimulation
intensities was not tried, so the variety of responses might be expected
to be less.
The lack of change in the "antidromic inhibition" seen by Nakamura
et al (413) after KA lesions of the striatum is interesting. However, in
this study, no change was seen in any of the effects on lesioning the
striatum (see Section 4.3). Complicated excitations and inhibitions still
appear after the lesion at the same stimulus strengths as without a
lesion. That these other effects still exist after the lesion does agree
with Nakamura et al (413) who report that all effects seen without a
lesion are seen with one, except that the initial inhibition is shorter.
These authors chose not to discuss the origin of these effects, and
concentrated only on the effect seen after antidromic activation (16 out
of 97 lesioned cells and 14 out of 65 control cells).
There are several explanations of why the complex response
patterns are still there after striato-nigral lesions. Firstly, there
exists the possibility that the lesion is not large enough and some
striato-nigral fibres escape damage and the effects are caused by
substance P and GABA as suggested by Collingridge and Davies (87).
Secondly, the current spread might be sufficient to spread to other
areas, espcially if the electrode is near the edge of the striatum. It
could also activate other SN afferents as they pass through the striatum.
Thirdly, it is possible that the effects are indeed all mediated by anti-
dromically released DA from the SNC dendrites.
The possibility that the lesion is not large enough is not likely to
be the whole explanation. Both the results presented here and those of
Nakamura et al (413) come from animals with extensive lesions as shown
by histology. Also in the NMA and KA lesioned animals used in this study
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extensive damage is suggested by biochemistry. All animals also have
marked asymmetry in the response to apomorphine indicating a significant
loss of the striato-nigral pathway. In the NMA lesioned animals, the
stimulating electrode was placed in the centre of the lesion and the
complicated patterns were seen even when the lowest currents were used.
In these cases it is unlikely that the effects seen in the PSTHs are due
to spread beyond the lesion.
If the stimulating electrode was near the edge of the striatum,
current spread could activate other areas projecting to the SN. The
most likely areas for current to spread to are the globus pallidus and
the nucleus accumbens. Both of these areas are known to project to
the SN (see Section 1.2). The input from the accumbens is thought to be
GABA-ergic and inhibitory on the SN cells. It is not clear which portion
of the SN it goes to, but as the SNC dendrites course through the SNR,
this does not matter. SNC cells could be affected by an input to either
part of the SN. The globus pallidus also has an inhibitory GABA-ergic
input to the SN and it has been suggested that there is an excitatory
component as well (see Section 1.2). Excitations could also result from
antidromic activation from the globus pallidus of subthalamic cells. The
subthalamic nucleus sends collaterals to both the globus pallidus and
the SN, and the projection is supposed to be excitatory (137), and to go
to the SNR. Again the input could affect the dendrites of the SNC cells
in this area. An action on the distal dendrites has already been used to
explain long latency effects in the SNC cells.
Stimuls spread to other brain areas was a problem in these experi¬
ments as the currents necessary for antidromic activation were so high.
From the control experiment on stimulus spread, it was seen that current
spread at the highest strengths used may have been as much as 6 mm,
242.
although it was considerably less at the lower, more usual currents.
This experiment can, at best, only give a very rough estimate of the
stimulus spread, as it is impossible to tell at which point in the striatum
the fibre is being activated. It could be at the terminal or further back
along the axon. As the fibres pass through a large part of the striatum
before synapsing with their target cells a large proportion of the axon
is available for activation. This means that the values obtained for
the current spread may, in fact, be misleading.
The more posterior the stimulating electrode was, the greater the
problem of the current spread. The crus cerebri lesioned animals had
more posterior placements of the stimulating electrode, and so stimulus
spread may have accounted for some effects in these cases. In these
animals the position of the stimulating electrode is not necessarily
related to the lesion position, whereas in the NMA lesioned animals, the
electrode was in the centre of the lesion and current would therefore be
less likely to spread beyond the area of the lesion. As complex effects
were still seen in cells from these animals, it seems that the effects are
less likely to be caused by stimulus spread than would appear from the
crus lesioned animals.
Activation of fibres passing through the striatum in the internal
capsule might possibly lead to excitation in the SNC cells. The pathway
for the proposed cortico-nigral pathway is not clear, but it is likely to
pass through the striatum with other corticofugal fibres. If this is
the case, stimulation of the striatum could lead to effects in the DA cells.
These effects are likely to be excitatory since the proposed transmitter
for the cortico-nigral pathway is glutamate (see Section 1.3). Excitation
could also result from activation of the cortico-substhalamic pathway, by
a polysynaptic mechanism. The subthalamic nucleus has been reported
to be excitatory in the SN (137).
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The final possibility is that the effects are indeed caused by
antidromic release of DA from the dendrites. That none of the effects
of striatal stimulation is altered by a striato-nigral lesion would suggest
that this could be the case. It has been reported that the initial
inhibition after an antidromic spike was not reduced by a striato-nigral
lesion, however when the initial inhibition did not follow an antidromic
spike, it was reduced (413). This supports the suggestion that the
inhibition after the antidromic spike is mediated by dendritically released
DA. The lesion studies described in Section 4.3 did not show this effect.
However, the fact that antidromic and effect thresholds are equally
correlated in lesioned and control animals does support the suggestion
of an inhibition by dendritically released DA. If the two thresholds
were not correlated in control animals but were in lesioned ones, it would
be a clear indication that the effect seen after that lesion was due to
antidromically released DA. Rather than explaining the fact that the
two thresholds are correlated in both lesioned and control animals by
saying that all the effects are mediated by dendritic DA, it seems more
likely that the high degree of reciprocal topography in the two systems
linking the SN and the striatum is reflected in the correlation in the
control animals. In the lesioned group it may be because the effects
are partly mediated by dendritic DA release.
The fact that there is no difference in the effect thresholds in
the lesioned and control animals would also point to effects being
mediated by the dendritic release of DA. However, it seems extremely
unlikely that the early, large, initial excitations are due to the dendritic
release of DA. These are more likely to be caused by the mechanisms
described above. However, later excitatory effects might be a rebound
excitation after the inhibitory effect of dendritically released DA.
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It seems most likely that the effects of striatal stimulation observed
after lesions of the striato-nigral pathway are due to the effects of
dendritically released DA and to the activation of cortico-fugal fibres
in the internal capsule as they pass through the striatum, either by a
mono- or polysynaptic pathway.
Drugs on the effect of striatal stimulation
Very few studies have looked at the effects of drugs on PSTHs of
SNC cell activity after striatal stimulation. Most have studied the effects
on spontaneous activity. Dray et al (153) and Collingridge and Davies
(87) have looked at the effects of bicuculline and strychnine on PSTHs
similar to those used in this study. Drayef al (153) do not make it
clear whether they are looking at SNC or SNR cells, although they do
separate the cells and say there is less inhibition in the SNC ones than
the SNR ones. Division into cell type is only done on position in the SN.
Nakamura et al (413) look at the effect of intravenous haloperidol and
iontophoretic trifluoperazine on the inhibition seen immediately after an
antidromic spike.
Collingridge and Davies (87) and Dray et al (153) show that the
amount of initial inhibition is reduced by bicuculline. Collingridge and
Davies also report that the amount of excitation in the PSTHs is increased
and some excitations appear that were not there before the drug.
The increase in excitation reported by these workers on the application
of iontophoretic bicuculline is also seen in this study on the administration
of intravenous picrotoxin. In the results described in Section 4.3 the
effect of picrotoxin in causing an increase in excitations was so great
that any effect on the inhibitions was masked and, if anything, the
inhibitions were increased. The cells seemed to fire so fast when
stimulated from the striatum after the drug that they briefly enter a
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state of depolarisation block (see later in Discussion) apparently-
leading to a paradoxical enhancement of the inhibition. The greater
effect seen in this study as compared to these other workers is possibly
due to the fact that the picrotoxin is administered intravenously in this
case. This means that the drug will get to more of the SN than if it
were applied iontophoretically and so will lead to a greater reduction of
inhibitory GAB A input.
Nakamura et al (413) have shown that intravenous haloperidol and
iontophoretic trifluoperazine reduce an inhibition seen after the anti¬
dromic invasion of the cell. This effect is also seen in these experiments
using intravenous haloperidol. The effect is small and not very con-
sistant. The haloperidol is most likely to be causing this effect by
acting in SN as the cells are being stimulated after the point at which
haloperidol could act in the striatum. This is evidence that the effects
that are reduced by haloperidol, are mediated by dendritically released
DA. The fact that the effect of haloperidol is small may be because of
the fact that the full SD spike is not always generated and that only
part of the observed inhibition is due to dendritic DA. A much greater
effect of haloperidol may be seen if enough information could be gathered
from cells responding with 100% full spikes. However, as the effect is
liable to be the result from lateral as well as auto-inhibition this may not,
in fact, help as it is impossible to tell whether or not neighbouring cells
are responding with a full spike or not. Haloperidol given after picro¬
toxin might help as the picrotoxin would remove any inhibitory input to
the cells and so a greater degree of SD invasion would occur. However,
it seems that systemic picrotoxin caused such a degree of early excitation
that spontaneous collision with the orthodromic excitation generally
prevents antidromic invasion of the cell body after the drug. A reduced
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effect of haloperidol after picrotoxin could be explained by the fact
that no DA is being released dendritically due to spontaneous collision
from the early excitation resulting from striatal stimulation after picro¬
toxin. As no DA is released, haloperidol will not be able to block its
effects.
Analysis of the post stimulus histograms
Other studies using PSTHs very rarely attempt to analyse them,
and the extent of effects are generally estimated by eye. On this
basis it is difficult to be consistent in deciding what is and is not an
excitation or an inhibition. A recent paper by Dorrscheidt (149)
discusses this problem and describes several models that could be used
for the statistical analysis of this type of PSTH. He shows that the
assumption that the data are Poissonian results in the widest confidence
limits for a statistical test. This means that statistical tests based on
this distribution will give fewest false positive results. In Section 4.3
"control" PSTHs were taken and used to generate a mean and calculate
limits above and below which a test bin would be considered to be
significantly different from control. These control PSTHs were con¬
structed as the others, but with the stimulation unit switched off.
A Poisson process is one in which the occurrence of one event does
not affect the time of occurrence of the next. If the distribution is
Poissonian a histogram built up by triggering the stimulator off a
spontaneous AP (a post-pulse histogram, PPH) should be completely
flat. This is not in fact the case and a slight "trough" is seen immediately
after the triggering spike. This effect is seen in the autocorrelation
histograms (ACHs) described by Wilson et al (628,629). In fact the
trough seen in these is longer than the one seen in this study, but
numbers here are not high. Also the ACH is constructed by superimposing
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the time period after each spike on top of that of the previous one.
In this study the time after each spike is superimposed on that of the
first spike after the previous time interval is over. This might lead to
a difference in the resulting histogram. In the results described in
Section 4.3, after the initial short trough, the PPHs are flat implying
a random firing pattern. Wilson ef al (628) only see this in slower
firing cells and in faster firing cells oscillatory patterns are seen.
Again this may be due to the difference in construction of the histograms.
However, the PPHs resemble the PSTHs in their construction and so
provide a better control than ACHs. That the PPH is flat even in
relatively "bursty" cells means that the effects seen in the PSTHs are
not merely linked to the time locked firing of the DA cells. This in
itself does not argue against the possibility of the effects of striatal
stimulation being caused by dendritically released DA as the firing is
random when no stimulus is applied, but large areas of the SN will be
induced to fire synchronously on the striatal stimulation. This will also
synchronise the effects of the released DA.
Wilson ef al (628) showed that the initial trough in the ACh was
reduced by haloperidol. They suggest that this could be simply due to
the increase in firing rate. If the cell rate increases, the interval
between spikes obviously decreases and so will the initial trough of an
ACH. However, as the trough sometimes reduced in length even when
the cell did not actually increase its firing rate was taken to show that
the haloperidol was blocking the effect of dendritically released DA.
Haloperidol was added to too few cells in which PPHs were obtained to
say whether this study supports this view or not. However, the results
from interval histograms would suggest that the pattern of firing can be
changed while leaving the overall rate very much the same. This may be
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related to the phenomenon of depolarisation block discussed later in
this Section.
Effect of drugs on the spontaneous activity of DA cells
In view of the accumulating evidence against the FLH (see
Section 4.1), it was surprising that GAB A antagonists blocked the
effects of amphetamine on the spontaneous firing of these cells (57,58),
and speeded the DA cells up on their own (87,619). What was even
more confusing was that GABA agonists had been reported to cause
excitations of DA cells as well as inhibitions (374,616,619). That
picrotoxin increases the firing rate of DA cells and blocks the inhibitory
action of amphetamine has been taken as evidence for the FLH (57) and
attempts have been made to explain the paradoxical effects of GABA
agonists by proposing a GABA interneurone in the striatum (234 and
Section 4.1).
The experimental results described in Section 4.3 confirm the
finding that picrotoxin does speed up the DA cells and that it does
block the effects of amphetamine and so would support a role for the
GABA-ergic striato-nigral pathway in the feedback control of the
activity of SNC DA cells.
Studies of the effects of drugs on the spontaneous activity of DA
cells after lesions of the striato-nigral pathway are to some extent
conflicting. Striatal KA lesions have been reported to reduce the effect
of haloperidol on DA cell turnover (347) whereas apomorphine has been
reported still to be effective after the lesion (24). Electrolytic lesions
in the striato-nigral pathway have also been reported not to affect
the effect of amphetamine on cell firing rate (206). On the other hand,
Bunney and Aghajanian (58) have reported that it needs five times the
dose of amphetamine to produce inhibition of cell firing after a KA lesion
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of the striatum and that it is not possible to produce complete inhibition
of firing in the DA cells with non-fatal doses of amphetamine after the
lesion. In the same paper (58) the authors also report that picrotoxin
reversed the inhibition of firing caused by amphetamine in control
animals but had no effect in the lesioned animals. The reason given by
these authors for this effect was that the feedback control of the DA
cells is mediated partly by the striato-nigral pathway and partly by DA
released from the dendrites in the SN. The experiments described in
this thesis do in principal agree with this conclusion.
First of all there is the observation, already mentioned that
picrotoxin speeds up the DA cells and blocks the action of amphetamine.
This suggests that GABA-ergic processes do have a role in controlling
the rate of the DA cells. However, this could be an intra-nigral process
rather than a striato-nigral one. That haloperidol and picrotoxin are
additive, on the firing rate of the DA cells regardless of which one is
administered first suggests that there is both a DA-dependent mechanism
and a GAB A-dependent mechanism for controlling DA cell firing rate,
and that the two are independent. This is supported by the fact that
apomorphine is still effective in reducing the cell firing rate after a dose
of picrotoxin large enough to increase the firing rate maximally. The
large increase in rate suggests that the GABA input is effectively
blocked and so apomorphine must be acting on DA receptors that do not
exert their effect via GABA cells, most probably in the SN. This is
also supported by the fact that haloperidol can still affect the firing rate
after picrotoxin by as big an amount as it did without it. Haloperidol
need not act via GABA receptors.
There appears to be a difference in the actions of apomorphine
and amphetamine. As amphetamine releases DA from terminals and
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dendrites and apomorphine acts on DA receptors, it might be expected
that the two drugs would have the same effect on cell firing. However,
the effect of amphetamine is blocked by picrotoxin, and the effect of
apomorphine is not, or at least not to such an extent (Section 4.3).
There are reports that suggest that the release process is different
in terminals and dendrites, but as amphetamine does release DA from
nerve ending particles prepared from the SN, and K+ will not (269),
it does not explain the difference observed. It may be that DA agonists
have a different affinity for the different types of receptor: post
synaptic cells in the striatum are less sensitive to iontophoretic DA and
intravenous apomorphine than the DA cells in the SN are (553). However,
as amphetamine releases DA this would still not explain a difference in
the action of DA and apomorphine. It may be that DA and apomorphine
do not have the same affinities, for the different DA receptor types and
that the distribution of the two types is sufficiently different in the two
areas to result in a difference in action: apomorphine acting in the SN
and/or striatum and the DA released by the amphetamine acting primarily
in the striatum. Alternately, it may be a matter of the amount and
location of DA released by the amphetamine. It is difficult to decide
on a dose of apomorphine that is equivalent to the amount of DA released
by the amphetamine. Also, release of DA will occur only at release sites,
possible
whereas the apomorphine may be able to act at^extrasynaptic sites as
well. The experiments comparing the effect of apomorphine before and
after picrotoxin need to be done as has been for amphetamine.
Depolarisation block
The possibility that DA cells are capable of entering a state of
"depolarisation block" has been discussed by Bunney and Grace (60,61).
These experiments investigate the difference between the effect of acute
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and chronic haloperidol on the firing of DA cells. Acute administration
leads to an increase in firing rate, but in chronically treated animals
there is a lack of spontaneous activity in the DA cells. Firing could be
induced in these cells by the application of the normally inhibitory
agents DA and GABA. The silent cells were also unresponsive to
glutamate applied iontophoretically, a procedure normally causing
excitation. Picrotoxin also had no effect in the cells from chronically
treated animals. KA lesions of the caudate nucleus before the chronic
administration of the haloperidol prevented the loss of spontaneous
firing in these cells. The effect was explained by the overactivation of
excitatory striato-nigral input to the cells caused by DA blockade in the
striatum and leading to state of tonic depolarisation block in the SNC DA
cells. Any inhibitory input to these cells will reduce the depolarisation
and so allow the cells to resume firing. Picrotoxin and glutamate will
have no effect as they tend to increase the depolarisation.
The experiments described in Section 4.3 also suggest that
picrotoxin itself can cause the cells to enter depolarisation block as it
can speed the cells up to the point where continuous depolarisation
occurs. As the rate increases the cells begin bursting, and decrease
in size with the cell disappearing into the noise at the end of the bursts.
The firing can to some extent be restored by the application of apo-
morphine, an inhibitory agent.
The picrotoxin experiments do not help clarify whether chronic
haloperidol acts in the striatum, as Bunney and Grace's results with
KA lesions would suggest, or in the SN via autoreceptors.
The shape changes in the IHs and the reduction of the initial
trough in the ACHs of Wilson et al (628) with no increase in firing rate,
could be due to some extent of depolarisation block occurring, the
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reduction in rate by the depolarisation offsetting the increase due to
the blockade of inhibitory receptors. The problem of depolarisation
block should always be considered in studying the effects of drugs on
the firing rate of SNC DA cells as it is possible to change the pattern
of firing without altering the rate. IHs or ACHs should always be
constructed as well as noting the firing rate. An apparent decrease
in rate might well be due to increased depolarisation. The conclusion
by Wilson et al (628) that the reduction in initial inhibition after firing
of DA cells by haloperidol, even when rate is unaffected, is evidence
for dendritic DA release may not be valid, although it is the most likely
explanation. The possible involvement of depolarisation block ought to
be considered and excluded, possibly by observing action potential
shape.
Conclusions and relation to the mechanism of control of
dopamine cell activity
Lesions of the striato-nigral pathway cause very few changes to
the effects of striatal stimulation on DA cell firing. There does, however,
appear to be an increase in the firing rate of DA cells in the lesioned
animals and possibly a reduction in the antidromic latency when the
cells are driven from the striatum. These effects may be due to the
decreased inhibitory input to the striatum after the striato-nigral lesion.
The lack of effect of the lesions on PSTHs taken over the 1 s
period after the stimulus, was taken to mean that a significant proportion
of the effects seen in normal animals is not due to activation of the
striato-nigral pathway, but to other causes. The other possible causes
include stimulus spread to other areas (minor except at the highest
stimulation strengths), activation of other afferent fibres, mono- or
polysynaptically, in the internal capsule as it passes through the striatum
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and finally to the effects of antidromically released DA from the dendrites
in the SN. The final possibility is supported by the effects of haloperidol
on the PSTHs.
Because of the lack of a clear effect of antidromic driving on the
DA cells it was not possible to say much about an intra-nigral mechanism
of feedback control of DA cell activity from the stimulation studies.
All that can be said is that because haloperidol causes a slight decrease
in the inhibition, the inhibition is possibly mediated to some extent by
dendritically released DA.
The action of drugs on spontaneous activity was more helpful in
further elucidating the mechanism of the control of the DA cell firing
rate. As picrotoxin blocked the effects of amphetamine on the cell
firing rate, it is evident that GABA-ergic mechanisms are involved in
controlling the firing rate of these cells to some extent. The fact that
the action of apomorphine is not blocked by picrotoxin implies that there
could also be an independent DA mechanism. This is further supported
by the fact that haloperidol and picrotoxin cause additive effects regard¬
less of which one is added first. This suggests that the action of DA
agents on DA cell firing need not be mediated by GABA-ergic processes,
but that GABA-ergic processes can affect the DA system in their own
right.
The GABA-ergic mechanism is likely to involve a GABA-ergic
interneurone in order to explain the paradoxical effects of GABA
agonists on the DA cell firing and as such it is not possible to say
whether the picrotoxin sensitive component of the action of DA takes
place in the striatum or in the SN. From lesion work it seems likely that
it could be in the striatum. The crucial experiment would be to repeat
the combined haloperidol and picrotoxin experiment in striato-nigral
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lesioned animals. If the two drugs were still additive, it would then
strongly suggest that the DA-GABA interaction took place in the SN.
However, if they were not, it would imply the striatum was involved.
The GABA independent mechanism of control of DA cells activity
may be the result of a direct lateral or auto-inhibition in the SN with
released DA acting directly to inhibit the DA cells. Alternately,
inhibitory nigral interneurones or afferent terminals other than the
striato-nigral ones could be involved.
There is evidence for a role of glycine in controlling the activity
of the DA cells. Glycine has been shown to reduce the firing rate of
DA cells (188), and it can be released from SN slices by K+ and this is
a Ca++ dependent process (329,330,331). However, it seems that this
process is affected by GABA rather than by DA (330,331) and so this
may not be involved in a DA inhibition of the DA cells in the SN. The
glycine interneurones may be involved in the GABA-dependent mechanism.
It has also been shown that dendritically released DA can release 5-HT
from afferent terminals in the SN (273). Also 5-HT is known to inhibit
the firing of DA cells when activated by glutamate (7) so this mechanism




In this thesis the functioning of the nigro-striatal pathway has
been investigated from two points of view. Firstly, an attempt was
made to further elucidate the role of DA in the nigro-striatal pathway.
The results presented suggest that DA in the nigro-striatal pathway
is involved in the expression of motor behaviour. There may also be
another component to the role of DA here. This may be involved with
the ability to generalise knowledge already acquired and to apply it in
new situations, or it may be an involvement with learning. There also
appears to be a role for DA in motivational behaviour, possibly in the
initiation of movement. Although this may be striatal in origin, it is
more likely to result from mesolimbic DA. The interaction of the meso-
limbic DA system and the extrapyramidal system is discussed by
Mogenson et al (403). Here the relations between the VTA and its
projection to the nucleus accumbens is discussed in light view of its
projection to the globus pallidus. It is suggested in this review that
the drives that result in the initiation of movement originate in the limbic
or cortical areas and the information is passed via the nucleus accumbens
to the globus pallidus. From there the behaviour of the animals can be
affected, the nature of the response being determined by the striatum.
The second approach for studying the functioning of the nigro-
striatal system was to study the firing of the individual DA cells and to
look at how this is controlled. It appears that the DA cells are under
the control of a local intranigral feedback mechanism, as well as a
striato-nigral feedback loop. From the introduction there would also
appear to be an intra-striatal mechanism affecting DA release in the
striatum.
The reasons for the existence of two mechanisms controlling DA
cell firing rate is unclear. It is possible that the striato-nigral pathway,
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which also mediates the output of the striatum to the executing systems
of the animal feeds back onto the DA cells as a means of monitoring
whether the signal that had been processed in the striatum had been
passed or not. If the striato-nigral input to the SNC was a monitoring
system it would be a means of ensuring that the action was terminated
once the need for it was over. An intra-nigral mechanism might be a
feedback mechanism in the more literal sense, that is it tries to offset
any change to the system, however caused. It might also be a means of
lateral inhibition, sharpening the signal to aid the integration in the
striatum. The intra-striatal mechanism for the feedback may also be
involved in lateral inhibition for this purpose. It may simply be a means
of preventing an excess of DA occurring in the striatum.
Insight into both aspects of the functioning of the nigro-striatal
DA system will be of help in understanding the various diseases related
to this pathway (150,151). The most studied of these is Parkinson's
Disease. If the mechanisms controlling the turnover of DA were under¬
stood better, it might be possible to treat the disease more effectively.
DA has also been implicated in aetiology of schizophrenia (571) as DA
antagonists greatly improve the symptoms of this disorder. However,
patients treated with DA antagonists frequently develop side effects,
that resemble the symptoms of Parkinson's Disease. A better under¬
standing of the control mechanisms might lead to a better treatment for
the disease. Also an understanding of the function of DA in the
behaviour of an animal is important in deciding how to treat these
diseases. One worrying experiment shows that in a passive avoidance
test, rats will learn the task under the influence of a neuroleptic, but
do not show that they have learned until the effect of the drug has worn
off (185). This means that the aversive stimuli must have been felt by
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the animals and must have had enough effect on them for the animals
learn to escape. However, the learned response could not be shown
while the animals were under the influence of the drug. This may mean
that psychotic patients treated with these drugs are still feeling the
effects of their abnormality, but cannot express their reaction to it.
If the role of DA were better understood, the effect that neuroleptics
have on these patients might also be better understood, and the cause
of the disease rather than the symptoms could be treated.
Conclusions
Evidence has been presented in this thesis to support both a motor
effect and another effect of DA in the nigro-striatal pathway. It is
possible, however, that the other effect is mediated by the mesolimbic
DA system as the 6-OHDA lesions used in the experiments also affect
this. The second component could be involved in learning or in the
generalisation of behaviour. More likely it is involved with the motiva¬
tion for or initiation of movements. Evidence is also presented to
support the existence of two mechanisms of control for the DA cells in
the SN. One of these involves the striato-nigral pathway and the other
involves the local release of DA in the SN. The effects of striatal
stimulation on the SNC DA cells has also been investigated and it seems
that all the effects that have been attributed to this pathway may not
necessarily be mediated by this pathway, but by other means. The
evidence for this comes from the fact that lesions of the pathway do not
change the pattern of response to .striatal stimulation.
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APPENDIX A: Raw Data from Paw Pressing Experiments
In this Appendix, all the raw data is given for the results
presented in Chapter III. The mean and standard errors (s.e.)
given in Tables B to J are those used to plot the graphs in Figures
15 to 23. Table A gives the information used to calculate the correla¬
tions between lever and paw preference.
The following tables show the total combined number of presses in four sessions except where the number is
specifically stated. The relevance of the data is discussed in Section 3.3 in relation to the correlation between
lever and paw preference.
TABLE A(i): Control animals.
Left lever: Right lever: Left lever: Right lever:
left right other left right other left right other left right other
paw paw presses paw paw presses paw paw presses paw paw presses
163 6 19 363 45 260 2 235 3 5 347 8
4 2 2 729 5 96 19 13 9 40 540 34
154 404 277 38 5 14 643 63 7 1 0 0
826 61 56 5 1 1 1 653 11 6 18 0
699 7 13 5 2 1 379 163 32 20 4 6
1 789 21 1 7 5 3 6 0 0 622 0
12 186 13 5 547 3 677 0 0 7 0 0
332 363 182 97 7 7 37 10 3 521 3 12
49 505 35 73 15 36 430 1 0 327 0 1
48 677 20 193 36 100 0 0 0 0 604 0
13 2 2 277 409 155 3 46 3 3 515 4
0 31 0 0 611 0 0 67 0 5 632 3
373 170 88 31 5 5 6 1 4 377 0 2
27 405 8 6 33 42 370 4 10 299 0 2
16 301 21 27 98 2 409 2 2 102 3 3
1 402 7 2 112 1 53 21 11 453 23 16
10 405 14 17 99 17 49 95 12 27 437 12
570 n 32 117 5 54 50 27 7 486 5 6
33 594 31 7 24 9 21 42 14 421 92 123
606 0 5 11 0 6 4 542 4 29 11 6
500 0 4 21 0 4 0 481 1 3 246 1
3 462 4 4 2 1 352 0 0 217 2 4
349 2 6 160 2 12 160 579 77 28 14 4
642 1 3 17 1 2 3 1 0 647 2 0
209 257 62 7 6 23 10 5 6 730 15 33
20 84 12 159 372 47 1 7 0 556 56 232
546 87 24 27 16 7 1 5 6 4 685 7
8 57 26 469 261 52 4 3 0 582 18 164
677 7 15 5 1 4 11 15 1 660 12 22
6 3 1 650 3 11 394 34 33 240 6 17
719 40 60 13 8 6 0 7 1 624 0 2
663 3 4 29 1 2 1 1 0 479 143 129
2 4 0 13 568 4 0 2 0 17 525 64
17 9 8 551 61 35 13 40 163 624 5 9
371 124 41 43 9 14 540 0 3 11 2 2
4 23 2 55 623 8 2 184 1 0 28 1
148 424 49 9 343 20 2 184 3 19 294 15
66 777 12 0 2 0 6 48 3 19 294 15
901 0 0 4 0 1 10 0 1 546 0 1
213 325 43 63 8 15 0 0 0 113 695 46
760 14 20 111 1 2 26 647 2 7 2 3
33 0 2 686 0 2 240 0 5 271 0 1
348 31 26 104 69 72 8 29 5 11 565 26
859 10 5 67 0 0 1 105 1 16 502 114
28 523 64 3 56 4 729 2 2 2 0 2
32 4 1 580 4 74 420 34 8 25 35 26
627 86 44 14 9 4 5 220 10 3 15 3
386 243 25 255 10 2 115 94 81 67 14 17
15 625 242 9 10 9 413 68 22 21 29 8
730 15 36 127 8 18 172 386 83 9 7 5
35 0 3 768 4 65 315 4 22 272 5 3
825 1 12 120 1 3 21 672 6 16 41 2
841 5 5 121 5 3 4 732 1 3 25 1
795 9 1 14 0 4 63 605 30 4 8 1
595 198 33 21 31 9 490 80 72 21 0 0
603 10 26 54 15 17 46 97 21 69 472 19
590 1 16 39 8 8 14 34 6 547 3 52
18 344 9 10 458 13 30 19 15 788 6 4
327 20 6 536 20 7 602 2 2 136 3 8
0 38 0 1 727 3 1 39 0 16 559 10
118 15 37 4 476 2 0 386 1 7 449 11
72 612 59 7 19 3 431 20 15 3 10 2
2 13 0 0 734 4 64 8 9 105 7 18
4 3 0 110 245 34 3 2 5 740 1 7
31 6 1 63 321 138 806 0 3 20 1 5
707 0 2 3 1 1
3/c?
TABLE A(ii): a) 6-0HDA lesioned animals
Left lever: Right lever:
left right other left right other
paw paw presses paw paw presses
Control 603 10 26 44 16 17
490 1 16 39 8 8
18 344 9 9 458 13
0 38 0 1 727 3
48 7 23 0 625 2
72 612 59 7 19 3
4 weeks after 3 510 1 3 103 4
6-OHDA injected 0 556 1 0 24 0
contralateral^ to 115 15 23 378 17 17
the initially 12 0 2 544 23 17
preferred paw 50 0 2 450 6 1
183 2 7 335 3 6
8 weeks after 0 1142 3 6 50 9
6-OHDA injected 0 1115 2 0 21 0
contralaterally to 62 0 16 1023 12 26
the initially 5 0 0 1074 0 5
preferred paw 26 0 1 941 0 4
98 0 10 1083 4 5
*3 sessions; +5 sessions
TABLE A(ii): b) 6-OHDA lesions, no pretraining
Left lever: Right lever:
left right other left right other
paw paw presses paw paw presses
71 0 0 443 1 2
115 0 2 344 0 3
40 2 1 526 0 0
34 3 6 829 1 4
35 2 5 559 1 1
37 0 0 504 0 0
7 2 0 907 0 0
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TABLE A(iii): 1 or 2 weeks after an injection of NMA into the
striatum contralateral to the initially preferred paw
Left lever: Right lever:
left right other left right other
paw paw presses paw paw presses
3 657 5 4 4 1
552 4 5 0 8 0
586 12 3 61 1 0
21 672 6 16 50 3
413 38 28 150 0 3
900 8 9 5 0 0
1 928 5 32 34 13
1 2 0 15 894 16
1 11 1 20 808 4
1 881 21 1 20 6
TABLE A(iv): During1 local anaesthesia of initially preferred paw.
All numbers here are for 3 sessions
Left lever: Right lever:
left right other left right other
paw paw presses paw paw presses
1 5 3 8 579 8
472 2 0 75 0 1
606 0 1 22 0 1
18 87 20 5 72 621
567 0 0 159 0 0
2 0 0 531 9 11
1 481 8 0 28 5
0 5 664 0 5 17
1 2 1 21 522 5
4 663 43 0 11 3
16 565 84 0 1 1
0 3 23 14 37 481
0 8 2 ni 549 13
8 784 3 2 22 0
11%
TABLE A(v): 8 weeks after local anaesthesia of initially preferred
paw (no residual effect). Here the totals are for
5 sessions except * which is 4 sessions.
Left lever: Right lever:
left right other left right other
paw paw presses paw paw presses
93 10 9 1119 181 23
197 1140 0 2 5 8
1020 40 120 0 6 26
9 14 2 256 951 9
1240 97 18 7 24 3
1240 4 1 1 1 0
0 8 0 0 1300 0
15 3 1 956 366 118
646 623 15 9 29 0
* 4 sessions
3/3
TABLE B: Pressing behaviour before and after an injection of 6-OHDA into the MFB contralateral to the initially preferred paw.
Pre-operation Operation + 1 week Operation + 4 weeks Operation + 8 weeks
Session: 1 2 3 4 1 2 3 1 2 3 1 2 3 4 5
Total presses
Rat 1 135 193 179 199 89 102 123 191 208 227 222 255 263 265 214
2 117 157 206 182 75 114 116 179 198 206 213 220 226 241 239
3 168 220 218 245 76 51 118 194 193 166 234 218 238 238 211
4 169 181 210 210 72 87 115 194 196 203 237 248 235 235 230
5 150 169 173 207 64 63 58 161 168 180 171 215 185 207 202
6 188 188 187 212 87 82 100 168 184 182 203 255 248 259 232
mean 154.5 184. 7 195.5 209.2 76.2 83.2 105.0 181.2 191. 2 194.,0 213.3 235. 2 232.5 238.,3 221
s .e. 10.5 8. 9 7.5 8.4 3.4 9.6 1.8 5.8 5. 6 9..0 9.9 7. 9 10,8 8.,7 5
Preferred presses
Rat 1 125 156 176 190 18 7 4 5 1 0 3 2 1 0 0
2 98 150 205 176 25 5 0 0 0 0 0 0 0 0 0
3 159 187 214 242 13 1 11 18 12 2 2 2 3 2 3
4 169 179 209 209 56 20 15 9 2 0 0 0 0 0 0
5 87 161 171 207 9 5 6 1 9 1 0 0 0 0 0
6 150 148 151 181 20 38 4 7 0 1 2 1 1 0 4
mean 131.3 163. 5 187.7 200.8 23. 5 12. 7 6. 7 6. 7 3. 2 0.7 1.,2 0.8 0. 8 0. 3 1.2
s .e. 13.7 6. 5 10.3 9.9 6. 9 5. 7 2. 2 2. 7 1. 9 0.3 0.,5 0.4 0. 5 0. 3 0.7
Other presses
Rat 1 10 47 3 9 71 95 119 186 207 227 219 253 262 265 214
2 19 7 1 6 50 109 116 179 198 206 213 220 226 241 239
3 9 33 4 3 63 50 107 176 182 164 232 216 235 236 208
4 0 2 1 1 16 67 100 185 194 203 237 248 235 235 230
5 53 8 2 0 55 58 52 160 164 179 171 215 185 207 202
6 38 40 36 31 61 44 96 161 184 181 201 254 247 259 228
mean 21.5 22. 8 7.8 8.3 52. 7 70. 5 98. 3 174. 5 188. 0 193.3 212. 2 234.3 231. 7 240. 5 220.2
s .e. 8.2 7. 9 5.7 4.7 7. 9 10. 6 9. 9 4. 7 6. 2 9.3 9. 8 7.8 10. 6 8. 4 5.9
3 l/f
TABLE C: Pressing behaviour before and after a break of 1 week









Rat 1 103 189 215 259 242 246 253 297
2 194 189 310 285 291 282 297 327
3 123 165 230 217 224 228 254 162
4 190 258 358 264 313 269 216 242
5 155 148 257 196 173 276 251 233
6 163 209 196 173 241 291 235 244
7 195 200 270 227 249 287 275 241
8 229 240 155 232 262 329 271 294
9 146 193 230 216 265 279 198 174
10 144 239 251 274 290 295 253 214
11 129 192 179 223 265 216 220 206
12 113 159 184 184 224 169 215 209
mean 157.00 198. 42 236. 25 229. 17 253. 25 272.,25 244. 80 236
s .e. 11.08 9. 73 16. 70 10. 26 10. 71 8. 00CO00 35 14
Preferred presses
Rat 1 102 177 213 241 222 218 237 280
2 86 107 135 91 179 276 292 233
3 53 107 187 196 196 205 237 156
4 34 113 312 254 209 257 210 231
5 12 20 102 98 112 217 182 213
6 161 209 158 243 217 291 235 244
7 181 181 126 128 204 253 197 187
8 226 219 128 206 253 300 255 294
9 145 193 229 216 265 279 198 174
10 128 224 245 274 285 295 253 214
11 .127 192 177 223 264 203 220 206
12 60 138 113 145 135 98 111 46
mean 109. 58 156. 67 177. 08 184. 58 219. 42 241. 00 218. 92 200




Initially + 1 week
Session: 1 2 3 4 1 23 4
Other presses
Rat 1 1 12 2 18 20 28 16 17
2 108 82 175 194 120 6 5 4
3 71 58 43 21 28 23 17 6
4 156 145 49 20 28 12 6 11
5 143 154 155 98 61 59 69 20
6 2 0 38 30 24 0 0 0
7 14 19 94 99 45 34 78 57
8 4 21 27 26 9 29 16 0
9 1 0 1 0 0 0 0 0
11 16 15 7 0 5 0 0 0
12 2 0 2 0 1 13 0 0
13 53 21 71 39 89 71 104 163
mean 47. 58 43. 92 55. 33 45. 42 35. 83 22. 92 25. 92 14













































Pressing behaviour before, during and after injection of local anaesthesia into the initially preferred paw
Local anaesthesia 8 weeks after local anaesthesia
1 2 3 4 1 2 3 4 1 2 3 4 5
119 132 132 152 207 193 204 181
82 192 161 136 170 210 176 197
41 144 161 182 187 204 237 248
156 232 178 223 201 249 249 334
157 192 152 197 215 271 240 286
153 199 186 164 101 177 195 - 258 284 278 297 324
140 149 206 211 138 188 197 - 281 293 291 261 227
117 185 202 204 206 248 258 - 245 270 316 294 332
152 182 204 215 224 191 137 - 162 234 258 285 299
225 230 231 268 248 245 231 - 301 310 293 278 273
218 210 178 226 228 231 217 - 221 275 225 252 277
168 126 169 229 180 213 174 - 232 281 250 246 300
170 166 190 254 173 204 201 - 225 280 274 279 294
179 184 118 240 270 293 274 - 315 281 258 313 290
148.4 173.1 176.3 207.2 209.1 222.6 212.1 248.9 278.7 271.4 278.3 290
13.0 12.8 8.1 10.2 10.5 9.2 9.6 15.5 6.8 9.0 7.3 10
106 126 82 116 2 4 5 6
52 181 144 127 0 2 0 0
32 136 158 182 0 0 0 0
111 180 175 221 23 0 0 0
147 173 122 176 0 0 0 0
46 123 140 148 9 0 0 - 3 25 86 25 52
94 115 151 210 0 0 1 - 2 0 21 65 111
106 172 200 205 0 0 0 - 0 90 308 291 328
144 181 203 213 20 2 0 - 38 121 65 34 7
190 208 225 254 4 0 0 - 221 290 281 262 259
218 209 179 226 2 10 2 - 220 272 223 252 277
166 126 169 229 8 12 18 - 231 281 250 246 300
145 139 182 242 7 0 0 - 170 202 228 231 240
119 111 85 165 10 0 0 - 132 105 199 161 157
118.3 155.2 158.2 193.7 6.1 2.1 1.9 113..0 154. 0 184.5 174. 1 192
17.6 9.1 11.2 11.4 2.0 1.1 1.3 34..0 37.,0 34.0 35.3 38
13 6 51 36 205 186 199 175
12 17 3 9 170 208 176 197
9 8 3 0 187 204 257 248
45 52 3 2 178 249 249 334
10 19 30 21 275 276 240 286
107 76 46 16 172 177 195 - 255 259 192 272 272
46 34 55 1 138 188 196 - 279 293 270 196 116
11 13 2 1 206 248 238 - 245 180 8 2 4
8 1 1 2 204 189 137 - 124 113 193 251 292
35 22 6 14 224 245 231 - 80 20 12 16 14
0 1 1 0 226 221 215 - 1 3 2 0 0
0 0 0 0 172 201 156 - 1 0 0 0 0
25 27 8 12 166 204 205 - 55 78 48 48 54
60 73 33 75 260 293 274 - 183 176 59 152 133
27.2 24.9 17.,3 13.5 194.5 220.3 212.0 135. 9 124.7 87.1 104.1 98
7.9 6.8 5.,6 5.5 8.4 9.4 10.5 36. 3 36.5 34.3 37.9 38
2,1?
TABLE E: Pressing behaviour before and after injection of KA into the
striatum contralateral to the initially preferred paw
Session: 1 2 3 4 1 2 3 4 5
Total presses
Rat 1 185 162 128 157 199 151 125 147 251
153 171 183 214 147 182 179 200 227
202 219 204 229 173 214 212 198 164
166 180 197 226 118 143 131 118 139
149 146 135 172 150 167 153 167 237
mean 171.0 175.0 169.4 199.6 157.4 171.4 160.0 166.0 203.6
s.e. 9.97 12.22 15.59 14.74 13.58 12.59 16.09 15.57 21.97
Preferred presses
Rat 1 173 139 105 115 128 100 58 30 97
2 153 167 182 213 94 26 5 1 0
3 122 135 145 155 44 41 30 23 3
4 134 135 154 163 59 73 43 30 60
5 129 139 122 169 11 0 3 0 2
mean 142.2 143.0 141.6 163.0 67.2 48.0 27.4 16.8 32.0
s.e. 9.26 6.07 13.27 15.66 20.22 17.56 11.06 6.78 19.87
Other presses
Rat 1 12 23 23 42 71 51 67 116 152
2 0 4 1 1 53 156 187 199 227
3 80 84 59 74 139 173 182 174 101
4 34 45 43 63 59 70 88 88 79
5 20 7 13 0 139 166 151 167 235
mean 29.2 32.6 27.8 36.0 92.2 123.2 135.4 148.8 168.8
s .e. 13.85 14.77 10.40 15.38 19.32 25.91 24.56 20.30 23.49
31 %
TABLE F: Pressing behaviour before and after injection of NMA into




Rat 1 147 205 207 203 198 216 212 219
2 150 217 239 229 210 236 223 261
3 114 157 156 197 133 211 207 208
4 109 187 184 163 145 155 171 159
5 171 163 173 194 286 242 240 217
6 138 187 195 168 170 149 153 183
7 127 152 183 195 110 127 154 167
8 82 145 156 180 179 152 178 162
9 116 165 186 177 230 229 242 257
10 196 219 224 223 254 256 259 257
mean 135. 0 179.7 190.3 192. 9 191.5 197.3 203.9 207. 0
s .e. 10. 4 8.6 8.5 6. 9 17.5 14.8 12.0 12. 0
Preferred presses
Rat 1 134 205 207 201 16 3 2 1
2 145 213 239 229 1 1 0 0
3 92 148 155 192 24 1 2 10
4 107 182 184 163 37 0 1 0
5 141 148 135 189 6 2 0 0
6 133 172 179 165 1 1 7 4
7 57 97 99 140 4 0 0 0
8 55 109 142 160 6 0 1 0
9 96 129 168 168 10 4 2 0
10 172 202 221 223 29 4 0 0
mean 113.2 160. 2 156. 3 183.0 14.2 1.6 1.5 1.5
s .e. 12.2 12. 9 20. 4 9.1 4.1 mo 0.7 1.0
Other presses
1 13 0 0 2 182 213 210 218
2 5 4 0 0 209 235 223 261
3 22 9 1 5 109 210 205 198
4 2 1 0 0 108 155 170 159
5 30 15 28 5 280 240 240 217
6 5 15 16 3 169 148 146 179
7 70 55 84 55 106 127 154 167
8 27 35 14 20 173 152 178 162
9 10 6 6 3 196 224 239 237
10 15 8 2 0 210 250 259 257
mean 18.9 14.8 15.1 9.3 174.2 195.,4 202.4 205.5
s .e. 6.5 5.5 8.2 5.4 17.5 14.,3 12.3 12.2
31?
TABLE F: Pressing behaviour before and after injection of NMA into
the striatum contralateral to the initially preferred paw
(ii) Gradual swappers
Session: 1 r»L 3 4 1 2 3 4
Total presses
Rat 1 125 141 154 139 193 186 182 203
2 93 49 38 36 123 135 165 173
3 145 155 166 178 178 194 188 232
4 161 176 223 206 207 171 201 167
5 150 179 200 195 167 195 186 189
mean 134.8 140.0 156.2 150.8 173.6 176.2 184.4 192.8
s .e. 12.0 23.8 32.0 30.9 14.3 11.2 5.8 11.6
Preferred presses
Rat 1 115 136 153 135 178 161 108 50
2 80 42 36 35 90 28 4 3
3 123 142 162 167 159 111 68 54
4 157 175 219 206 191 137 99 7
5 95 148 169 157 108 7 33 15
mean 114.0 128.0 147.8 140.0 145.2 88.8 62.4 25.8
s .e. 13.1 22.7 30.2 28.7 19.7 30.3 19.7 10.9
Other presses
1 10 5 1 4 15 25 74 153
2 7 7 2 1 33 107 161 170
3 22 13 4 11 19 83 120 178
4 4 0 3 0 12 25 99 158
5 36 21 23 35 57 184 139 174
mean 9.6 9.2 6.6 10.2 26.0 84.8 118.6 166.6
s.e. 3.3 3.6 4.1 6.5 7.2 29.6 15.2 4.8
3 %o
TABLE G: Pressing behaviour before and after electrolytic lesions
of the striato-nigral pathway in the crus cerebri contra¬
lateral to the initially preferred paw
Session: 1 2 3 1 2 3
Total presses
Rat 1 97 106 54 138 149 132
2 90 136 132 169 112 120
3 50 127 106 146 151 157
4 63 80 74 85 96 112
5 47 61 91 97 122 124
mean 69.4 102.0 91.4 127.0 126.0 129.0
s .e. 10.2 14.0 h-4 CO CO 15.6 10.6 7.7
Preferred presses
Rat 1 67 76 34 7 7 2
2 50 90 123 9 28 41
3 21 36 50 15 25 18
4 53 76 68 4 5 5
5 23 55 82 32 36 35
mean 42.8 66.6 71.4 13.4 20.2 20.2
s .e. 9.0 9.5 15.2 5.0 6.1 7.8
Other presses
Rat 1 30 30 20 131 142 130
2 40 46 9 160 84 79
3 29 91 56 131 126 129
4 10 4 6 81 91 107
5 24 6 9 65 86 89
mean 26.6 35.4 20.0 113.6 105.8 106.8
s .e. 4.9 15.9 9.3 17.6 11.8 10.3
TABLE H: Pressing behaviour before, during and after training the rats to press with the other paw
Initially During retraining 8 weeks after retraining
Session: 1 2 3 4 1 2 3 4 5 1 2 3 4
Total presses
Rat 1 135 200 232 232 172 192 226 231 219
2 102 190 296 250 241 319 267 244 186
3 186 192 275 241 239 209 280 284 214
4 226 229 254 222 123 229 236 217 232
5 146 172 149 261 241 220 240 217 228
6 122 216 251 235 250 230 256 270 275
7 242 286 256 297 86 158 210 223 146 168 249 200 225
8 291 282 297 327 296 297 228 268 236 173 247 235 252
9 224 228 254 160 150 153 188 174 161 269 218 229 207
10 313 269 216 242 218 206 233 229 241 220 301 249 272
11 173 276 251 233 291 239 255 257 230 195 253 228 242
12 148 161 161 172 214 128 184 224 205 208 239 330 247
13 130 164 194 185 286 249 223 206 203 241 275 260 276
mean 187. 50 217. 31 237. 38 235. 15 215. 92 217. 62 232. 77 232. 62 213.54 210. 60 254. 60 247.30 245
s .e. 18. 50 11. 64 12. 83 12. 80 18. 21 14. 97 7. 83 8. 61 9.52 13. 70 10. 10 15.50 9
Preferred presses
Rat 1 81 70 190 185 118 36 27 18 1
2 80 181 253 221 193 151 37 6 4
3 148 106 115 70 98 12 8 11 (3)
4 171 204 235 221 64 68 14 2 0
5 132 168 143 261 *88 58 2 1 1
6 97 213 251 235 151 27 80 6 4
7 222 218 257 280 79 150 118 52 11 65 139 41 60
8 171 276 292 323 161 123 44 34 15 12 8 49 147
9 196 205 237 156 22 15 8 14 3 11 52 133 122
10 289 257 210 231 51 11 2 9 3 5 1 28 160
11 112 217 182 213 124 19 4 1 3 85 196 199 217
12 148 161 161 172 190 63 58 41 40 110 221 301 241
13 90 90 103 122 167 68 23 2 0 0 1 3 161
mean 149..00 182. 00 200.,69 206.,92 115. 85 61. 62 32. 69 15.,15 6.77 41. 10 88..30 107.90 151
s .e. 17. 05 17. 24 15..96 18. 57 15. 01 13. 99 9. 71 4.,64 3.02 16. 90 33.,30 41.20 23
Other presses
Rat 1 54 130 42 47 54 166 199 213 218
2 22 9 43 29 48 168 230 240 240
3 68 86 160 171 141 197 272 273 (211)
4 55 12 19 1 59 161 222 215 232
5 12 4 6 0 153 162 238 216 227
6 25 3 0 0 99 203 176 143 266
(276)
7 20 28 16 17 7 8 92 171 135 103 110 158 165
8 120 6 5 4 135 174 184 234 221 161 239 186 105
9 28 23 17 6 128 138 186 160 185 258 166 96 75
10 24 12 6 12 167 195 231 220 238 215 300 221 112
11 61 59 69 20 157 220 251 256 227 106 51 29 25
12 0 0 0 0 24 65 146 162 165 89 15 29 5
13 40 74 91 63 119 181 200 204 203 241 274 257 114
mean 33..00 34. 31 36.,46 28. 46 99.,30 153. 77 201.,62 208,,23 212.92 167.,60 165,.00 139.40 85
s .e. 5.74 11.24: 12.90 1.13 15.09 16.26 13.24 10.90 9.87 26.70 42.00 34.20 21.00
M
TABLE I: Pressing behaviour before and after an injection of KA in
the striatum ipsilateral to the initially preferred paw
Session: 1 2 3 4 1 2 3 4 5
Total presses
Rat 1 96 146 133 144 258 148 165 172 223
2 139 144 134 155 136 150 150 139 172
3 155 161 176 229 28 90 119 115 129
4 146 277 175 212 97 104 100 107 107
5 151 138 129 163 150 150 123 139 235
mean 137.4 173.2 149.4 100.6 132.2 128.4 129.9 134.4 173.2
s.e. 10.69 26.22 10.69 16.80 36.26 13.02 11.64 11.36 25.14
Preferred presses
Rat 1 96 142 130 140 257 147 164 172 221
2 130 136 118 126 113 124 142 133 170
3 134 144 168 225 28 90 119 109 127
4 118 185 158 179 86 102 89 96 98
5 147 121 114 154 139 145 118 137 230
mean 125.0 145.6 137.6 164.8 124.6 121.6 126.4 129.4 169.2
s.e. 8.60 10.64 10.81 17.41 37.87 11.36 12.61 13.07 25.72
Other presses







3 4 1 1 1 0 2
16 29 23 26 8 6 2
8 4 0 0 0 6 2
17 33 11 0 11 11 7
15 9 11 5 5 2 5
11.8 15.8 9.2 6.4 5.0 5.0 3
2.71 6.30 4.12 4.98 2.07 1.90 l.i
3^3
TABLE J: Pressing behaviour before and after an electrolytic
lesion in the striato-nigral pathway in the crus cerebri
ipsilateral to the initially preferred paw
Session: 1 2 3 4 1 2 3 4
Total presses
Rat 1 159 118 180 143 136 143 137 162
2 154 166 171 187 174 161 161 180
mean 156.5 142.0 175.5 165.0 155.0 152.0 149.0 171.0
s .e. 2.5 24.0 4.5 22.0 19.0 9.0 12.0 9.0
Preferred presses
Rat 1 72 89 118 118 132 142 157 162
2 154 166 171 187 174 161 161 180
mean 113.0 127.5 144.5 152.5 153.0 151.5 149.0 171.0
s .e. 41.0 38.5 26.5 34.5 21.0 9.5 12.0 9.0
Other presses
Rat 1 87 29 62 25 4 1 0 0
2 0 0 0 0 0 0 0 0
mean 43.5 14.5 31.0 12.5 2 0.5 0 0
s .e. 43.5 14.5 31.0 12.5 2 0.5 0 0
"bVt
APPENDIX B : Examples of post-stimulus histograms resulting
from striatal stimulation in control and lesioned
animals
The PSTHs on the following pages are all 1 s long and the verticle
scale bar is for 10 spikes in each case. They are grouped together,
as far as possible into similar groups, and give a reflection of the
variation in the whole population of cells. The differing thickness of
lines underneath the graphs indicates how the pattern of response
varies with stimulus strength. The top line is the highest strength
(illustrated). A blank indicates an inhibition of firing, a thin line
normal firing and a thick line an increase in firing rate. The arrow
indicates the point of stimulation in each case and the asterisk marks
the antidromic threshold. Artifacts and spikes due to the antidromic
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